tremend
advanc
made
medic
care
newborn
foal
past
year
thank
pioneer
effort
mani
individu
research
group
increas
sophist
veterinari
medicin
whole
although
field
human
neonatolog
provid
critic
import
guidanc
regard
physiolog
pathophysiolog
neonat
foal
continu
fundament
insight
achiev
uniqu
characterist
special
popul
foundat
equin
neonatolog
built
earliest
descript
specif
condit
foal
clinician
research
septicemia
joint
ill
hemolyt
icteru
well
dummi
foal
syndrom
respiratori
distress
syndrom
rd
associ
primari
surfact
defici
signific
stride
also
made
understand
physiolog
equin
fetu
neonat
larg
part
effort
group
research
work
uk
knowledg
base
grew
dramat
increas
interest
provid
improv
care
equin
neonat
larg
part
substanti
invest
time
energi
equiti
involv
lengthi
process
concept
gestat
parturit
juvenil
develop
owner
interest
optim
foal
surviv
interest
along
increas
capabl
provid
effect
critic
care
foal
led
develop
neonat
intens
care
unit
icu
worldwid
sinc
time
steadi
increas
understand
abil
success
treat
manag
critic
ill
foal
result
dramat
improv
likelihood
surviv
also
abil
surviv
foal
matur
sound
healthi
individu
abl
perform
intend
function
knowledg
base
equin
neonatolog
continu
grow
goal
chapter
provid
overview
current
knowledg
field
well
provid
insight
deriv
human
medicin
fetal
assess
monitor
effort
owner
manag
veterinarian
maxim
equin
reproduct
success
extend
far
beyond
success
concept
close
attent
must
paid
varieti
influenc
pregnanc
influenc
includ
numer
matern
placent
fetal
risk
factor
assess
variabl
monitor
chang
cours
pregnanc
may
possibl
implement
medic
therapi
minim
risk
least
ensur
manag
strategi
place
reduc
risk
problem
deliveri
regard
matern
risk
factor
one
must
begin
detail
assess
mare
reproduct
histori
includ
endometri
health
breed
problem
concept
vaccin
histori
possibl
twin
previou
gestat
length
number
previou
foal
number
success
deliveri
histori
type
dystocia
occurr
problem
previou
foal
birth
neonat
isoerythrolysi
addit
number
matern
factor
pregnanc
assess
includ
matern
underor
overnutrit
matern
ill
especi
colic
sever
stressor
endocrin
metabol
matern
abnorm
physic
abnorm
abdomin
wall
muscular
tear
prepub
tendon
ruptur
repres
seriou
risk
dam
fetu
uterin
torsion
repres
lifethreaten
situat
mare
fetu
correct
success
fetu
must
regard
high
risk
durat
pregnanc
although
difficult
appreci
placent
risk
factor
critic
issu
given
complet
depend
fetu
dam
energi
oxygen
suppli
condit
endometriosi
twin
reduc
avail
surfac
area
placent
attach
result
impair
transfer
nutrient
wast
product
fetu
dam
potenti
caus
intrauterin
growth
retard
iugr
placent
dysfunct
result
abnorm
placent
detach
placent
placent
edema
hydrop
vascular
inflamm
injuri
exposur
mare
possibl
infecti
caus
abort
matern
ingest
endophyteinfest
fescu
also
repres
seriou
risk
factor
fetu
although
often
outward
sign
placent
abnorm
develop
excess
abdomin
distent
vulvar
discharg
prematur
udder
develop
may
suggest
presenc
number
fetal
factor
complic
pregnanc
well
includ
fetal
malform
congenit
development
fetal
malposit
twin
exposur
infecti
agent
neonat
isoerythrolysi
potenti
risk
factor
identifi
pregnanc
character
high
risk
requir
assess
c
ha
p
e
r
harold
c
mckenzi
iii
mare
placenta
fetu
evalu
mare
includ
thorough
physic
examin
pay
particular
attent
extern
genitalia
udder
abdomen
evalu
sign
excess
enlarg
ventral
edema
pendul
appear
evid
system
ill
fever
tachycardia
tachypnea
abnorm
mucou
membran
etc
serv
indic
addit
diagnost
evalu
ascertain
focu
sever
inflamm
complet
blood
count
serum
chemistri
profil
may
help
regard
evalu
reproduct
tract
includ
rectal
examin
feasibl
well
vagin
examin
transrect
transabdomin
ultrasound
examin
allow
detect
abnorm
cervic
discharg
uterin
torsion
hydrop
prepub
tendon
ruptur
ultrasound
examin
provid
opportun
thoroughli
evalu
placenta
assess
placent
attach
placent
thick
echogen
fetal
fluid
transabdomin
approach
allow
prolong
period
examin
allow
thorough
assess
uteru
placenta
fetu
month
gestat
transabdomin
transrect
ultrasonograph
examin
perform
ensur
thorough
assess
month
gestat
transrect
ultrasonographi
also
use
regularli
monitor
variabl
fetal
heart
rate
eye
diamet
fetal
activ
although
transrect
ultrasound
examin
allow
visual
fetal
structur
use
late
gestat
caudal
uterin
bodi
common
site
ascend
placent
develop
measur
combin
thick
uteru
placenta
ctup
use
indic
placent
abnorm
assess
perform
area
placenta
contact
fetu
although
ctup
measur
transabdomin
approach
challeng
variat
locat
measur
well
potenti
fetal
contact
compress
placenta
prefer
measur
ctup
transrect
site
near
cervicoplacent
junction
branch
uterin
visual
uteru
bladder
use
averag
sever
measur
normal
measur
ctup
report
cm
month
gestat
less
cm
month
less
cm
month
cm
end
gestat
import
rememb
even
though
increas
ctup
may
suggest
placent
abnorm
repres
definit
find
report
increas
ctup
measur
associ
placent
patholog
convers
ascend
placent
alway
associ
increas
ctup
although
may
also
breed
pariti
influenc
ctup
measur
upper
limit
repres
reason
cutoff
light
hors
warmblood
breed
placent
detach
may
associ
accumul
exud
placent
uterin
surfac
typic
hyperecho
ultrasonograph
appear
addit
ctup
number
ultrasonograph
paramet
use
assess
monitor
highrisk
fetu
fetal
viabil
assess
use
fetal
heart
rate
rhythm
well
fetal
activ
pattern
fetal
respons
stimul
fetal
heart
rate
chang
throughout
gestat
trend
high
beat
per
minut
day
gestat
beat
per
minut
day
gestat
transient
alter
fetal
heart
rate
may
observ
like
indic
fetal
distress
unless
persist
persist
tachycardia
bradycardia
may
indic
impend
fetal
death
fetal
heart
rate
increas
period
fetal
activ
return
normal
rang
thereaft
fetal
electrocardiographi
use
monitor
fetal
heart
rate
rhythm
well
wide
use
sever
decad
ago
fallen
favor
readi
avail
eas
use
diagnost
yield
associ
ultrasonograph
fetal
assess
recent
report
describ
use
telemetr
electrocardiographi
equip
monitor
fetal
heart
rate
fetal
heart
rate
variabl
tool
may
hold
promis
fetal
assess
futur
biophys
profil
base
ultrasonograph
fetal
assess
develop
use
late
gestat
includ
fetal
heart
rate
fetal
activ
fetal
aortic
diamet
ctup
uteroplacent
contact
maxim
allanto
fluid
depth
determin
made
pregnanc
high
risk
particularli
uteroplacent
fetal
abnorm
indic
risk
presenc
fetal
compromis
next
challeng
interven
appropri
late
matur
equin
fetu
last
week
gestat
combin
difficulti
determin
fetal
readi
birth
rare
advis
induc
deliveri
far
better
situat
attempt
support
fetu
utero
best
possibl
await
natur
deliveri
complic
threaten
surviv
dam
cesarean
section
induct
parturit
may
indic
although
surviv
foal
consid
highli
unlik
situat
intervent
may
indic
fetu
thought
near
term
mare
suffer
condit
sever
colic
endang
fetal
surviv
although
prognosi
foal
surviv
remain
poor
medic
manag
highrisk
pregnanc
two
goal
first
treatment
primari
condit
possibl
second
treatment
intend
support
fetu
utero
maintain
pregnanc
primari
condit
commonli
encount
mare
placent
specif
treatment
consist
antimicrobi
therapi
antiinflammatori
therapi
antimicrobi
therapi
although
typic
empir
natur
ideal
reli
drug
capabl
reach
therapeut
concentr
within
uteru
trimethoprimsulfamethoxazol
penicillin
gentamicin
shown
reach
appropri
level
within
allanto
fluid
trimethoprimsulfamethoxazol
commonli
use
eas
oral
administr
low
cost
ceftiofur
crystallinefre
acid
ccfa
although
appeal
perspect
eas
administr
expens
achiev
therapeut
concentr
within
placenta
fetal
fluid
effect
experiment
model
bacteri
placent
antiinflammatori
therapi
case
consist
flunixin
meglumin
pentoxifyllin
although
agent
aspirin
corticosteroid
investig
although
efficaci
antiinflammatori
therapi
placent
uncertain
commonli
use
flunixin
meglumin
common
agent
use
potent
nonsteroid
antiinflammatori
drug
nsaid
clear
reach
therapeut
concentr
within
placenta
uteru
antiinflammatori
drug
interest
although
one
studi
find
benefit
addit
antiinflammatori
dexamethason
aspirin
trimethoprimsulfamethoxazol
therapi
experiment
induc
bacteri
placent
addit
potenti
antiinflammatori
effect
corticosteroid
use
interest
widespread
use
treatment
acceler
fetal
matur
human
patient
administr
corticosteroid
mare
late
gestat
shown
acceler
fetal
matur
one
experiment
studi
report
regard
use
therapeut
approach
clinic
practic
treatment
may
benefici
support
gestat
includ
exogen
progestagen
tocolyt
agent
promot
oxygen
deliveri
fetu
progestagen
supplement
may
multitud
effect
includ
antiprostaglandin
effect
primarili
thought
function
tocolyt
typic
accomplish
use
altrenogest
synthet
progestin
although
inject
progesteron
sometim
use
although
use
agent
somewhat
controversi
altrenogest
therapi
shown
indic
efficaci
reduc
fetal
loss
bacteri
placent
clenbuterol
sympathomimet
drug
shown
induc
uterin
relax
late
gestat
shortact
hour
durat
effect
reason
clenbuterol
use
acut
situat
manag
dystocia
prepar
cesarean
section
assist
deliveri
treatment
may
improv
fetal
oxygen
deliveri
utero
assist
deliveri
includ
pentoxifyllin
intranas
oxygen
administr
mare
addit
antiinflammatori
effect
pentoxifyllin
rheolog
effect
may
enhanc
oxygen
deliveri
placenta
improv
microcircul
intranas
oxygen
administr
lmin
pregnant
mare
increas
partial
pressur
oxygen
oxygen
satur
arteri
blood
suppli
placenta
may
improv
oxygen
deliveri
fetu
vitamin
e
use
manag
highrisk
pregnanc
antioxid
administ
oral
pregnant
mare
time
combin
trimethoprimsulfamethoxazol
flunixin
meglumin
pentoxifyllin
remain
commonli
use
treatment
protocol
medic
manag
bacteri
placent
mare
gener
manag
mare
highrisk
pregnanc
critic
wellform
plan
develop
deal
parturit
also
highrisk
foal
deliveri
surviv
ideal
mare
hous
facil
abl
provid
monitor
team
avail
deal
eventu
appropri
time
manner
necessari
equip
need
organ
readili
avail
thorough
discuss
owner
agent
need
occur
crise
involv
know
prioriti
regard
procedur
author
whether
mare
life
foal
life
focu
team
effort
assess
equin
neonat
import
rememb
first
minut
hour
birth
profound
adapt
period
normal
paramet
use
assess
continu
chang
time
foal
bodi
system
transit
protect
intrauterin
environ
mani
function
primarili
perform
mare
via
placenta
extern
environ
system
assum
full
respons
maintain
homeostasi
time
requir
transit
vari
bodi
system
adapt
requir
cardiopulmonari
system
time
critic
birth
lung
must
expand
clear
fluid
ga
exchang
occur
process
must
coordin
shift
blood
flow
pulmonari
circul
element
transit
occur
within
minut
foal
abl
surviv
extern
environ
adapt
requir
nervou
musculoskelet
endocrin
alimentari
thermoregulatori
system
similarli
critic
occur
longer
period
time
follow
birth
number
endocrin
chang
occur
periparturi
period
chang
critic
readi
number
bodi
system
lung
gastrointestin
tract
kidney
liver
function
respons
follow
birth
critic
appear
activ
hypothalamicpituitaryadren
hpa
axi
process
begin
period
start
approxim
day
birth
fetal
cortisol
concentr
rapidli
begin
rise
increas
prepar
bodi
mani
process
may
littl
role
utero
critic
surviv
birth
respir
renal
sodium
conserv
glucos
metabol
serum
cortisol
concentr
continu
rise
first
hour
birth
decreas
normal
basal
valu
approxim
day
age
healthi
foal
prematur
foal
day
gestat
low
cortisol
concentr
birth
increas
appropri
first
hour
life
addit
chang
hpa
axi
also
increas
circul
catecholamin
insulin
glucagon
well
thyroid
hormon
associ
immedi
postpartum
period
neurolog
system
equin
fetu
fulli
develop
function
precoci
natur
foal
birth
requir
immedi
abil
ambul
function
independ
fetu
maintain
sleep
state
utero
combin
inhibitori
factor
includ
physic
factor
warmth
cushion
tactil
stimul
buoyanc
well
chemic
factor
includ
high
circul
andor
cerebr
concentr
adenosin
prostaglandin
pregnan
neurosteroid
allopregnanolon
pregnanolon
inhibitori
neurosteroid
synthes
progesteron
primarili
within
placenta
late
gestat
follow
deliveri
concentr
within
normal
neonat
declin
rapidli
usual
first
hour
life
loss
cerebr
inhibit
combin
potent
stimul
aris
transit
birth
canal
onset
breath
onset
multipl
extern
stimuli
light
cold
hard
surfac
unlimit
space
graviti
etc
lead
rapid
increas
activ
awar
neonat
foal
pass
birth
canal
chest
undergo
signific
compress
aid
shift
fluid
airway
lung
begin
inflat
action
surfact
contribut
clearanc
airway
fluid
mainten
alveolar
stabil
lung
inflat
birth
fetal
circul
function
bypass
pulmonari
circul
shunt
ductu
arteriosu
foramen
oval
foal
begin
breath
resist
pulmonari
vasculatur
dramat
decreas
allow
blood
pulmonari
arteri
enter
pulmonari
vasculatur
rather
pass
ductu
arteriosu
aorta
pressur
left
side
heart
increas
foramen
oval
close
prevent
shunt
blood
right
atrium
left
atrium
complet
closur
ductu
arteriosu
may
take
sever
day
unusu
hear
machineri
type
murmur
associ
patenc
ductu
arteriosu
foal
first
day
life
rare
foramen
oval
remain
patent
foal
foal
initi
respir
primarili
occur
respons
rapid
rise
carbon
dioxid
bloodstream
follow
loss
placent
ga
exchang
loss
placent
deriv
prostaglandin
suppress
breath
utero
like
contribut
well
along
initi
cold
tactil
stimuli
associ
extern
environ
spontan
breath
may
begin
soon
chest
clear
birth
canal
begin
within
minut
birth
first
breath
may
quit
exagger
natur
high
carbon
dioxid
level
degre
effort
requir
initi
lung
expans
follow
initi
breath
foal
continu
exhibit
elev
respiratori
rate
breath
per
minut
first
minut
life
respiratori
rate
decreas
around
breath
per
minut
remain
fairli
stabl
remaind
first
day
life
day
age
foal
exhibit
respiratori
rate
approxim
breath
per
minut
foal
show
much
exagger
respiratori
pattern
adult
hors
inspir
expir
requir
activ
respiratori
effort
foal
highli
compliant
thorac
wall
immedi
follow
birth
foal
typic
exhibit
bradycardia
heart
rate
beat
per
minut
heart
rate
rapidli
increas
peak
beat
per
minut
around
minut
birth
highest
heart
rate
often
observ
associ
foal
first
attempt
stand
heart
rate
gradual
decreas
rest
rate
beat
per
minut
hour
birth
follow
rate
beat
per
minut
hour
birth
day
age
normal
rest
heart
rate
rang
beat
per
minut
rel
late
matur
hpa
axi
fetal
foal
cardiovascular
system
birth
appear
fulli
develop
hors
compar
speci
result
neonat
foal
welldevelop
baroreceptor
respons
risk
hypotens
especi
prematur
mare
begin
interact
foal
shortli
parturit
use
vocal
tactil
stimuli
normal
foal
respons
stimul
shortli
birth
minut
age
foal
respond
visual
stimuli
appropri
ocular
head
movement
within
minut
foal
respond
auditori
stimuli
independ
orient
ear
direct
stimulu
risk
associ
prolong
recumb
foal
born
natur
environ
strong
imper
foal
abl
stand
quickli
becom
ambulatori
normal
foal
move
sternal
recumb
within
minut
birth
begin
make
effort
stand
within
minut
birth
abl
stand
unassist
within
minut
breed
differ
time
stand
poni
foal
stand
less
minut
larger
breed
foal
thoroughbr
typic
requir
minut
longer
first
stand
foal
exhibit
degre
incoordin
dysmetria
assum
brace
posit
limb
spread
later
forelimb
posit
forward
hindlimb
extend
posteriorli
stand
normal
foal
rapidli
gain
coordin
begin
circl
mare
attempt
burst
speed
within
hour
foal
display
flexor
tendon
laxiti
birth
primarili
note
form
drop
fetlock
foal
flexor
tendon
laxiti
demonstr
mild
moder
abnorm
typic
consist
rock
back
onto
heel
caudal
hoof
wall
lead
pastern
hyperextens
upward
flip
toe
affect
foal
usual
recov
rapidli
increas
strength
activ
first
day
life
rare
foal
may
demonstr
dramat
musculoskelet
abnorm
windswept
conform
either
front
hindlimb
affect
match
angular
limb
deform
one
limb
valgu
deform
wherea
opposit
limb
exhibit
match
varu
deform
unless
underli
boni
abnorm
foal
also
selfcorrect
time
activ
normal
foal
begin
display
suckl
behavior
shortli
birth
even
still
recumb
abl
nurs
unassist
within
hour
stand
foal
requir
hour
suckl
consid
abnorm
success
nurs
present
sever
challeng
newborn
foal
begin
absolut
requir
success
stand
ambul
access
udder
weak
foal
suffer
musculoskelet
neurolog
problem
great
difficulti
nurs
reason
abl
stand
success
foal
must
locat
udder
like
requir
combin
visual
olfactori
abil
part
foal
ingest
milk
fairli
complex
neurolog
process
begin
success
captur
teat
lip
follow
coordin
tongu
pharynx
larynx
epiglotti
esophagu
ensur
milk
enter
gastrointestin
tract
rather
respiratori
tract
addit
potenti
advers
impact
muscular
weak
neurolog
dysfunct
process
may
physic
abnorm
cleft
palat
subepiglott
cyst
may
interfer
normal
passag
milk
gastrointestin
tract
must
undergo
number
chang
accommod
use
ingest
colostrum
milk
first
hour
birth
small
intestin
remain
permeabl
macromolecul
importantli
immunoglobulin
allow
absorpt
ingest
antibodi
contain
colostrum
absorpt
occur
number
mechan
includ
pinocytosi
lymphat
transport
exocytosi
period
maxim
absorpt
first
hour
birth
approxim
ingest
immunoglobulin
abl
absorb
time
period
hour
birth
effici
absorpt
decreas
substanti
ingest
immunoglobulin
abl
absorb
rate
absorpt
advers
affect
prior
ingest
macromolecul
although
absorpt
may
possibl
hour
effici
absorpt
continu
decreas
absorpt
essenti
absent
hour
age
follow
loss
matern
deriv
glucos
suppli
via
placenta
foal
must
take
control
glucos
homeostasi
particularli
challeng
nutrient
intak
transit
continu
mode
dam
ensur
continu
regul
suppli
glucos
time
intermitt
energi
intak
base
milk
ingest
pancrea
must
assum
respons
mainten
normoglycemia
differenti
product
glucagon
insulin
dramat
alter
energi
metabol
may
alway
occur
smoothli
unfortun
foal
possess
limit
energi
reserv
form
glycogen
fat
result
hypoglycemia
occur
first
hour
life
even
normal
neonat
foal
sick
foal
risk
profound
hypoglycemia
depriv
energi
intak
even
hour
metabol
respons
foal
increas
product
glucagon
epinephrin
cortisol
suppress
insulin
product
increas
circul
blood
glucos
concentr
glycogenolysi
provid
readi
sourc
glucos
hepat
glycogen
store
minim
foal
gluconeogenesi
rapidli
becom
primari
rout
endogen
glucos
product
prematur
dysmatur
foal
often
impair
glucos
regul
suscept
patholog
hypoglycemia
absenc
appropri
dietari
parenter
supplement
birth
foal
transit
normal
steril
intrauterin
environ
environ
teem
nonpathogen
pathogen
organ
colon
variou
tissu
expos
outsid
environ
occur
rapidli
begin
birth
process
phenomenon
particularli
import
gastrointestin
tract
microbi
activ
critic
full
function
local
immun
system
digest
colon
occur
environment
exposur
like
facilit
coprophag
behavior
routin
exhibit
foal
colostr
immunoglobulin
oligosaccharid
may
play
role
regul
composit
gastrointestin
flora
affect
abil
certain
bacteria
attach
mucos
surfac
opson
certain
bacteria
facilit
mucos
immun
respons
organ
week
age
microbi
popul
becom
similar
composit
complex
foal
dam
indic
transit
adult
pattern
readi
dietari
transit
milkbas
diet
roughagebas
diet
thermoregul
challeng
neonat
foal
transit
uterin
environ
typic
much
colder
extern
environ
challeng
increas
presenc
initi
wet
hair
coat
enhanc
thermal
loss
environ
well
larg
surfac
area
bodi
mass
ratio
minim
store
fat
healthi
foal
high
rest
metabol
rate
compar
adult
immedi
neonat
period
metabol
rate
increas
two
three
time
basal
rate
associ
high
concentr
cortisol
high
metabol
rate
allow
substanti
endogen
heat
product
achiev
maintain
normothermia
metabol
heat
product
requir
substanti
input
energi
form
fat
carbohydr
deriv
colostrum
milk
reinforc
critic
need
earli
success
nurs
foal
anoth
import
mechan
foal
reli
heat
product
immedi
neonat
period
shiver
thermogenesi
appear
particularli
import
foal
appear
use
nonshiv
thermogenesi
minim
nonexist
store
brown
fat
foal
also
use
behavior
approach
thermoregul
rang
mainten
sternal
recumb
minim
heat
loss
vigor
activ
attempt
stand
ambulatori
gener
substanti
addit
heat
prematur
dysmatur
abnorm
gestat
associ
substanti
risk
affect
foal
primari
syndrom
risk
factor
number
syndrom
unfortun
abnorm
gestat
also
term
unreadi
birth
difficult
character
highli
variabl
durat
equin
gestat
human
gener
accept
definit
prematur
birth
day
full
term
concept
appli
hors
well
deliveri
day
gestat
consid
prematur
unfortun
gestat
durat
hors
much
less
consist
human
report
gestat
length
result
live
foal
rang
day
mean
day
thoroughbr
mare
day
mean
day
warmblood
mare
poni
breed
typic
similar
gestat
length
rang
day
although
anecdot
report
draft
mare
routin
gestat
length
day
durat
one
recent
report
suggest
median
durat
gestat
heavi
hors
day
longer
light
breed
addit
influenc
breed
number
variabl
impact
durat
gestat
includ
fetal
gender
fetal
weight
matern
age
pariti
environment
factor
month
concept
foal
matern
nutrit
climat
difficulti
defin
specif
time
point
would
indic
fetal
matur
equin
prematur
consid
much
physic
function
character
tempor
one
foal
size
physic
appear
import
characterist
relat
prematur
small
bodi
size
low
birth
weight
along
promin
round
forehead
silki
hair
coat
entropion
floppi
ear
common
find
prematur
foal
affect
foal
may
promin
reddish
discolor
tongu
mucou
membran
may
appear
somewhat
pale
flexor
periarticular
laxiti
also
common
although
prematur
foal
may
exhibit
carpal
fetlock
contractur
incomplet
ossif
cuboid
bone
carpu
tarsu
also
common
find
prematur
foal
area
risk
crush
injuri
affect
foal
stand
ambul
risk
minim
limit
amount
time
foal
allow
stand
minim
activ
level
function
perspect
prematur
foal
typic
exhibit
gener
weak
great
difficulti
stand
without
assist
affect
foal
often
impair
thermoregul
abnorm
glucos
metabol
well
impair
cardiovascular
pulmonari
gastrointestin
renal
function
impair
thermoregul
like
caus
inadequ
endocrin
respons
chang
uterin
environ
extern
environ
abnorm
glucos
regul
also
indic
endocrin
dysfunct
potenti
caus
impair
insulin
product
peripher
insulin
insensit
cardiovascular
dysfunct
often
present
persist
hypotens
poorli
respons
pressor
therapi
increas
vascular
permeabl
may
present
well
potenti
result
fluid
shift
vasculatur
interstitium
reason
fluid
inotrop
pressor
support
target
mainten
perfus
rather
target
blood
pressur
rang
failur
use
approach
put
patient
risk
fluid
overload
complic
respiratori
dysfunct
may
caus
surfact
defici
also
frequent
associ
decreas
respiratori
drive
weak
muscl
respir
highli
compliant
chest
wall
poorli
compliant
lung
gastrointestin
dysfunct
typic
caus
inadequ
motil
result
distent
colic
diarrhea
renal
dysfunct
may
manifest
primarili
decreas
urin
output
rather
azotemia
care
must
taken
avoid
fluid
overload
patient
clinicopatholog
assess
may
aid
character
foal
leukopenia
caus
neutropenia
combin
lymphocytosi
lead
neutrophil
lymphocyt
ratio
n
l
ratio
less
oppos
normal
ratio
greater
revers
n
l
ratio
commonli
use
defin
characterist
equin
prematur
directli
associ
impair
adrenocort
function
impair
adren
function
happen
matur
hpa
axi
normal
occur
last
sever
day
gestat
continu
first
week
perhap
even
month
birth
result
prematur
foal
exhibit
low
serum
cortisol
concentr
birth
combin
elev
serum
adrenocorticotrop
hormon
acth
concentr
inabl
prematur
foal
produc
appropri
concentr
cortisol
caus
impair
adren
respons
endogen
acth
exhibit
impair
respons
exogen
acth
well
assess
respons
exogen
acth
may
help
character
foal
prematur
although
subset
clinic
ill
fullterm
foal
may
also
exhibit
impair
respons
acth
stimul
test
although
specif
prematur
clinicopatholog
chang
may
includ
arteri
hypoxemia
hypercapnia
hypoglycemia
acidosi
lowgrad
macrocyt
normochrom
anemia
dysmatur
typic
refer
foal
deliv
appear
full
term
exhibit
characterist
prematur
foal
discuss
earlier
dysmatur
common
secondari
placent
insuffici
result
iugr
placent
insuffici
caus
placent
diseas
placent
separ
twin
caus
iugr
may
includ
matern
undernutrit
system
diseas
postmatur
distinguish
dysmatur
refer
foal
born
postterm
foal
utero
excess
length
time
commonli
secondari
matern
ingest
fescu
infect
endophyt
fungu
acremonium
coenophialum
physic
characterist
associ
postmatur
includ
normal
high
birth
weight
associ
larg
frame
size
poor
bodi
condit
affect
foal
may
also
display
flexor
contractur
long
hair
coat
fulli
erupt
incisor
may
share
number
function
characterist
prematur
foal
includ
impair
thermoregul
abnorm
glucos
metabol
well
impair
gastrointestin
renal
function
sever
abnorm
associ
prematur
extent
associ
durat
predispos
diseas
process
led
prematur
deliveri
foal
suffer
prolong
utero
stress
caus
placent
diseas
may
surprisingli
readi
birth
stimul
endogen
cortisol
product
earli
matur
endocrin
system
rare
case
foal
may
surviv
aggress
medic
intervent
even
born
earli
day
gestat
age
base
author
person
experi
foal
experienc
utero
stress
suffer
acut
onset
condit
result
prematur
deliveri
much
like
unreadi
birth
exhibit
dramat
clinic
abnorm
foal
unlik
surviv
born
week
expect
due
date
prematur
dysmatur
foal
requir
medic
intervent
support
care
surviv
condit
affect
bodi
system
thorough
evalu
indic
substanti
crossov
clinic
present
foal
term
septic
foal
difficult
discrimin
among
syndrom
given
prematur
dysmatur
foal
also
heighten
risk
sepsi
clinician
reason
assum
bacteri
infect
present
present
case
appropri
broadspectrum
antimicrobi
therapi
indic
specif
recommend
treatment
support
critic
ill
foal
discuss
detail
relev
section
chapter
prognosi
surviv
foal
suffer
prematur
postmatur
dysmatur
good
appropri
care
surviv
rate
high
mani
foal
catch
peer
attain
normal
adult
size
normal
function
import
howev
owner
foal
born
profoundli
prematur
less
day
gestat
understand
surviv
adulthood
foal
like
reach
normal
adult
size
morpholog
unlik
abl
function
athlet
best
approach
prevent
abnorm
gestat
close
monitor
pregnanc
identifi
condit
may
affect
fetal
viabil
may
lead
prematur
deliveri
earli
treatment
placent
infect
antimicrobi
antiinflammatori
progesteron
altrenogest
may
allow
prolong
gestat
minim
abnorm
associ
prematur
deliveri
induct
parturit
avoid
possibl
must
perform
care
taken
avoid
induct
deliveri
mare
unless
gestat
length
known
great
certainti
remov
mare
pastur
contain
endophyteinfect
fescu
combin
administr
dopamin
receptor
antagonist
domperidon
decreas
risk
dysmatur
although
need
resuscit
foal
uncommon
critic
timesensit
natur
intervent
requir
involv
appropri
train
recogn
implement
resuscit
effort
also
requir
appropri
equip
drug
organ
readili
avail
event
delay
implement
cardiopulmonari
arrest
cpa
foal
commonli
begin
respiratori
arrest
subsequ
lead
cardiac
arrest
caus
asphyxia
primari
cardiac
diseas
rare
foal
differ
situat
seen
human
patient
cardiac
arrest
usual
primari
initi
factor
protocol
resuscit
foal
differ
substanti
approach
use
human
patient
establish
patent
airway
provis
ventilatori
support
initi
prioriti
foal
rather
cardiac
compress
box
first
challeng
recogn
foal
requir
resuscit
earli
intervent
cardiac
arrest
associ
much
higher
likelihood
success
resuscit
potenti
high
situat
foal
like
requir
resuscit
parturit
asphyxia
occur
utero
dystocia
foal
may
arrest
prolong
period
time
unabl
establish
normal
respir
without
resuscit
clinic
sign
may
indic
need
resuscit
immedi
postparturi
period
includ
absenc
breath
irregular
gasp
respiratori
rate
less
breath
per
minut
heart
rate
less
beat
per
minut
irregular
absent
muscl
flaccid
lack
respons
tactil
stimul
situat
resuscit
may
requir
includ
primari
lung
diseas
septic
shock
hypovolemia
metabol
acidosi
hyperkalemia
hypoglycemia
vasovag
reflex
hypothermia
import
recogn
prognosi
success
resuscit
patient
surviv
much
lower
diseas
process
sever
system
ill
likelihood
multipl
organ
failur
although
may
possibl
resuscit
patient
unless
underli
diseas
effect
address
likelihood
surviv
low
cardiac
caus
cpa
foal
may
includ
secondari
myocardi
damag
associ
sever
hypoxia
sepsi
myocard
congenit
cardiac
defect
endocard
coronari
arteri
embol
cardiac
tamponad
direct
monitor
foal
deliveri
veterinari
staff
unlik
except
case
dystocia
hospit
highrisk
pregnanc
foal
attend
assess
foal
respiratori
cardiovascular
function
begin
deliveri
foal
note
meconium
stain
upper
respiratori
tract
suction
immedi
prefer
still
birth
canal
first
breath
deliveri
suction
trachea
may
requir
foal
heavili
meconium
stain
meconium
detect
upper
respiratori
tract
mechan
suction
discourag
often
aggress
may
actual
worsen
hypoxemia
potenti
bradycardia
caus
vagal
reflex
use
limit
second
suction
time
follow
deliveri
foal
may
gasp
time
establish
regular
breath
pattern
within
second
persist
gasp
openmouth
breath
sever
respiratori
distress
may
indic
sever
total
upper
airway
obstruct
bilater
choanal
atresia
dorsal
displac
soft
palat
stenot
nare
tactil
stimul
vigor
dri
towel
may
aid
stimul
initi
respir
rapid
examin
perform
time
identifi
congenit
defect
would
render
resuscit
inappropri
inhuman
foal
fail
begin
breath
spontan
regularli
airway
need
establish
immedi
basic
life
support
bl
implement
best
approach
establish
airway
pass
cuf
nasotrach
tube
facilit
place
foal
head
extend
posit
urgenc
situat
maximum
two
attempt
place
nasotrach
tube
allow
maximum
second
nasotrach
intub
unsuccess
one
immedi
proceed
orotrach
intub
placement
tracheotomi
tube
nasotrach
tube
avail
mouthtonos
ventil
use
foal
oblig
nasal
breather
care
taken
occlud
opposit
nostril
manual
prevent
air
leakag
site
ventil
attempt
effect
ventil
easili
gaug
monitor
chest
rise
ventil
intub
ventil
provid
selfinfl
valv
manual
resuscit
devic
ambu
inc
ballerup
denmark
breath
per
minut
tidal
volum
mlkg
difficult
limit
breath
low
rate
howev
stress
excit
resuscit
effort
often
lead
ventil
rate
upward
breath
per
minut
unfortun
excess
ventil
neg
affect
cardiac
return
coronari
perfus
associ
worsen
outcom
anoth
challeng
associ
monitor
tidal
volum
tremend
rang
manual
resuscit
bag
avail
differ
intern
volum
deliv
variabl
amount
air
depend
fulli
compress
reason
best
monitor
ventil
observ
chest
excurs
ventil
keep
mind
aggress
ventil
contraind
although
somewhat
controversi
may
benefit
ventil
newborn
foal
oxygen
brief
period
time
minut
immedi
deliveri
encourag
revers
persist
fetal
circul
howev
indic
continu
administr
supraphysiolog
oxygen
concentr
may
actual
harm
deliveri
room
air
appropri
foal
without
underli
respiratori
dysfunct
follow
second
assist
ventil
discontinu
ventil
observ
foal
spontan
breath
also
assess
cardiovascular
function
monitor
heartbeat
heart
rate
greater
increas
present
respir
resum
ventil
stop
everi
minut
monitor
spontan
effort
sooner
effort
obviou
mani
foal
requir
resuscit
birth
respond
ventilatori
support
alon
requir
addit
therapi
heartbeat
absent
rate
low
immedi
initi
thorac
compress
delay
may
deleteri
second
spent
tri
assess
cardiac
function
risk
associ
unnecessari
thorac
compress
less
associ
failur
provid
compress
anim
need
place
foal
later
recumb
firm
surfac
quickli
palpat
rib
fractur
initi
compress
unilater
rib
fractur
posit
foal
affect
side
face
bilater
rib
fractur
place
side
cranial
rib
fractur
face
person
provid
compress
posit
dorsal
aspect
foal
knee
spine
prevent
foal
shift
compress
hand
use
one
close
fist
place
palm
foal
heart
hand
place
top
close
fist
arm
kept
straight
upper
bodi
weight
use
drive
compress
rapid
rate
compress
per
minut
advis
depth
compress
difficult
gaug
push
hard
recommend
chest
compress
briefli
stop
everi
minut
monitor
presenc
heartbeat
resum
within
second
singl
individu
avail
initi
resuscit
patient
requir
chest
compress
adjust
must
made
patient
intub
recommend
provid
chest
compress
ventil
wherea
intub
patient
recommend
provid
continu
chest
compress
ventilatori
effort
although
feasibl
singlerescu
resuscit
multipl
individu
particip
resuscit
effort
intraven
iv
cathet
place
resuscit
effort
ongo
iv
access
administr
drug
fluid
foal
respond
bl
aggress
measur
advanc
life
support
indic
may
includ
administr
pharmacolog
agent
implement
improv
monitor
mani
drug
use
empir
foal
resuscit
none
specif
studi
foal
util
mani
agent
debat
either
direct
toward
primari
cardiac
dysfunct
rare
foal
use
human
cardiopulmonari
resuscit
cpr
discontinu
drug
like
use
epinephrin
although
subject
ongo
debat
human
literatur
epinephrin
administ
mg
kg
iv
everi
minut
iv
access
avail
epinephrin
administ
intratrach
mgkg
prefer
dilut
small
volum
ml
steril
water
salin
vasopressin
use
either
place
combin
epinephrin
cpr
use
given
singl
dose
ukg
iv
follow
first
dose
epinephrin
doxapram
commonli
use
foal
resuscit
respiratori
stimul
contraind
revers
secondari
apnea
shown
decreas
cerebr
blood
flow
increas
cerebr
oxygen
consumpt
atropin
glycopyrrol
also
use
foal
resuscit
high
vagal
tone
unlik
caus
bradycardia
benefit
treatment
unclear
administr
singl
dose
atropin
seem
unlik
harm
howev
use
atropin
administ
mgkg
iv
corticosteroid
calcium
glucon
lidocain
magnesium
sulfat
sodium
bicarbon
potenti
indic
treatment
primari
cardiac
arrest
recommend
routin
resuscit
neonat
foal
time
defibril
indic
case
ventricular
fibril
pulseless
ventricular
tachycardia
access
appropri
equip
often
limit
howev
widespread
avail
human
autom
electr
defibril
may
alter
situat
time
publish
studi
regard
use
foal
perform
defibril
cardiac
compress
ventil
continu
moment
defibril
resum
immedi
afterward
initi
charg
jkg
increas
jkg
subsequ
attempt
defibril
present
danger
oper
anyon
contact
foal
oper
receiv
appropri
train
use
defibril
patient
statu
resuscit
extrem
dynam
requir
constant
reassess
difficult
monitor
return
spontan
circul
spontan
respir
without
interf
process
resuscit
follow
initi
resuscit
effort
cardiac
respiratori
function
reassess
interv
unless
foal
show
obviou
sign
respons
box
monitor
via
electrocardiographi
challeng
electr
activ
necessarili
repres
effect
cardiac
contractil
phenomenon
term
pulseless
electr
activ
respiratori
effort
much
readili
observ
effect
subject
evalu
one
techniqu
greatli
facilit
monitor
resuscit
monitor
endtid
co
etco
capnographi
avail
sensor
place
endotrach
tube
realtim
monitor
readili
perform
normal
rest
etco
healthi
spontan
breath
patient
approxim
mm
hg
mm
hg
wherea
co
room
air
mm
hg
resuscit
reason
target
etco
mm
hg
indic
adequ
degre
perfus
ventil
achiev
resuscit
success
rapid
increas
etco
toward
normal
rang
observ
indic
perfus
ventil
improv
decreas
etco
resuscit
indic
inadequ
ventil
perfus
requir
reevalu
resuscit
perform
respons
detect
minut
resuscit
extrem
unlik
patient
respond
effort
follow
success
resuscit
patient
consid
high
risk
presenc
primari
initi
diseas
likelihood
secondari
hypox
injuri
appropri
medic
care
monitor
critic
period
time
foal
receiv
intranas
insuffl
humidifi
oxygen
lmin
demonstr
stabl
adequ
cardiopulmonari
function
fluid
therapi
like
benefit
ensur
normovolemia
support
cardiovascular
function
care
taken
avoid
overhydr
patient
may
risk
pulmonari
edema
pressor
inotrop
therapi
may
indic
cardiovascular
function
inadequ
glucos
support
import
especi
neonat
care
taken
avoid
hyperglycemia
resuscit
occur
field
seriou
consider
given
immedi
refer
foal
facil
equip
provid
intens
care
manag
critic
equin
neonat
extrem
challeng
tremend
advanc
care
foal
past
sever
decad
gradual
declin
mortal
rate
hospit
foal
past
year
although
like
number
factor
addit
advanc
treatment
serv
strong
evid
progress
achiev
report
surviv
rate
hospit
foal
north
america
slowli
trend
upward
approxim
around
encourag
number
import
note
surviv
rate
foal
suffer
sepsi
lower
sick
foal
present
hospit
report
septicem
foal
surviv
wherea
recent
studi
report
septic
foal
surviv
compar
report
surviv
rate
hospit
sick
nonsept
foal
rel
poor
prognosi
septic
foal
caus
mani
factor
least
fact
sepsi
repres
system
inflammatori
respons
infect
injuri
rapidli
progress
septic
shock
death
despit
aggress
treatment
tradit
term
septicemia
use
refer
process
equin
neonat
describ
system
diseas
process
involv
presenc
pathogen
microorgan
andor
toxin
blood
histor
typic
present
sepsi
foal
dissemin
gramneg
bacteri
infect
howev
becom
clear
ident
syndrom
may
occur
patient
gramposit
mix
bacteri
infect
viral
infect
trauma
hypovolemia
hemorrhag
immunolog
drug
reaction
abnorm
associ
clinic
syndrom
sepsi
result
nonspecif
innat
inflammatori
respons
term
system
inflammatori
respons
syndrom
sir
sir
repres
common
termin
phase
inflammatori
respons
character
malign
global
activ
multipl
proinflammatori
pathway
character
paramet
readili
defin
clinic
patient
manifest
diseas
previous
use
defin
sepsi
appreci
mani
differ
stimuli
induc
respons
result
sepsi
redefin
sir
infect
tabl
chang
associ
sir
lead
shock
character
sever
hypotens
respons
iv
fluid
therapi
box
shock
result
hypoperfus
organ
dysfunct
homeostasi
maintain
without
intervent
process
term
multipl
organ
dysfunct
syndrom
mod
mod
repres
progress
syndrom
initi
dysfunct
seen
cardiovascular
system
follow
involv
respiratori
hepat
gastrointestin
renal
cardiac
neurolog
system
process
result
develop
refractori
hypotens
lactic
acidosi
oliguria
may
progress
death
sir
criteria
propos
year
ago
neonat
foal
popul
base
human
criteria
use
inform
regard
normal
valu
foal
sir
criteria
use
number
studi
clinic
ill
foal
sinc
time
correl
increas
lactat
concentr
mortal
recent
report
propos
revis
set
sir
criteria
age
depend
base
insight
revis
human
pediatr
sir
criteria
incorpor
chang
normal
valu
occur
increas
age
foal
tabl
inflamm
repres
respons
tissu
either
injuri
presenc
microorgan
serv
vital
role
enhanc
movement
phagocyt
cell
defens
molecul
immunoglobulin
complement
bloodstream
site
infect
injuri
first
step
process
recognit
tissu
injuri
microbi
invas
trauma
microbi
invas
result
tissu
injuri
injur
cell
releas
produc
damageassoci
molecular
pattern
mediat
initi
nonspecif
inflammatori
respons
altern
specif
bacteri
cell
compon
term
pathogenassoci
molecular
pattern
pamp
may
recogn
immun
cell
produc
inflammatori
mediat
lead
initi
inflammatori
respons
subsequ
amplif
respons
pamp
recogn
immun
system
includ
lipopolysaccharid
lp
endotoxin
exotoxin
gramneg
bacteria
peptidoglycan
lipoteicho
acid
enterotoxin
superantigen
exotoxin
gramposit
bacteria
develop
inflammatori
respons
depend
product
primarili
activ
mononuclear
phagocyt
numer
inflammatori
mediat
includ
proinflammatori
cytokin
tumor
necrosi
interleukin
il
proinflammatori
enzym
induc
nitric
oxid
synthas
phospholipas
adhes
molecul
selectin
intercellular
adhes
molecul
transcript
mani
gene
encod
mediat
enzym
produc
depend
transcript
activ
nuclear
molecul
may
potenti
target
intervent
sir
import
understand
although
bacteri
infect
may
respons
initi
inflammatori
respons
inflammatori
process
result
sole
product
endogen
mediat
initi
chang
seen
inflammatori
respons
primarili
result
local
vasodilat
increas
vascular
permeabl
caus
effect
vasoact
mediat
releas
injur
infect
cell
arriv
site
tissu
injuri
neutrophil
macrophag
phagocytos
foreign
materi
injur
dead
tissu
cell
attempt
destroy
phagocytos
materi
addit
macrophag
releas
number
factor
augment
immun
respons
includ
proinflammatori
cytokin
proinflammatori
cytokin
increas
product
secondari
inflammatori
mediat
includ
phospholipid
deriv
prostaglandin
thromboxan
leukotrien
reactiv
oxygen
speci
ro
increas
activ
inflammatori
respons
system
manifest
inflammationinfect
fever
lethargi
malais
loss
appetit
cachexia
primarili
caus
cytokin
initi
acut
phase
respons
liver
increas
product
acutephas
protein
fibrinogen
serum
amyloid
plasminogen
complement
haptoglobin
ceruloplasmin
ferritin
creactiv
protein
etc
substanc
import
mani
phase
respons
inflammatori
stimuli
includ
complement
activ
coagul
fibrinolysi
transport
substanc
within
bloodstream
inhibit
neutrophil
proteas
modul
inflammatori
respons
acut
phase
respons
critic
inflamm
heal
adapt
noxiou
stimuli
also
includ
acut
phase
respons
counterregulatori
antiinflammatori
compon
normal
function
minim
resolv
inflammatori
respons
local
stimuli
counterregulatori
respons
consist
antiinflammatori
mediat
inhibit
macrophag
activ
adren
corticosteroid
transform
growth
prostaglandin
antagonist
receptor
proinflammatori
cytokin
receptor
antagonist
solubl
receptor
proinflammatori
cytokin
solubl
receptor
type
ii
solubl
tnf
receptor
balanc
proinflammatori
antiinflammatori
compon
import
determin
characterist
inflammatori
respons
excess
activ
antiinflammatori
compon
may
result
immunosuppress
sever
inflammatori
respons
term
compensatori
antiinflammatori
respons
syndrom
moder
chang
associ
inflammatori
respons
protect
result
enhanc
kill
microb
antigenspecif
nonspecif
mechan
gener
immun
stimul
increas
activ
system
requir
heal
damag
tissu
sir
excess
malign
form
inflammatori
acutephas
respons
character
system
activ
numer
proinflammatori
mediat
mediat
repres
compon
normal
inflammatori
respons
local
stimulu
system
activ
proinflammatori
mediat
may
result
excess
often
detriment
respons
one
first
effect
seen
sir
widespread
endotheli
activ
result
increas
product
vasoact
mediat
alter
vascular
homeostasi
inflammatori
cytokin
respons
activ
endothelium
activ
cell
produc
inflammatori
cytokin
well
increas
amount
nitric
oxid
prostaglandin
activ
endotheli
cell
retract
one
anoth
increas
size
intercellular
pore
allow
increas
vascular
permeabl
increas
product
tissu
factor
von
willebrand
factor
result
local
thrombosi
platelet
adher
one
earliest
system
effect
pulmonari
vasoconstrict
lead
pulmonari
hypertens
phase
follow
system
hypotens
caus
decreas
arteri
tone
result
decreas
left
ventricular
afterload
combin
venou
vasodilat
largecapac
vessel
decreas
venou
return
right
ventricular
preload
effect
progress
syndrom
hyperdynam
shock
increas
heart
rate
cardiac
output
develop
compensatori
mechan
maintain
tissu
perfus
compensatori
respons
impair
reduct
left
ventricular
preload
result
decreas
peripher
vascular
resist
combin
decreas
cardiac
contractil
chang
occur
microvasculatur
contribut
impair
tissu
perfus
arteriolar
vasoconstrict
develop
impair
normal
autoregulatori
system
caus
inflammatori
cytokin
combin
increas
product
vasoconstrict
substanc
adher
neutrophil
endothelium
endotheli
cell
swell
reduc
blood
flow
accumul
fibrin
aggreg
platelet
red
blood
cell
secondari
activ
clot
system
result
occlus
vasculatur
result
tissu
hypoperfus
arterioven
shunt
occur
tissu
wherea
increas
vascular
permeabl
result
leakag
intravascular
fluid
interstiti
space
contribut
hypotens
hypovolemia
contribut
develop
tissu
edema
progress
alter
microcircul
lead
failur
may
repres
common
final
pathway
sirsrel
injuri
contribut
result
mod
activ
coagul
occur
primarili
extrins
pathway
endotheli
injuri
secondari
neutrophil
degranul
result
increas
platelet
adhes
normal
state
accumul
result
excess
amount
fibrin
would
prevent
action
plasmin
primari
mediat
fibrinolysi
presenc
sir
fibrinolyt
system
suppress
increas
plasma
concentr
plasminogenactiv
inhibitor
type
primari
inhibitor
fibrinolysi
widespread
activ
clot
system
combin
impair
fibrinolysi
depress
inhibitor
coagul
result
consumpt
coagulopathi
potenti
lead
dissemin
intravascular
coagul
dic
sever
report
demonstr
clinicopatholog
histopatholog
evid
coagulopathi
common
septic
foal
find
associ
worsen
prognosi
surviv
progress
process
affect
cardiovascular
system
ultim
result
shock
shock
occur
cardiovascular
function
sever
impair
point
hypotens
correct
iv
fluid
administr
requir
use
inotrop
andor
vasopressor
agent
shock
repres
sever
cardiovascular
dysfunct
associ
sir
primari
compon
mod
develop
mod
like
result
cardiovascular
dysfunct
lead
tissu
hypoperfus
combin
chang
cellular
metabol
result
impair
oxygen
deliveri
uptak
tissu
hypoxia
manifest
increas
oxygen
extract
ratio
metabol
acidosi
caus
increas
lactat
product
pulmonari
dysfunct
manifest
refractori
hypoxemia
potenti
caus
increas
pulmonari
vascular
permeabl
microthrombi
format
pulmonari
epitheli
injuri
pulmonari
edema
impair
surfact
product
renal
dysfunct
manifest
develop
azotemia
oliguria
acut
renal
failur
like
caus
alter
distribut
intraren
blood
flow
aris
microvascular
alter
without
system
hypotens
gastrointestin
dysfunct
primarili
manifest
presenc
ileu
may
also
result
loss
normal
barrier
function
gastrointestin
mucosa
impair
mucos
barrier
may
contribut
pathogenesi
mod
caus
bacteri
transloc
endotoxin
absorpt
hepat
dysfunct
manifest
develop
hyperbilirubinemia
case
increas
serum
activ
hepat
enzym
sorbitol
dehydrogenas
sdh
aspart
aminotransferas
ast
hepat
dysfunct
may
result
hypoperfus
may
heighten
product
inflammatori
mediat
hepat
kupffer
cell
secondari
action
system
mediat
stimuli
deriv
gastrointestin
tract
dysfunct
central
nervou
system
cn
frequent
present
may
manifest
depress
progress
septic
encephalopathi
extens
neuron
injuri
develop
consumpt
coagulopathi
dic
could
also
consid
compon
mod
rather
mere
pathophysiolog
process
contribut
develop
organ
failur
number
factor
identifi
increas
likelihood
septicemia
equin
neonat
risk
factor
may
includ
histori
placent
prenat
vulvar
discharg
dystocia
matern
ill
prematur
delay
parturit
prematur
placent
separ
induc
parturit
partial
complet
failur
transfer
passiv
immun
ftpi
poor
sanitari
condit
improp
umbil
care
prolong
transport
pregnant
mare
presenc
local
diseas
neonat
anterior
uveiti
diarrhea
pneumonia
infecti
arthriti
open
wound
inadequ
transfer
passiv
immun
serum
igg
concentr
mgdl
repres
critic
risk
factor
septicemia
death
foal
risk
infect
death
increas
proport
decreas
igg
concentr
see
later
section
immunolog
disord
pathogen
organ
infect
equin
neonat
numer
rout
although
intrauterin
environ
fetu
may
expos
organ
invad
placenta
cross
placentochori
barrier
gain
direct
access
foal
bloodstream
bacteria
associ
placent
diseas
may
enter
amniot
fluid
gain
access
respiratori
gastrointestin
tract
fetu
birth
infect
occur
follow
contamin
umbil
stump
ingest
inhal
secondari
wound
present
sign
associ
sepsi
neonat
foal
often
vagu
nonspecif
foal
may
exhibit
depress
lethargi
partial
complet
absenc
nurs
behavior
tachycardia
tachypnea
also
common
initi
sign
consist
present
sign
system
inflamm
may
includ
abnorm
mucou
membran
prolong
capillari
refil
time
dark
red
inject
appear
petechi
mucou
membran
skin
inner
pinna
may
present
fever
consist
present
neonat
foal
may
exhibit
impair
thermoregul
hypothermia
uncommon
popul
may
addit
sign
local
infect
diarrhea
joint
effus
without
lame
respiratori
diseas
distress
lame
uveiti
seizur
subcutan
abscess
omphal
patent
urachu
addit
diagnost
evalu
use
ultrasonographi
may
use
identifi
presenc
pulmonari
inflamm
infect
joint
physeal
infect
intern
involv
umbil
remnant
clinicopatholog
evalu
clinic
ill
foal
help
support
clinic
suspicion
sepsi
septic
neonat
foal
demonstr
exhibit
lower
white
blood
cell
wbc
neutrophil
lymphocyt
count
higher
band
neutrophil
monocyt
count
compar
healthi
agematch
control
foal
azotemia
commonli
encount
popul
may
reflect
placent
insuffici
spuriou
hypercreatininemia
rather
neonat
sepsi
renal
insuffici
azotemia
typic
resolv
rapidli
standard
treatment
unless
underli
renal
diseas
uroperitoneum
present
blood
glucos
abnorm
common
septic
foal
hypoglycemia
common
like
caus
decreas
milk
intak
combin
limit
endogen
energi
store
may
also
associ
sir
arteri
blood
ga
evalu
extrem
use
often
reveal
presenc
acidosi
may
metabol
respiratori
mix
natur
hypoxemia
andor
hypercapnia
may
also
identifi
typic
sever
affect
patient
measur
blood
lactat
concentr
increasingli
perform
avail
handheld
lactat
meter
hyperlactatemia
common
find
blood
lactat
concentr
consist
higher
normal
neonat
foal
normal
adult
hors
first
hour
life
normal
foal
exhibit
valu
mmoll
first
hour
recent
report
find
valu
high
mmoll
immedi
birth
studi
lactat
concentr
steadili
decreas
first
day
life
median
concentr
hour
remain
slightli
increas
rel
normal
adult
concentr
mmoll
serial
measur
blood
lactat
may
use
assess
foal
respons
therapi
failur
normal
lactat
time
associ
poor
prognosi
surviv
definit
test
antemortem
identif
septicem
equin
neonat
remain
blood
cultur
perform
present
equin
neonat
clinic
suspicion
sepsi
ideal
administr
antimicrobi
therapi
test
report
fairli
poor
sensit
fals
neg
result
obtain
case
fatal
septicemia
like
fals
neg
rate
would
much
higher
less
sever
ill
foal
recov
antimicrobi
therapi
reason
recommend
multipl
sampl
collect
maxim
sensit
blood
cultur
major
isol
report
present
first
cultur
sampl
need
immedi
antimicrobi
therapi
usual
result
one
sampl
obtain
although
recommend
blood
cultur
sampl
occur
initi
antimicrobi
therapi
evid
human
patient
delay
initi
antimicrobi
therapi
hour
onset
clinic
sign
associ
increas
morbid
mortal
current
recommend
suggest
delay
hour
referr
set
foal
exhibit
sign
sepsi
longer
period
time
earli
blood
cultur
collect
initi
antimicrobi
therapi
critic
reason
case
refer
field
advis
initi
antimicrobi
therapi
farm
referr
transport
referr
center
like
requir
minut
although
may
decreas
likelihood
obtain
posit
blood
cultur
benefit
earli
treatment
like
outweigh
loss
diagnost
inform
also
import
obtain
bacteri
cultur
suspect
area
infect
cours
treatment
blood
cultur
may
fals
neg
nosocomi
infect
may
develop
cours
treatment
appropri
sampl
depend
system
affect
could
includ
transtrach
aspir
blood
urin
synovi
fluid
periton
fluid
cerebrospin
fluid
csf
umbil
remnant
follow
surgic
resect
although
histor
gramposit
organ
commonli
associ
neonat
infect
past
year
common
bacteria
isol
infect
foal
gramneg
organ
tabl
gramposit
organ
isol
infect
foal
often
present
mix
infect
gramneg
organ
streptococc
speci
common
organ
associ
sever
system
inflamm
equin
neonat
includ
equin
herpesviru
type
equin
viral
arter
also
possibl
sever
hypoxia
lead
hypox
ischem
encephalopathi
hie
neonat
encephalopathi
ne
neonat
asphyxia
dummi
foal
syndrom
repres
caus
factor
induct
sir
equin
neonat
rapid
identif
septic
neonat
critic
import
ensur
appropri
treatment
administ
determin
prognosi
surviv
identif
septic
neonat
remain
problemat
howev
neonat
present
clinic
abnorm
consist
sepsi
sir
may
neg
blood
cultur
evid
focal
site
infect
attempt
identifi
equin
neonat
septicemia
includ
develop
sepsi
score
system
combin
histor
inform
object
data
subject
measur
deriv
numer
represent
patient
condit
use
cutoff
sensit
specif
modifi
version
score
system
report
respect
unfortun
specif
sensit
may
alway
high
subsequ
studi
found
modifi
sepsi
score
yield
sensit
specif
posit
predict
valu
ppv
npv
author
report
suggest
might
score
system
must
adapt
icu
appli
achiev
reason
high
level
sensit
specif
anoth
studi
modifi
sepsi
score
system
fail
predict
sepsi
bacterem
foal
recent
studi
invest
applic
modifi
sepsi
score
system
larg
popul
foal
propos
revis
cutoff
valu
result
sensit
specif
compar
origin
cutoff
sensit
specif
ultim
sepsi
score
substitut
clinic
judgment
score
use
diagnost
aid
identif
highrisk
individu
full
consider
given
limit
interest
use
serum
amyloid
saa
earli
accur
biomark
bacteri
infect
neonat
foal
earli
report
suggest
cutoff
mgl
highli
suggest
infect
recent
unpublish
studi
jokisalo
et
al
found
use
cutoff
point
mgl
yield
sensit
specif
npv
unfortun
foal
consid
septic
studi
saa
concentr
mgl
septic
foal
saa
concentr
less
mgl
indic
low
saa
concentr
rule
possibl
bacteri
sepsi
potenti
biomark
sepsi
foal
plasma
creactiv
protein
haptoglobin
investig
appear
strong
accur
predictor
sepsi
although
abnorm
blood
glucos
concentr
lactat
concentr
common
septic
foal
biomark
appear
use
prognost
rather
identif
septic
neonat
difficulti
definit
identifi
neonat
bacteri
infect
appropri
make
assumpt
highrisk
neonat
foal
present
clinic
ill
septic
aggress
earli
antimicrobi
therapi
indic
although
risk
associ
antimicrobi
therapi
greatli
outweigh
risk
associ
withhold
antimicrobi
therapi
patient
sepsi
secondari
bacteri
infect
initi
antimicrobi
regimen
provid
broadspectrum
coverag
includ
organ
commonli
identifi
practic
popul
region
detail
discuss
antimicrobi
therapi
found
antimicrobi
section
chapter
reason
initi
approach
use
penicillin
ampicillin
combin
aminoglycosid
typic
amikacin
concern
regard
renal
insuffici
aminoglycosid
replac
thirdgener
cephalosporin
monotherapi
thirdor
fourthgener
cephalosporin
may
reason
altern
combin
therapi
particularli
sever
dehydr
patient
may
provid
full
coverag
gramposit
pathogen
manag
septic
neonat
challeng
requir
constant
monitor
need
substanti
nurs
care
fluid
therapi
indic
resuscit
stabil
clinic
ill
foal
initi
take
form
intermitt
bolus
given
minut
typic
need
accompani
appropri
mainten
fluid
therapi
see
later
section
fluid
therapi
foal
presenc
fluidrefractori
hypotens
may
requir
use
inotrop
vasopressor
therapi
see
later
section
inotrop
vasopressor
therapi
respiratori
support
benefici
case
consist
intranas
insuffl
humidifi
oxygen
lmin
use
nasal
cannula
respiratori
stimul
caffein
doxapram
may
benefici
foal
decreas
respiratori
drive
intervent
adequ
mechan
ventil
may
necessari
addit
therapi
may
includ
administr
hyperimmun
plasma
either
supplement
immunoglobulin
colloid
support
treatment
sir
antiinflammatori
therapi
sometim
use
primarili
consist
nonsteroid
sometim
includ
corticosteroid
therapi
critic
illnessassoci
corticosteroid
insuffici
circi
suspect
see
later
section
antiinflammatori
analges
therapi
endocrin
disord
care
taken
regard
use
antiinflammatori
therapi
critic
ill
foal
howev
risk
gastrointestin
ulcer
renal
injuri
gastroprotect
therapi
use
proton
pump
inhibitor
gener
use
first
day
life
concern
regard
increas
suscept
nosocomi
infect
sucralf
may
reason
option
drug
see
later
section
gastrointestin
disord
use
lowmolecularweight
heparin
andor
administr
fresh
fresh
frozen
plasma
suggest
address
coagulopathi
critic
ill
foal
nurs
care
one
import
aspect
treat
septic
foal
foal
kept
warm
dri
difficult
recumb
patient
frequent
urin
defec
placement
urinari
cathet
consid
patient
even
though
may
present
risk
regard
urinari
tract
infect
greatli
facilit
nurs
care
decreas
risk
decubit
ulcer
provid
mean
monitor
urin
output
recumb
foal
kept
sternal
posit
much
possibl
minim
develop
atelectasi
depend
lung
turn
longer
interv
feed
septic
foal
challeng
gastrointestin
function
abnorm
parenter
nutrit
may
need
see
later
section
nutrit
support
foal
blood
glucos
level
monitor
frequent
especi
foal
receiv
parenter
nutrit
support
develop
persist
hyperglycemia
may
requir
institut
insulin
therapi
possibl
foal
weigh
daili
anoth
mean
monitor
fluid
retent
cost
associ
intens
care
affect
foal
substanti
reason
import
strive
provid
accur
prognosi
surviv
well
longterm
athlet
function
given
broad
rang
prognost
indic
one
use
assess
odd
surviv
critic
ill
foal
challeng
provid
accur
time
prognosi
owner
patient
experienc
clinician
abl
provid
accur
predict
surviv
given
alway
variat
clinician
experi
level
perform
substanti
interest
develop
score
system
could
use
prospect
enhanc
prognost
accuraci
hoffman
et
al
perform
studi
predict
variabl
surviv
hospit
neonat
foal
studi
retrospect
identifi
two
predict
variabl
anion
gap
venou
partial
pressur
oxygen
pvo
appli
prospect
popul
foal
model
show
ppv
surviv
npv
furr
et
al
perform
similar
studi
develop
predict
equat
outcom
popul
hospit
neonat
foal
identifi
sever
variabl
associ
nonsurviv
model
ultim
retain
differ
set
predict
variabl
heart
rate
rectal
temperatur
neutrophil
count
model
yield
ppv
npv
retrospect
popul
appli
prospect
two
popul
hospit
foal
model
perform
differ
two
popul
ppv
npv
one
popul
oppos
ppv
npv
like
caus
fundament
differ
type
case
refer
time
present
two
differ
hospit
rohrbach
et
al
perform
larg
multicent
studi
creat
predict
model
probabl
hospit
discharg
hospit
foal
less
day
age
variabl
retain
model
foal
age
abil
stand
presenc
suckl
reflex
wbc
count
serum
creatinin
concentr
anion
gap
model
yield
ppv
npv
retrospect
popul
appli
prospect
model
demonstr
ppv
npv
rohrbach
et
al
also
report
accuraci
clinician
predict
outcom
retrospect
popul
oppos
accuraci
mathemat
model
howev
predict
well
correl
interestingli
combin
clinician
initi
predict
model
output
abl
improv
accuraci
surviv
estim
anoth
multicent
studi
perform
dembek
et
al
develop
surviv
score
system
critic
ill
foal
final
model
retain
six
variabl
cold
extrem
prematur
infectioninflamm
site
igg
concentr
glucos
concentr
wbc
count
variabl
assign
score
depend
respect
valu
total
individu
score
yield
final
surviv
score
tabl
score
associ
probabl
surviv
wherea
maximum
score
associ
probabl
surviv
tabl
valid
foal
surviv
score
fss
prospect
use
score
cutoff
foal
predict
surviv
foal
predict
die
result
valu
ppv
npv
foal
fss
like
surviv
foal
score
foal
score
time
like
surviv
recent
et
al
report
retrospect
studi
examin
factor
associ
surviv
popul
hospit
foal
year
one
academ
referr
hospit
variabl
retain
model
includ
posit
blood
cultur
neutropenia
hypothermia
bicarbon
pco
presenc
infecti
orthoped
disord
sepsi
score
report
sensit
model
specif
particular
interest
increas
odd
surviv
foal
born
time
greater
compar
born
wherea
foal
born
time
greater
odd
surviv
compar
born
weak
abnorm
behavior
common
present
sign
clinic
ill
foal
may
associ
neurolog
dysfunct
howev
may
also
caus
myriad
condit
reason
thorough
evalu
assess
abnorm
foal
extrem
import
evalu
includ
collect
thorough
histori
includ
matern
health
reproduct
histori
perform
complet
physic
examin
includ
detail
neurolog
assess
first
object
neurolog
assess
ascertain
whether
true
neurolog
dysfunct
present
subsequ
establish
neuroanatom
local
lesion
inform
use
direct
diagnost
therapeut
effort
first
stage
neurolog
examin
assess
foal
behavior
level
alert
import
rememb
normal
develop
progress
foal
behavior
first
hour
parturit
foal
exhibit
fairli
dramat
increas
conscious
strength
coordin
well
awar
interact
environ
thu
import
understand
point
along
continuum
base
time
sinc
birth
foal
abl
stand
within
hour
birth
typic
initi
effort
stand
poorli
coordin
time
unsuccess
initi
stanc
base
wide
promin
sway
back
forth
howev
foal
stand
success
rapid
improv
ambul
note
foal
begin
seek
mare
udder
suckl
reflex
present
within
minut
birth
foal
activ
engag
suckl
behavior
even
recumb
without
access
udder
foal
suckl
success
within
hour
birth
rang
hour
nurs
episod
last
minut
typic
follow
period
drowsi
recumb
sleep
foal
becom
increasingli
coordin
confid
first
day
life
avoid
handler
possibl
restrain
typic
struggl
vigor
becom
limp
compress
along
long
axi
relax
respons
respons
squeez
particularli
pronounc
first
sever
hour
birth
next
stage
examin
assess
foal
conform
postur
gait
head
horizont
plane
foal
stand
head
tilt
rotat
note
foal
carri
head
pronounc
flexion
atlantooccipit
joint
tend
move
head
jerki
motion
may
resembl
cerebellar
dysfunct
adult
foal
gait
evalu
observ
foal
unrestrain
spontan
movement
facilit
lead
dam
observ
foal
follow
neonat
foal
may
appear
somewhat
dysmetr
compar
adult
typic
improv
exercis
foal
typic
somewhat
exagger
bounci
hypermetr
gait
compar
adult
examin
cranial
nerv
similar
adult
begin
observ
facial
express
muscl
tone
symmetri
touch
nasal
septum
insid
ear
canal
elicit
avoid
behavior
aid
assess
facial
sensat
flick
reflex
evalu
gentli
touch
tip
hemostat
pinna
ear
medial
later
canthi
eye
commissur
lip
eye
examin
orient
pupillari
size
pupillari
light
reflex
globe
typic
show
ventromedi
deviat
resolv
month
age
pupil
somewhat
round
birth
direct
consensu
pupillari
light
reflex
although
somewhat
slow
initi
birth
present
normal
foal
first
day
life
dazzl
reflex
present
well
menac
respons
present
birth
develop
within
week
life
even
though
menac
respons
present
foal
show
visual
avoid
move
head
away
threaten
gestur
toward
eye
eye
assess
presenc
nystagmu
although
later
movement
head
elicit
normal
physiolog
nystagmu
spontan
nystagmu
head
stationari
abnorm
suckl
reflex
jaw
tone
assess
insert
glove
finger
mouth
foal
also
observ
nurs
pay
close
attent
swallow
movement
pharyng
region
observ
nasal
regurgit
nurs
test
cervicofaci
reflex
along
neck
cutan
trunci
reflex
along
thorax
allow
assess
long
spinal
reflex
abnorm
segment
cutan
sensat
assess
assess
spinal
reflex
best
accomplish
place
foal
later
recumb
also
allow
better
assess
muscl
tone
limb
substanti
extensor
tone
limb
abl
flex
persist
gentl
pressur
tricep
extensor
carpi
radiali
bicep
patellar
sciatic
gastrocnemiu
reflex
abl
reliabl
elicit
pronounc
adult
foal
respond
pressur
sole
hoof
flexion
upper
limb
extensor
respons
known
extensor
thrust
reflex
flexor
withdraw
reflex
present
respons
pinch
skin
distal
limb
foal
exhibit
cross
extensor
respons
extend
opposit
limb
time
cross
extensor
reflex
absent
first
week
life
although
foal
neurolog
dysfunct
display
gener
sign
abnorm
behavior
seizur
depress
poor
affin
mare
loss
suckl
find
neurolog
examin
use
assess
natur
sever
dysfunct
provid
neuroanatom
local
lesion
may
present
tabl
ne
human
clinic
defin
syndrom
neonat
brain
dysfunct
manifest
difficulti
initi
mainten
respir
depress
tone
reflex
subnorm
level
conscious
frequent
seizur
ne
repres
broad
categor
encompass
neonat
neurolog
sign
regardless
etiolog
term
recent
come
use
equin
literatur
well
hie
specif
type
ne
typic
associ
advers
peripartum
event
result
episod
cerebr
hypoxia
ischemia
wide
varieti
term
use
synonym
hie
refer
affect
foal
includ
neonat
maladjust
syndrom
perinat
asphyxia
syndrom
dummi
foal
wander
barker
foal
clinic
present
associ
hie
foal
rang
quit
dramat
mild
behavior
abnorm
sever
neurolog
abnorm
includ
central
blind
seizur
coma
death
unfortun
clinic
sign
specif
hie
diagnosi
typic
made
base
elimin
potenti
etiolog
inde
confus
associ
nomenclatur
reflect
clinic
challeng
associ
determin
etiolog
neurolog
dysfunct
neonat
foal
long
recogn
mani
foal
present
clinic
sign
typic
associ
hie
document
evid
asphyxi
hypoxicischem
event
fact
mani
affect
foal
recov
rapidli
demonstr
neurolog
sequela
contrast
situat
human
infant
reinforc
dilemma
evid
elev
neurosteroid
concentr
may
associ
ne
case
particularli
discern
histori
hypox
insult
novel
squeez
techniqu
report
primarili
aid
foal
restraint
although
anecdot
time
techniqu
may
benefit
moder
excess
inhibitori
neurosteroid
concentr
improv
foal
conscious
introduct
term
ne
human
medicin
effort
toward
restrict
term
hie
subset
case
ne
evid
hypoxicischem
caus
approach
use
multipl
condit
associ
peripartum
asphyxia
hie
foal
includ
dystocia
induct
parturit
cesarean
section
placent
prematur
placent
separ
meconium
aspir
twin
utero
infect
sever
matern
ill
surgeri
postterm
pregnanc
affect
foal
may
appear
normal
birth
typic
demonstr
neurolog
dysfunct
within
first
hour
life
clinic
sign
hie
highli
variabl
may
includ
behavior
chang
loss
affin
mare
inappropri
nurs
behavior
loss
awar
environ
headpress
abnorm
vocal
alter
mentat
depress
stupor
somnol
difficult
arous
coma
cranial
nerv
dysfunct
loss
suckl
reflex
weak
tongu
tone
tongu
protrus
dysphagia
cn
dysfunct
hypotonia
tremor
hypertonia
propriocept
deficit
central
blind
irregular
respiratori
pattern
opisthotonu
seizur
two
major
categori
hieaffect
foal
describ
categori
foal
born
normal
develop
sign
within
first
hour
life
categori
foal
abnorm
birth
usual
associ
document
risk
factor
hie
common
see
multisystem
involv
hypox
injuri
advers
affect
bodi
system
gastrointestin
tract
renal
system
appear
suscept
cardiovascular
system
pulmonari
system
liver
endocrin
system
may
involv
pathophysiolog
hypox
injuri
complex
may
vari
extent
differ
bodi
system
focu
nervou
system
initi
insult
tissu
hypoxia
initi
cascad
deleteri
event
first
shift
toward
anaerob
metabol
lead
deplet
highenergi
phosphat
adenosin
triphosph
atp
reserv
accumul
lactat
failur
cellular
homeostasi
decreas
activ
transcellular
pump
depend
atp
lead
intracellular
accumul
sodium
calcium
water
membran
depolar
lead
releas
potent
excitatori
amino
acid
glutam
accumul
extracellular
space
glutam
act
nmethyldaspart
nmda
receptor
open
nmda
channel
potenti
calcium
influx
neuron
contribut
neuron
injuri
cascad
event
result
develop
perpetu
excitotox
ultim
lead
neuron
cell
death
brain
injuri
hypoxia
subsequ
reperfus
also
initi
increas
product
ro
ultim
result
process
known
reperfus
injuri
lead
tissu
damag
via
cell
death
activ
apoptot
cascad
tissu
injuri
initi
inflammatori
respons
lead
increas
local
blood
flow
vascular
permeabl
may
result
develop
edema
inflammatori
cell
infiltr
lead
tissu
injuri
upregul
ro
product
increas
concentr
neurosteroid
document
affect
foal
role
pathophysiolog
hie
unclear
may
actual
neuroprotect
effect
situat
degre
durat
hypoxia
overwhelm
biphas
pattern
injuri
may
observ
initi
acut
phase
injuri
stabil
follow
ongo
latent
phase
injuri
result
sever
clinic
deterior
sever
hour
later
diagnosi
hie
challeng
substanti
overlap
clinic
sign
associ
hie
caus
ne
previous
discuss
unfortun
definit
test
hie
diagnosi
typic
made
base
histor
inform
clinic
present
elimin
potenti
caus
addit
diagnost
use
human
infant
includ
electroencephalographi
eeg
well
imag
modal
comput
tomographi
ct
magnet
reson
imag
mri
eeg
difficult
accomplish
unsed
foal
interpret
confound
patient
movement
sedat
render
modal
limit
use
foal
brainstem
auditori
evok
respons
test
wide
use
human
neonat
icu
aid
assess
cn
function
diagnosi
hie
techniqu
describ
valid
foal
recent
report
describ
mri
find
associ
presumpt
case
ne
foal
increas
avail
mri
equin
referr
center
may
render
modal
util
futur
tremend
interest
identifi
biomark
hie
human
infant
two
potenti
biomark
hie
investig
foal
recent
studi
measur
plasma
concentr
phosphoryl
axon
form
neurofila
h
pnfh
ubiquitin
ctermin
hydrolas
found
diagnost
perform
significantli
higher
pnfh
sensit
specif
diagnosi
neonat
hie
report
respect
test
avail
clinic
use
time
howev
prevent
hie
difficult
occult
natur
injuri
mani
case
effort
made
identifi
mare
risk
matern
placent
diseas
pregnanc
implement
appropri
treatment
monitor
close
observ
atrisk
mare
parturit
may
allow
earli
intervent
assist
need
foal
close
observ
parturit
sign
distress
neurolog
dysfunct
appropri
support
care
resuscit
provid
foal
exhibit
seizur
activ
within
first
hour
hospit
shown
poorer
outcom
foal
exhibit
seizur
activ
prognosi
surviv
foal
uncompl
diseas
surviv
first
day
life
demonstr
neurolog
improv
time
appear
good
brain
dysfunct
occur
result
sever
system
inflamm
secondari
infect
involv
overt
cn
infect
type
encephalopathi
term
sepsisassoci
encephalopathi
sae
syndrom
also
refer
septic
encephalopathi
sepsisassoci
brain
dysfunct
sae
thought
repres
neglect
caus
neurolog
dysfunct
human
patient
difficulti
diagnos
condit
precis
clinic
biolog
marker
situat
like
similar
ne
foal
human
clinic
spectrum
sae
may
includ
sign
rang
mild
behavior
abnorm
alter
sleep
state
sever
disturb
conscious
even
coma
pathophysiolog
sae
appear
involv
direct
neuron
cell
injuri
mitochondri
endotheli
dysfunct
disturb
neurotransmiss
derang
neuron
calcium
homeostasi
given
substanti
overlap
present
hie
sae
frequent
involv
sepsi
critic
ill
foal
popul
sae
consid
potenti
caus
ne
foal
seizur
common
manifest
neurolog
dysfunct
human
neonat
foal
seizur
foal
idiopath
result
primari
cn
disord
secondari
numer
condit
involv
bodi
system
diffus
diseas
seizur
defin
abnorm
stereotyp
paroxysm
alter
neurolog
function
may
includ
behavior
chang
motor
dysfunct
autonom
dysfunct
loss
conscious
seizur
activ
indic
neurolog
dysfunct
forebrain
associ
abnorm
electr
activ
neonat
appear
increas
risk
seizur
activ
rel
excit
develop
brain
combin
high
risk
brain
injuri
neonat
period
diagnosi
seizur
activ
primarili
base
clinic
sign
challeng
subtl
sign
case
potenti
confound
effect
condit
alter
patient
behavior
neurolog
function
level
conscious
subtl
sign
may
includ
abnorm
eye
movement
tremor
excess
stretch
excess
extensor
tone
hyperesthesia
apneust
breath
wherea
overt
sign
seizur
typic
includ
rapid
nystagmu
paddl
hyperextens
excess
movement
mouth
unexplain
physic
trauma
may
repres
evid
unobserv
seizur
activ
confirm
seizur
activ
achiev
eeg
examin
challeng
foal
specif
treatment
may
requir
individu
subtl
rare
sign
seizur
activ
clearli
indic
patient
repeat
gener
seizur
activ
foal
exhibit
seizur
activ
within
first
hour
hospit
shown
poorer
outcom
foal
exhibit
seizur
activ
bacteri
mening
uncommon
condit
appear
frequent
foal
adult
report
occur
foal
suffer
sepsi
associ
high
mortal
rate
common
clinic
find
foal
bacteri
mening
lethargi
weak
recumb
decreas
suckl
reflex
abnorm
pupillari
light
reflex
hyperesthesia
cervic
pain
fever
blind
seizur
coma
clinicopatholog
find
may
includ
ftpi
neutropenia
neutrophilia
hyperfibrinogenemia
often
reflect
system
inflamm
relat
sepsi
definit
diagnosi
mean
csf
analysi
neutrophil
pleocytosi
total
nucleat
cell
count
increas
total
protein
tp
concentr
tp
mg
dl
present
case
cellular
degener
frequent
observ
csf
along
intracellular
bacteria
mening
commonli
associ
type
bacteria
associ
neonat
sepsi
escherichia
coli
actinobacillu
spp
klebsiella
spp
streptococcu
spp
salmonella
spp
commonli
report
treatment
depend
intens
antimicrobi
therapi
use
drug
capabl
achiev
therapeut
concentr
within
cn
ideal
guid
cultur
result
drug
penicillin
ceftiofur
aminoglycosid
unlik
effect
poor
penetr
consider
given
treatment
ceftriaxon
cefepim
cefotaxim
imipenem
chloramphenicol
rifampin
adjunct
much
damag
occur
cn
mening
secondari
inflammatori
respons
rational
use
antiinflammatori
therapi
case
use
corticosteroid
adjunct
therapi
human
patient
associ
reduct
neurolog
sequela
alter
mortal
prognosi
surviv
foal
appropri
treatment
fair
poor
depend
sever
present
sign
trauma
alway
consid
evalu
foal
acut
onset
neurolog
sign
brain
trauma
may
associ
blunt
forc
trauma
region
frontal
pariet
bone
may
secondari
trauma
poll
tempor
region
secondari
foal
flip
backward
vertebr
injuri
occur
well
may
associ
foal
run
immobil
object
outward
sign
trauma
may
obviou
imag
studi
may
requir
confirm
examin
may
reveal
superfici
abras
pain
palpat
affect
area
soft
tissu
swell
crepitu
bleed
nare
ear
treatment
support
natur
along
stabil
boni
injuri
possibl
antiinflammatori
antioxid
therapi
may
benefit
corticosteroid
administr
recommend
appropri
antimicrobi
therapi
indic
possibl
cn
may
contamin
botul
syndrom
flaccid
paralysi
caus
neurotoxin
produc
clostridium
botulinum
colloqui
known
shaker
foal
syndrom
equin
case
associ
toxin
type
b
c
although
type
case
report
syndrom
foal
thought
toxicoinfecti
natur
foal
ingest
spore
environ
germin
gastrointestin
tract
spread
toxin
oppos
common
form
forag
poison
associ
ingest
preform
toxin
seen
adult
botul
toxin
act
presynapt
neuromuscular
junction
inhibit
releas
neurotransmitt
acetylcholin
sever
affect
foal
may
found
dead
commonli
sudden
develop
weak
trembl
dysphagia
previous
healthi
foal
progress
deterior
typic
observ
even
appropri
treatment
respiratori
paralysi
caus
death
case
diagnosi
typic
presumpt
base
histori
clinic
present
confirm
requir
demonstr
spore
andor
toxin
fece
affect
anim
difficult
mous
bioassay
valid
diagnosi
botul
hors
foal
assay
highli
specif
foal
specif
ppv
report
exhibit
low
sensit
npv
treatment
base
administr
antitoxin
provis
support
care
foal
becom
recumb
like
die
unless
receiv
ventilatori
support
form
mechan
ventil
may
requir
long
week
earli
appropri
care
prognosi
surviv
case
type
b
c
botul
report
good
type
botul
associ
sever
clinic
sign
higher
case
fatal
rate
recent
report
describ
success
treatment
foal
affect
type
botul
tetanu
syndrom
spastic
paralysi
caus
neurotoxin
tetanospasmin
produc
c
tetani
although
rare
widespread
use
tetanu
toxoid
vaccin
recent
case
report
foal
syndrom
usual
affect
foal
day
age
associ
develop
anaerob
site
infect
reportedli
often
within
umbil
remnant
tetanospasmin
act
prevent
releas
inhibitori
neurotransmitt
gaba
spinal
interneuron
lead
disinhibit
spinal
motor
neuron
result
excess
motor
activ
spastic
paralysi
primari
clinic
sign
rigid
excess
autonom
activ
episod
muscl
spasm
lead
trismu
facial
spasm
thirdeyelid
protrus
dysphagia
progress
lead
recumb
death
usual
caus
respiratori
failur
treatment
tetanu
depend
administr
tetanu
antitoxin
support
care
control
muscl
spasm
sourc
control
control
muscl
spasm
often
accomplish
use
benzodiazepin
either
administ
need
continu
rate
infus
cri
magnesium
sulfat
repres
afford
viabl
option
benzodiazepin
human
may
reason
option
foal
well
sourc
control
may
involv
surgic
excis
drainag
site
infect
combin
antimicrobi
therapi
penicillin
standard
treatment
metronidazol
may
also
use
prognosi
surviv
good
case
progress
recumb
guard
poor
recumb
occur
although
recent
success
report
number
metabol
derang
potenti
advers
affect
neurolog
function
potenti
caus
neurolog
injuri
foal
includ
hypoglycemia
hyponatremia
hypernatremia
hypocalcemia
hyperbilirubinemia
hyperammonemia
hypoglycemia
common
critic
ill
foal
sever
hypoglycemia
associ
nonsurviv
hospit
discharg
persist
sever
hypoglycemia
associ
neuron
degener
central
peripher
nervou
system
interestingli
phenomenon
seen
human
patient
receiv
insulin
therapi
suffer
hyperinsulinemia
although
shortterm
hypoglycemia
may
caus
perman
injuri
certainli
caus
neurolog
dysfunct
advers
affect
bodi
system
therefor
address
dextros
supplement
sodium
disord
fairli
common
critic
ill
foal
typic
associ
neurolog
dysfunct
unless
derang
sever
dramat
acut
chang
serum
sodium
concentr
rapid
chang
sodium
concentr
caus
dramat
fluid
shift
tissu
cn
hyponatremia
potenti
associ
develop
cerebr
edema
wherea
hypernatremia
may
caus
osmot
demyelin
syndrom
hyponatremia
common
hypernatremia
neurolog
sign
typic
associ
sodium
concentr
less
meql
neurolog
manifest
hyponatremia
may
includ
abnorm
stanc
gait
depress
blind
seizur
treatment
disord
involv
correct
underli
whole
bodi
sodiumwat
imbal
hyponatremia
repres
freewat
excess
hypernatremia
freewat
deficit
hyponatremia
address
administ
fluid
rel
hyperton
compar
plasma
osmol
although
literatur
suggest
initi
correct
rapid
follow
slower
correct
conserv
approach
may
appropri
foal
hypernatremia
address
use
fluid
rel
hypoton
gradual
meqlh
hypocalcemia
often
asymptomat
associ
tetani
seizur
rapid
decreas
ioniz
calcium
concentr
appear
like
associ
clinic
sign
critic
ill
foal
syndrom
hypocalcem
seizur
describ
young
foal
typic
week
age
condit
thought
caus
primari
hypoparathyroid
bilirubin
capabl
cross
bloodbrain
barrier
especi
plasma
concentr
bilirubin
high
neonat
bloodbrain
barrier
permeabl
bilirubin
neurotox
caus
neurolog
dysfunct
irrevers
brain
damag
clinic
syndrom
term
kernicteru
import
caus
clinic
icteru
equin
neonat
neonat
isoerythrolysi
ni
treatment
ni
discuss
elsewher
chapter
primarili
consist
support
care
blood
transfus
treatment
address
hyperbilirubinemia
reduc
use
therapeut
plasma
exchang
hyperammonemia
associ
neurolog
dysfunct
foal
adult
hors
clinic
sign
associ
hyperammonemia
includ
depress
blind
aimless
wander
head
press
ataxia
circl
recumb
death
hyperammonemia
may
develop
secondari
hepat
insuffici
portosystem
shunt
increas
gastrointestin
product
intestin
hyperammonemia
disord
suspect
repres
hyperornithinemiahyperammonemiahomocitrullinuria
hhh
syndrom
genet
defect
urea
cycl
result
persist
hyperammonemia
report
morgan
foal
intestin
hyperammonemia
typic
seen
associ
clinic
sign
gastrointestin
diseas
hydrocephalu
condit
result
impair
drainag
csf
caus
congenit
defect
inflamm
result
compress
brain
caus
increas
intracrani
pressur
condit
consid
uniformli
fatal
rare
hors
may
frequent
friesian
breed
diagnosi
typic
presumpt
confirm
postmortem
examin
ct
mri
use
definit
antemortem
diagnosi
necessari
foal
born
occipitoatlantoaxi
malform
typic
exhibit
paresi
ataxia
four
limb
case
foal
may
born
dead
comatos
foal
may
head
tilt
abnorm
head
carriag
movement
head
may
reveal
click
sound
neurolog
deficit
may
rang
inappar
sever
enough
result
quadriplegia
condit
famili
arabian
breed
may
occur
breed
well
diagnosi
typic
confirm
radiograph
although
contrast
myelographi
ct
mri
may
use
case
foal
exhibit
clinic
sign
typic
euthan
poor
longterm
prognosi
equin
cerebellar
abiotrophi
neurodegen
condit
affect
cerebellum
result
ataxia
head
tremor
loss
equilibrium
cerebellar
abiotrophi
rel
rare
hors
although
occur
multipl
breed
common
arabian
hors
inherit
autosom
recess
trait
clinic
sign
gener
detect
week
month
age
diagnosi
typic
presumpt
base
breed
associ
clinic
present
definit
antemortem
diagnosi
difficult
syndrom
juvenil
idiopath
epilepsi
jie
describ
arabian
foal
egyptian
lineag
syndrom
character
recurr
tonicclon
seizur
resembl
benignfamili
neonat
convuls
syndrom
human
jie
exhibit
earli
onset
clinic
sign
first
day
month
life
appear
selflimit
resolv
year
age
narcolepsi
hors
character
paroxysm
sleep
attack
affect
anim
may
remain
stand
wherea
cataplexi
repres
complet
loss
muscl
tone
combin
areflexia
lead
recumb
narcolepsi
without
cataplexi
describ
thoroughbr
warmblood
iceland
hors
case
may
famili
compon
narcolepsi
cataplexi
rare
describ
hors
broad
rang
diseas
process
associ
develop
ne
foal
singl
treatment
strategi
discuss
focu
treatment
direct
toward
prevent
cn
injuri
normal
nervou
system
function
foal
ne
typic
suffer
sever
system
inflamm
well
specif
treatment
recommend
support
care
infect
control
correct
metabol
disord
normal
cardiovascular
pulmonari
gastrointestin
renal
function
critic
ill
foal
cover
detail
elsewher
chapter
first
object
stabil
patient
system
restor
mainten
cn
perfus
critic
ensur
adequ
deliveri
oxygen
glucos
iv
fluid
therapi
often
requir
correct
hypovolemia
support
cardiovascular
function
vasopressor
inotrop
may
requir
normal
blood
pressur
import
avoid
overhydr
hypertens
howev
may
potenti
cn
injuri
normal
blood
glucos
concentr
import
well
care
must
taken
avoid
hyperglycemia
critic
ill
foal
may
intoler
dextros
infus
intranas
oxygen
supplement
recommend
weak
recumb
foal
document
arteri
hypoxemia
support
oxygen
deliveri
blood
transfus
may
need
anem
patient
reason
second
object
control
seizur
activ
present
specif
treatment
may
requir
individu
subtl
rare
sign
seizur
activ
clearli
indic
patient
repeat
gener
seizur
activ
benzodiazepin
diazepam
midazolam
repres
firstchoic
therapi
control
acut
seizur
foal
rapid
onset
action
minim
depress
effect
tabl
bolu
iv
dose
use
control
singl
seizur
episod
cri
midazolam
use
control
persist
seizur
option
control
persist
seizur
includ
phenobarbit
pentobarbit
potassium
bromid
phenobarbit
caus
substanti
cn
depress
first
administ
gener
well
toler
even
prolong
use
serum
phenobarbit
level
monitor
use
long
term
ensur
concentr
remain
within
therapeut
rang
report
foal
pentobarbit
use
case
statu
epilepticu
control
medic
associ
substanti
risk
caus
profound
respiratori
cardiovascular
depress
phenytoin
unpredict
kinet
wide
use
suggest
anticonvuls
use
foal
potassium
bromid
may
use
longterm
mainten
foal
epilepsi
fewer
side
effect
phenobarbit
well
toler
report
effect
plasma
concentr
bromid
speci
mgdl
valid
foal
next
goal
control
ongo
cn
injuri
prevent
damag
hypothermia
consid
standard
care
treatment
human
neonat
suffer
hie
involv
cool
patient
use
whole
bodi
hypothermia
although
select
headcool
approach
use
well
recent
systemat
review
confirm
therapeut
hypothermia
benefici
human
infant
suffer
hie
hypothermia
reduc
mortal
without
increas
longterm
neurolog
disabl
survivor
complic
associ
hypothermia
notabl
overcool
skin
problem
alter
drug
metabol
increas
risk
seizur
rewarm
logist
provid
therapeut
hypothermia
foal
includ
appropri
techniqu
cool
patient
select
durat
cool
remain
defin
clinic
applic
approach
equin
medicin
number
pharmacolog
approach
neuroprotect
use
empir
foal
hie
use
valid
tabl
one
wide
use
drug
decad
dimethyl
sulfoxid
dmso
use
purport
free
radic
scaveng
antiinflammatori
effect
perhap
reinforc
eas
administr
low
cost
dmso
osmot
diuret
effect
may
help
reduc
intracrani
pressur
reportedli
block
sodium
channel
activ
suppress
calcium
influx
prevent
glutam
excitotox
cell
death
promis
appear
actual
littl
scientif
evid
efficaci
regard
dmso
treatment
hie
clinic
consensu
use
lack
mannitol
administ
reduc
cerebr
edema
evid
efficaci
also
lack
treatment
modal
commonli
use
magnesium
sulfat
treatment
interest
nmdareceptor
antagonist
effect
magnesium
may
also
stabil
cell
membran
inhibit
free
radic
product
reduc
secondari
cn
inflamm
associ
injuri
use
magnesium
sulfat
foal
hie
report
treatment
appear
well
toler
although
excess
dose
caus
muscular
weak
hyotens
data
avail
regard
efficaci
foal
although
studi
encourag
result
therapeut
approach
current
remain
preclin
human
infant
hie
pentoxifyllin
phosphodiesteras
inhibitor
antiinflammatori
immunemodul
effect
may
improv
local
tissu
perfus
suggest
pentoxifyllin
may
inhibit
product
foal
ne
antioxid
administr
may
benefit
address
cn
inflamm
vitamin
c
e
thiamin
vitamin
b
administ
foal
hie
allopurinol
antioxid
shown
promis
human
infant
remain
preclin
time
allopurinol
administr
suggest
foal
hie
report
use
myriad
addit
treatment
investig
human
neonat
hie
appear
promis
includ
inhal
xenon
antiexcitotox
agent
melatonin
antioxid
erythropoietin
growth
factor
stem
cell
therapi
respiratori
disord
lower
respiratori
tract
diseas
common
foal
account
substanti
morbid
mortal
foal
risk
develop
respiratori
diseas
caus
complex
interact
innat
immunolog
factor
number
risk
factor
immunolog
factor
includ
possibl
fpti
delay
endogen
immunoglobulin
product
potenti
impair
immunolog
respons
risk
factor
neonat
includ
system
sepsi
congenit
abnorm
meconium
aspir
milk
aspir
birth
trauma
risk
factor
older
foal
includ
stress
wean
sale
prepar
transport
well
confin
crowd
dusti
condit
result
heavi
exposur
potenti
respiratori
pathogen
sever
syndrom
associ
respiratori
distress
foal
syndrom
result
varieti
initi
caus
defin
characterist
chang
age
caus
normal
matur
pulmonari
function
newborn
foal
extent
caus
chang
natur
insult
result
respiratori
distress
find
acut
respiratori
distress
immedi
birth
like
associ
extrapulmonari
disord
caus
upper
respiratori
obstruct
bilater
choanal
atresia
stenosi
nare
sever
laryng
edema
collaps
dorsal
displac
soft
palat
subepiglott
cyst
sever
congenit
pulmonari
abnorm
congenit
cardiac
anomali
malposit
great
vessel
result
sever
righttoleft
shunt
may
also
involv
deal
respiratori
distress
foal
beyond
immedi
postpartum
period
situat
becom
confus
broad
rang
etiolog
involv
broad
spectrum
clinic
syndrom
although
appreci
human
veterinari
medicin
mani
year
past
decad
consensu
approach
situat
develop
veterinari
medicin
term
acut
lung
injuri
ali
acut
rd
ard
origin
develop
human
medicin
refer
syndrom
respiratori
failur
associ
noncardiogen
pulmonari
edema
decreas
pulmonari
complianc
ventilationperfus
mismatch
syndrom
associ
exagger
selfperpetu
inflammatori
respons
result
sever
tissu
damag
within
lung
proteinrich
edema
fluid
accumul
within
alveoli
interstitium
result
impair
ga
exchang
lead
hypoxemia
ali
ard
primari
diseas
syndrom
alway
occur
secondari
diseas
process
risk
factor
ali
ard
human
patient
includ
process
result
direct
pulmonari
injuri
pneumonia
aspir
gastric
content
smoke
inhal
pulmonari
contus
drown
indirect
pulmonari
injuri
nonpulmonari
sepsi
pancreat
multipl
transfus
major
trauma
accur
assess
respiratori
function
neonat
requir
arteri
blood
ga
analysi
readi
avail
portabl
blood
ga
analyz
greatli
improv
access
import
diagnost
tool
manag
critic
ill
foal
without
inform
extrem
difficult
import
initi
evalu
formul
appropri
treatment
plan
monitor
respons
treatment
prognost
foal
readili
sampl
later
recumb
use
later
metatars
arteri
brachial
transvers
facial
arteri
sampl
perform
quickli
place
foal
later
recumb
patient
return
sternal
stand
posit
soon
possibl
posit
later
recumb
substanti
neg
impact
arteri
oxygen
mm
hg
diagnost
impact
address
use
appropri
refer
rang
deriv
foal
sampl
later
recumb
tabl
major
element
factor
interpret
arteri
blood
ga
data
neonat
foal
chang
pulmonari
function
occur
cours
first
sever
day
life
newborn
foal
small
degre
shunt
fraction
render
rel
hypoxem
less
respons
oxygen
supplement
adult
phenomenon
also
address
tabl
common
arteri
blood
ga
abnorm
identifi
neonat
foal
hypoxemia
normocapnia
hypocapnia
hypoxemia
hypercapnia
hypoxemia
result
sever
mechan
hypoventil
ventilationperfus
mismatch
impair
diffus
intrapulmonari
extrapulmonari
cardiac
shunt
decreas
concentr
oxygen
inspir
air
high
altitud
inappropri
ventil
set
weak
recumb
neonat
foal
frequent
suffer
hypoventil
wherea
presenc
intrapulmonari
inflamm
surfact
defici
caus
substanti
ventilationperfus
mismatch
intrapulmonari
shunt
blood
sever
inflamm
pulmonari
edema
caus
diffus
impair
wherea
extrapulmonari
shunt
commonli
associ
persist
fetal
circul
cardiac
anomali
foal
suffer
pneumonia
typic
show
profound
hypoxemia
initi
develop
hypercapnia
respiratori
acidosi
indic
substanti
worsen
pulmonari
function
associ
poorer
prognosi
surviv
ali
human
patient
character
acut
onset
presenc
bilater
pulmonari
infiltr
thorac
radiograph
decreas
ratio
partial
pressur
oxygen
arteri
blood
pao
fraction
inspir
oxygen
fio
mm
hg
pulmonari
arteri
wedg
pressur
less
mm
hg
absenc
clinic
evid
left
atrial
hypertens
ard
repres
sever
degre
dysfunct
character
criteria
lower
pao
fio
ratio
mm
hg
similar
terminolog
definit
propos
foal
suffer
respiratori
distress
multipl
classif
defin
includ
neonat
equin
rd
nerd
equin
neonat
ali
eqnali
equin
neonat
ard
eqnard
veterinari
ali
vetali
veterinari
ard
vetard
diagnost
criteria
syndrom
provid
tabular
form
box
although
term
nerd
new
syndrom
sever
progress
respiratori
distress
foal
within
first
hour
life
recogn
least
year
nerd
similar
infant
rd
human
infant
caus
primari
surfact
defici
associ
prematur
deliveri
surfact
three
primari
role
within
lung
prevent
atelectasi
end
expir
increas
pulmonari
complianc
facilit
recruit
collaps
airway
surfact
defici
lead
progress
atelectasi
decreas
pulmonari
complianc
worsen
ventilationperfus
mismatch
caus
intrapulmonari
possibl
extrapulmonari
shunt
blood
hypoventil
increas
work
breath
address
end
result
progress
hypoxia
hypercapnia
ultim
respiratori
failur
treatment
nerd
challeng
primari
intervent
use
human
infant
readili
avail
equin
medicin
exogen
surfact
avail
tertiari
care
referr
center
mechan
ventil
given
benefit
surfact
therapi
human
respiratori
distress
syndrom
rd
patient
intervent
great
interest
affect
foal
author
person
experi
limit
refer
therapi
literatur
suggest
effect
therapi
short
durat
need
repeat
frequent
make
difficult
justifi
signific
expens
surfact
even
avail
interestingli
one
primari
chang
manag
human
neonat
rd
driven
recognit
mechan
ventil
via
endotrach
intub
although
lifesav
mani
case
also
associ
potenti
seriou
acut
complic
longterm
pulmonari
dysfunct
acut
complic
may
includ
trauma
upper
respiratori
tract
associ
intub
increas
risk
lower
respiratori
tract
infect
pulmonari
barotrauma
volutrauma
air
leak
syndrom
pneumothorax
hemodynam
complic
caus
impair
venou
return
wherea
primari
longterm
complic
bronchopulmonari
dysplasia
concern
noninvas
form
respiratori
support
wide
use
human
infant
rd
includ
form
respiratori
support
deliv
endotrach
tube
simplest
readili
implement
form
noninvas
respiratori
support
foal
intranas
administr
humidifi
oxygen
via
intranas
cannula
although
singl
cannula
often
use
may
provid
suffici
oxygen
flow
rate
case
second
cannula
place
opposit
nostril
combin
flow
rate
lminut
readili
deliv
potenti
downsid
bilater
cannula
placement
may
caus
degre
upper
respiratori
obstruct
small
foal
potenti
impair
exhal
co
elimin
although
effect
detect
techniqu
investig
healthi
foal
nasal
cannul
possibl
achiev
adequ
flow
rate
intratrach
cathet
use
oxygen
insuffl
rare
repres
anyth
shortterm
solut
although
oxygen
insuffl
tremend
help
unlik
suffici
foal
sever
respiratori
impair
secondari
surfact
defici
caus
progress
alveolar
collaps
worsen
ventilationperfus
mismatch
sever
affect
case
mechan
ventil
repres
viabl
mean
respiratori
support
techniqu
discuss
detail
later
section
howev
noninvas
respiratori
support
strategi
provid
continu
posit
distend
pressur
continu
posit
airway
pressur
cpap
wide
use
human
neonat
rd
shown
reduc
respiratori
failur
mortal
older
report
noninvas
ventilatori
support
techniqu
foal
use
mechan
ventil
either
nasal
prong
face
mask
recent
report
describ
adapt
commerci
human
cpap
devic
face
mask
provid
cpap
foal
author
report
although
cpap
nonpressur
oxygen
supplement
face
mask
normal
pretreat
hypoxemia
oxygen
extract
co
elimin
highest
cpap
lower
respiratori
rate
nonpressur
oxygen
administr
treatment
associ
develop
modest
hypercarbia
associ
advers
effect
treatment
modal
hold
promis
foal
suffer
nerd
evalu
affect
foal
need
syndrom
eqnali
eqnard
repres
subset
ali
ard
occur
foal
first
week
life
criteria
eqnalieqnard
differ
aliard
chang
occur
effici
pulmonari
ga
exchang
foal
develop
must
meet
least
one
first
four
criteria
criterion
five
recommend
option
measur
acut
onset
hour
tachypnea
labor
breath
rest
known
risk
factor
evid
pulmonari
capillari
leak
without
increas
pulmonari
capillari
pressur
one
follow
bilateraldiffus
infiltr
thorac
radiograph
one
quadrant
per
lobe
b
bilater
depend
densiti
gradient
ct
c
proteinac
fluid
within
conduct
airway
increas
extravascular
lung
water
evid
ineffici
ga
exchang
one
time
frame
diagnosi
syndrom
fundament
similar
vetali
vetard
except
use
agespecif
scale
pao
fio
ratio
base
blood
ga
valu
obtain
foal
breath
room
air
posit
later
recumb
typic
encount
clinic
practic
import
rememb
eqnalieqnard
primari
diagnosi
affect
foal
may
suffer
broad
rang
diseas
process
certainli
may
overlap
nerd
bacteri
sepsi
bacteri
pneumonia
common
diseas
process
foal
age
potenti
etiolog
includ
meconium
aspir
milk
aspir
viral
pneumonia
fungal
pneumonia
thorac
trauma
cover
detail
follow
section
treatment
eqnalieqnard
primarili
focus
address
hypoxemia
hypercapnia
pursu
correct
primari
etiolog
possibl
respiratori
support
may
involv
provis
intranas
oxygen
cpap
mechan
ventil
depend
sever
pulmonari
dysfunct
substanti
inflamm
present
may
indic
antiinflammatori
therapi
nonsteroid
antiinflammatori
unlik
suffici
evid
adult
human
ard
older
foal
vetard
corticosteroid
therapi
may
benefici
although
specif
therapeut
protocol
defin
recent
work
suggest
hydrocortison
administr
dosag
mgkg
per
day
iv
divid
four
six
dose
may
appropri
septic
foal
circi
approach
investig
septic
foal
foal
eqnalieqnard
likelihood
bacteri
infect
may
involv
age
group
broadspectrum
antimicrobi
therapi
also
indic
along
judici
fluid
therapi
support
care
definit
descript
acut
respiratori
distress
foal
associ
bronchointerstiti
pneumonia
foal
month
age
affect
foal
often
appear
clinic
normal
found
acut
respiratori
distress
dead
case
may
histori
previou
respiratori
diseas
associ
sudden
clinic
deterior
physic
examin
find
affect
foal
depress
letharg
inappet
sever
respiratori
distress
character
tachycardia
tachypnea
nostril
flare
paradox
breath
pattern
may
present
thorax
abdomen
move
opposit
one
anoth
rather
synchron
inspir
expir
auscult
may
reveal
widespread
abnorm
sound
promin
wheez
crackl
lung
sound
may
quiet
absent
larg
airway
sound
detect
fever
inject
mucou
membran
common
well
care
taken
auscult
heart
thoroughli
may
difficult
presenc
diffus
abnorm
respiratori
sound
rule
cardiac
caus
pulmonari
edema
clinicopatholog
evalu
import
assess
pulmonari
function
identif
primari
underli
diseas
process
arteri
blood
ga
analysi
extrem
help
perform
initi
intranas
oxygen
insuffl
clinic
appropri
complet
blood
count
fibrinogen
concentr
saa
concentr
help
character
sever
system
inflamm
high
wbc
count
fibrinogen
saa
concentr
although
definit
may
suggest
rhodococcu
equi
infect
thorac
imag
extrem
help
stage
degre
pulmonari
inflamm
identifi
underli
primari
diseas
process
thorac
ultrasonographi
readili
perform
may
provid
use
inform
presenc
sever
atelectasi
pleural
effus
pulmonari
abscess
diffus
lung
inflamm
occur
ali
seen
thicken
viscer
pleura
appear
echogen
project
array
perpendicular
surfac
lung
comettail
artifact
thorac
radiograph
provid
much
detail
inform
regard
sever
extent
pulmonari
inflamm
reason
imag
qualiti
obtain
stallsid
digit
radiograph
equip
radiograph
abnorm
observ
affect
foal
may
rang
diffus
interstiti
pattern
focal
diffus
coalesc
alveolar
pattern
multipl
air
bronchogram
serial
radiographi
help
monitor
progress
diseas
respons
treatment
presenc
pulmonari
abscess
thorac
ultrasonograph
examin
thorac
radiograph
strongli
suggest
r
equi
involv
definit
ct
imag
thorax
evalu
foal
pulmonari
diseas
recent
report
well
ct
imag
provid
much
detail
inform
regard
natur
degre
pulmonari
chang
avail
specialti
referr
set
time
foal
affect
vetalivetard
commonli
suffer
primari
bacteri
pneumonia
caus
viral
pneumonia
possibl
transtrach
aspir
perform
unless
patient
unstabl
undergo
procedur
sampl
provid
import
cytolog
evid
regard
type
sever
pulmonari
inflamm
presenc
extracellular
intracellular
bacteria
also
submit
bacteri
cultur
sensit
neutrophil
inflamm
typic
present
detect
intracellular
gramposit
coccobacilli
within
pulmonari
macrophag
strong
evid
presenc
r
equi
polymeras
chain
reaction
pcr
test
tracheal
aspir
may
help
confirm
rhodococc
involv
treatment
aliardsaffect
foal
focu
address
hypoxemia
treat
primari
underli
diseas
process
control
excess
inflammatori
respons
provid
support
care
intranas
oxygen
insuffl
describ
previous
initi
soon
possibl
foal
suffer
respiratori
distress
repres
primari
mean
respiratori
support
older
foal
antimicrobi
therapi
target
like
bacteri
pathogen
base
overal
assess
younger
foal
sepsi
may
play
primari
role
broadspectrum
antimicrobi
therapi
recommend
older
foal
empir
treatment
address
possibl
involv
r
equi
aggress
system
antiinflammatori
therapi
use
potent
corticosteroid
dexamethason
methylprednisolon
sodium
succin
shown
import
intervent
effect
surviv
affect
foal
corticosteroid
therapi
gradual
taper
clinic
condit
improv
rather
rapidli
withdrawn
prolong
therapi
shown
benefici
human
ard
patient
bronchodil
therapi
use
affect
foal
sever
respiratori
distress
bronchoconstrict
promin
featur
ard
bronchodil
administr
may
actual
worsen
ventilationperfus
mismatch
result
clinic
deterior
even
death
use
bronchodil
therapi
administ
nasal
insuffl
oxygen
institut
clinician
prepar
address
sudden
chang
clinic
statu
use
inhal
rout
administr
corticosteroid
bronchodil
patient
suffer
sever
pulmonari
dysfunct
substanti
ventilationperfus
mismatch
often
unreward
poor
pulmonari
penetr
deliveri
system
rout
recommend
prognosi
surviv
affect
foal
poor
guard
earli
aggress
corticosteroid
antimicrobi
therapi
offer
best
chanc
surviv
persist
pulmonari
hypertens
newborn
pphn
also
known
persist
fetal
circul
revers
fetal
circul
syndrom
character
sustain
increas
pulmonari
vascular
resist
increas
pulmonari
vascular
resist
possibl
combin
decreas
right
ventricular
function
result
righttoleft
shunt
ductu
arteriosu
andor
foramen
oval
pphn
idiopath
human
infant
commonli
associ
pulmonari
diseas
meconium
aspir
perinat
asphyxia
surfact
defici
pneumonia
foal
pphn
may
also
develop
secondari
system
sepsi
hypoxemia
acidosi
pathophysiolog
pphn
complex
fundament
repres
dysfunct
factor
regul
pulmonari
vascular
tone
pphn
suspect
neonat
foal
exhibit
progress
refractori
hypercapn
hypoxemia
care
taken
rule
presenc
congenit
cardiac
anomali
may
caus
extrapulmonari
shunt
blood
caus
hypoxem
respiratori
failur
sepsi
infecti
pneumonia
pphn
suspect
case
hypoxemia
show
signific
increas
pao
follow
institut
intranas
oxygen
therapi
definit
diagnosi
challeng
ultrasonographi
help
rule
congenit
cardiac
anomali
detect
primari
pulmonari
diseas
treatment
pphn
challeng
depend
address
predispos
underli
factor
address
sever
hypoxia
foal
respond
well
nasal
insuffl
oxygen
requir
intub
mechan
ventil
oxygen
use
address
hypoxia
potenti
stimul
pulmonari
vascular
relax
follow
brief
period
hyperoxia
recommend
taper
inhal
oxygen
concentr
target
pao
mm
hg
therapeut
agent
directli
address
pulmonari
vasoconstrict
wide
use
human
neonat
inhal
nitric
oxid
ino
approv
pulmonari
vasodil
human
use
success
use
ino
therapi
foal
report
unfortun
impract
set
requir
mechan
ventil
along
special
equip
introduc
ga
ventil
circuit
sildenafil
viagra
pfizer
inc
new
york
phosphodiesteras
type
inhibitor
use
human
report
effect
anecdot
report
use
sildenafil
foal
pphn
dosag
rate
mgkg
po
everi
hour
start
lower
end
dosag
rang
avoid
system
hypotens
although
support
one
case
report
human
use
pentoxifyllin
nonselect
phosphodiesteras
inhibitor
adjunct
therapi
may
worthi
consider
foal
avail
low
cost
accept
safeti
profil
number
congenit
upper
respiratori
tract
disord
foal
although
none
common
includ
wri
nose
choanal
atresia
cleft
palat
nasopharyng
cyst
subepiglott
cyst
wri
nose
involv
later
rotat
deviat
structur
nose
moder
sever
case
caus
signific
upper
airway
obstruct
surgic
repair
possibl
must
regard
salvag
procedur
prognosi
athlet
function
poor
choanal
atresia
rare
foal
involv
unilater
bilater
soft
tissu
narrow
complet
obstruct
caudal
aspect
nasal
passag
foal
born
bilater
complet
obstruct
die
without
rapid
intervent
establish
airway
oblig
nasal
breath
natur
equin
foal
unilater
choanal
atresia
often
remain
undiagnos
later
life
diagnosi
often
made
use
endoscopi
ct
examin
use
case
surgic
correct
feasibl
prognosi
perform
remain
guard
persist
airway
narrow
mani
case
cleft
palat
deform
rare
report
foal
affect
foal
show
clinic
sign
dysphagia
nurs
includ
cough
nasal
milk
drainag
inconsist
aspir
pneumonia
common
complic
primari
site
involv
soft
palat
defect
rang
small
focal
site
essenti
absenc
entir
soft
palat
diagnosi
readili
made
endoscop
although
surgic
correct
theoret
possibl
approach
difficult
outcom
uncertain
especi
larg
defect
one
recent
report
success
transor
endoscop
assist
repair
foal
subepiglott
cyst
also
rare
foal
present
interfer
epiglott
placement
result
persist
palat
displac
sever
dysphagia
aspir
pneumonia
diagnosi
primarili
endoscop
examin
although
visual
may
difficult
cyst
posit
palat
radiograph
ct
may
help
detect
lesion
treatment
cyst
remov
either
via
laryngotomi
nasal
oral
endoscop
approach
meconium
aspir
syndrom
ma
defin
respiratori
distress
foal
born
amniot
fluid
stain
meconium
symptom
explain
etiolog
meconium
stain
occur
immedi
parturit
meconium
passag
utero
thought
primarili
occur
respons
fetal
hypoxia
lead
fetal
stress
fetal
hypoxia
also
may
result
fetal
gasp
facilit
introduct
meconium
respiratori
tract
utero
meconium
aspir
may
also
occur
associ
first
breath
birth
presenc
meconiumstain
amniot
fluid
guarante
ma
occur
howev
human
infant
born
meconiumstain
amniot
fluid
develop
ma
meconium
contamin
lower
respiratori
tract
occur
number
pathophysiolog
mechan
lead
pulmonari
dysfunct
includ
mechan
airway
obstruct
region
air
trap
surfact
inactiv
surfact
displac
chemic
pneumon
alveol
persist
pulmonari
hypertens
meconium
aspir
suspect
aspir
materi
nasal
passag
pharynx
perform
even
foal
birth
canal
birth
attend
sever
contamin
suspect
nasotrach
intub
follow
asept
suction
suggest
although
care
must
taken
avoid
contamin
lower
respiratori
tract
overli
zealou
suction
intranas
oxygen
supplement
recommend
affect
foal
mechan
ventil
requir
sever
affect
case
associ
worsen
prognosi
mechan
ventil
challeng
case
degre
pulmonari
inflamm
airway
compromis
well
sever
ventilationperfus
mismatch
strategi
minim
barotrauma
cpap
ventil
synchron
intermitt
mandatori
ventil
simv
may
help
surfact
administr
lung
lavag
dilut
surfact
appear
effect
human
neonat
ma
routin
use
foal
antiinflammatori
therapi
may
benefici
substanti
pulmonari
inflamm
associ
ma
pentoxifyllin
shown
promis
anim
model
appear
safe
foal
easili
administ
corticosteroid
either
inhal
system
administ
commonli
use
human
infant
ma
although
meconium
aspir
associ
primari
bacteri
pneumonia
affect
foal
risk
secondari
bacteri
infect
broadspectrum
antimicrobi
therapi
recommend
neonat
foal
may
aspir
milk
lower
respiratori
tract
secondari
number
condit
although
common
secondari
gener
weak
poor
suckl
reflex
dysphagia
relat
prematur
ne
risk
may
exacerb
attempt
bottl
feed
foal
affect
problem
potenti
caus
aspir
includ
physic
abnorm
subepiglott
cyst
cleft
palat
megaesophagu
esophag
stenosi
esophag
compress
vascular
anomali
persist
dorsal
displac
soft
palat
function
abnorm
pharynx
larynx
esophagu
result
aspir
associ
pharyng
dysfunct
unknown
etiolog
botul
hyperkalem
period
paralysi
incorrect
placement
nasoesophag
feed
tube
also
associ
direct
instil
milk
lung
lead
aspir
pneumonia
detect
milk
aspir
difficult
affect
foal
may
cough
show
nasal
milk
regurgit
diagnosi
base
histor
inform
may
reveal
episod
nasal
milk
regurgit
physic
examin
find
demonstr
abnorm
lower
respiratori
sound
clinicopatholog
evid
system
inflamm
inflammatori
leukogram
hyperfibrinogenemia
increas
saa
pulmonari
dysfunct
arteri
hypoxemia
endoscop
examin
upper
respiratori
tract
may
reveal
structur
abnorm
pharynx
larynx
esophagu
suggest
aspir
pharyng
dysfunct
may
observ
thorac
radiograph
typic
reveal
alveolar
pattern
without
air
bronchogram
caudoventr
lung
may
local
perihilar
region
import
pursu
identif
correct
caus
aspir
possibl
prevent
aspir
placement
nasoesophag
feed
tube
allow
safe
deliveri
milk
pend
correct
underli
disord
broadspectrum
antimicrobi
therapi
indic
address
bacteri
pneumonia
accompani
milk
aspir
success
treatment
may
requir
sever
week
treatment
idiopath
transient
tachypnea
report
clydesdal
thoroughbr
arabian
foal
gener
seen
hot
humid
weather
condit
condit
believ
result
immatur
dysfunct
thermoregulatori
mechan
affect
foal
usual
normal
birth
normal
gestat
age
develop
hyperthermia
tachypnea
variabl
time
follow
birth
critic
potenti
caus
respiratori
diseas
rule
make
diagnosi
idiopath
tachypnea
consequ
withhold
antimicrobi
treatment
could
sever
treatment
primarili
direct
control
hyperthermia
may
includ
bodi
clip
alcohol
bath
movement
cool
shadi
environ
foal
condit
selflimit
resolv
within
day
week
rib
fractur
fairli
common
problem
report
gener
popul
neonat
foal
mani
foal
present
neonat
icu
fractur
rib
caus
number
traumat
insult
thorac
viscera
includ
pulmonari
contus
lacer
lung
major
arteri
heart
diaphragm
pneumothorax
hemothorax
diaphragmat
herniat
may
occur
result
traumat
insult
myocardi
injuri
typic
fatal
rib
fractur
singl
often
multipl
often
affect
adjac
rib
one
side
chest
common
site
injuri
costochondr
junction
immedi
dorsal
flail
chest
paradox
thorac
wall
motion
may
occur
multipl
rib
fractur
affect
region
move
inward
inspir
outward
expir
counter
movement
intact
portion
thorac
wall
rib
fractur
commonli
found
physic
examin
palpat
fractur
detect
crepitu
site
fractur
auscult
may
reveal
grind
click
sound
area
fractur
well
confirm
diagnosi
best
accomplish
ultrasonograph
modal
much
sensit
radiographi
purpos
ultrasonographi
may
also
use
document
presenc
air
blood
abdomin
viscera
within
thorac
caviti
although
radiographi
may
help
evalu
treatment
depend
structur
involv
sever
complic
observ
minim
displac
rib
fractur
particularli
involv
costochondr
junction
manag
conserv
stall
rest
avoid
pressur
affect
area
foal
handl
mild
moder
pneumothorax
may
requir
intervent
substanti
air
present
within
pleural
caviti
caus
respiratori
distress
evacu
placement
indwel
thorac
cathet
facilit
ongo
drainag
multipl
rib
fractur
particularli
sharp
boni
project
expos
threaten
intern
injuri
surgic
repair
may
indic
hemothorax
lifethreaten
pulmonari
compress
andor
sever
blood
loss
anemia
treatment
focu
address
primari
caus
hemorrhag
patient
stabil
support
viral
pneumonia
uncommon
neonat
foal
associ
equin
influenza
viru
eiv
equin
arter
viru
eav
equin
adenoviru
eadv
infect
neonat
foal
sever
typic
fatal
despit
aggress
treatment
one
challeng
associ
case
difficulti
ascertain
involv
present
sign
similar
neonat
sepsi
foal
may
deliv
somewhat
earli
littl
warn
impend
parturit
placenta
usual
grossli
normal
farm
outbreak
report
clinic
sign
cardiovascular
respiratori
insuffici
mucou
membran
sever
congest
icter
clinicopatholog
abnorm
includ
sever
leukopenia
neutropenia
toxic
neutrophil
morpholog
lymphopenia
combin
sever
leukopenia
icteru
may
suggest
infect
bone
marrow
examin
reveal
deplet
myeloid
cell
line
mani
affect
foal
display
dilat
retin
vasculatur
reddish
discolor
optic
disk
diagnost
confirm
readili
accomplish
pcr
test
nasal
secret
whole
blood
treatment
affect
foal
acyclovir
attempt
appear
efficaci
less
sever
affect
foal
given
superior
bioavail
valacyclovir
adult
hors
drug
may
repres
suitabl
choic
use
foal
appear
rare
caus
neonat
diseas
commonli
associ
abort
stillbirth
associ
neonat
mortal
caus
multisystem
diseas
infect
eiv
neonat
foal
common
particularli
endem
area
mare
routin
vaccin
foal
typic
protect
matern
colostr
antibodi
outbreak
report
eiv
introduc
popul
eiv
infect
suscept
foal
associ
sever
bronchointerstiti
pneumonia
lead
respiratori
distress
antemortem
diagnosi
pcr
nasal
secret
specif
treatment
eiv
infect
neonat
infect
eav
associ
sever
interstiti
pneumonia
report
uniformli
fatal
solitari
case
farm
outbreak
report
clinic
sign
associ
neonat
eav
infect
sever
primarili
respiratori
initi
includ
edema
weak
depress
ultim
progress
termin
respiratori
distress
although
acut
death
also
report
gastrointestin
involv
report
case
consist
present
clinicopatholog
abnorm
specif
eav
infect
often
includ
leukopenia
thrombocytopenia
specif
antivir
treatment
eav
despit
attempt
aggress
medic
therapi
report
success
treatment
neonat
eav
infect
diagnost
confirm
eav
involv
readili
achiev
pcr
test
blood
respiratori
secret
tissu
lung
kidney
spleen
eadv
infect
rare
immunocompet
foal
primari
concern
immunocompromis
foal
best
describ
syndrom
associ
eadv
infect
arabian
foal
sever
combin
immunodefici
syndrom
although
similar
syndrom
may
occur
fell
poni
foal
unidentifi
immunodefici
two
distinct
eadv
identifi
ubiquit
readili
isol
normal
diseas
foal
hors
wherea
isol
foal
upper
respiratori
tract
diseas
diarrhea
experiment
infect
healthi
foal
eadv
associ
pneumonia
regardless
breed
pcr
test
avail
care
must
taken
interpret
frequent
detect
normal
anim
confirm
diagnosi
may
requir
histopatholog
evid
eadv
infect
viru
isol
viral
respiratori
infect
common
older
foal
neonat
foal
respiratori
diseas
age
group
associ
eiv
eav
clinic
sign
associ
ehv
eiv
infect
age
group
similar
consist
report
adult
hors
clinic
sign
typic
includ
dri
cough
fever
although
mucopurul
nasal
discharg
may
present
well
presenc
discharg
may
suggest
secondari
bacteri
involv
howev
eiv
ehv
infect
older
foal
typic
much
less
sever
neonat
ultim
selflimit
rare
fatal
pulmonari
vasculotrop
form
infect
also
describ
young
hors
eav
infect
typic
show
similar
respiratori
sign
fever
affect
individu
often
exhibit
substanti
ventral
limb
edema
secondari
vascul
potenti
role
gammaherpesvirus
foal
pneumonia
intrigu
current
unclear
virus
ubiquit
equin
popul
worldwid
foal
becom
infect
within
first
sever
month
life
infect
foal
gener
consid
occur
without
clinic
sign
infect
associ
mild
sever
chronic
pharyng
foal
follow
natur
experiment
infect
sign
upper
respiratori
tract
diseas
lymphadenopathi
mild
pyrexia
rhiniti
may
associ
natur
infect
intrigu
evid
exist
may
play
role
potenti
lower
respiratori
bacteri
infect
report
use
vaccin
protect
foal
r
equi
pneumonia
natur
infect
foal
associ
fever
immunopatholog
chang
similar
observ
human
adolesc
suffer
infecti
mononucleosi
follow
infect
epsteinbarr
viru
addit
genom
contain
homolog
well
encod
sever
protein
may
immunomodulatori
effect
could
predispos
patient
bacteri
infect
case
pathogen
role
stronger
viru
convincingli
associ
syndrom
equin
multinodular
pulmonari
fibrosi
although
fungal
pneumonia
rare
neonat
foal
condit
awar
popul
utero
infect
histoplasma
capsulatum
associ
placent
abort
birth
infect
foal
affect
foal
multisystem
diseas
includ
granulomat
pneumonia
antemortem
diagnosi
challeng
may
facilit
tracheal
aspir
bronchoalveolar
lavag
cytolog
characterist
yeastlik
organ
diamet
may
detect
within
macrophag
serolog
use
well
mare
foal
posit
antihistoplasma
antibodi
detect
use
agar
gel
immunodiffus
test
although
success
treatment
infect
adult
report
use
amphotericin
b
report
success
treatment
neonat
foal
although
candida
spp
infect
major
problem
human
intens
care
patient
appear
infrequ
problem
foal
system
candidiasi
report
foal
superfici
infect
mucou
membran
thrush
appear
common
presenc
superfici
infect
may
relat
develop
system
infect
lesion
taken
serious
treatment
implement
time
manner
concern
reinforc
fact
clinic
sign
associ
system
candidiasi
indistinguish
seen
bacteri
sepsi
confirm
diagnosi
system
candidiasi
blood
cultur
organ
success
treatment
report
iv
amphotericin
b
andor
oral
fluconazol
fluconazol
prefer
follow
ingest
larvat
egg
parascari
equorum
infect
larva
emerg
intestin
lumen
migrat
liver
lung
cough
reingest
return
small
intestin
matur
adult
passag
lung
associ
substanti
inflamm
infect
foal
may
present
clinic
sign
lower
respiratori
diseas
larva
migrat
lung
infest
ultim
selflimit
pulmonari
sign
rare
requir
medic
treatment
concern
regard
possibl
colic
secondari
intestin
obstruct
adult
parasit
recommend
foal
suspect
parasit
pneumonia
deworm
ivermectin
recommend
tradit
widespread
emerg
macrocycl
lactoneresist
strain
led
recommend
benzimidazol
pyrimidin
anthelmint
use
resist
demonstr
class
well
unfortun
requir
individu
monitor
fecal
egg
count
ensur
efficaci
anthelmint
therapi
bacteri
pneumonia
neonat
often
associ
hematogen
spread
secondari
bacteremia
may
also
occur
secondari
infect
utero
meconium
milk
aspir
bacteria
associ
neonat
pneumonia
typic
involv
neonat
sepsi
gramneg
bacteria
organ
commonli
involv
gramposit
infect
appear
increas
preval
howev
mix
infect
occur
well
common
isol
e
coli
klebsiella
spp
actinobacillu
spp
pasteurella
spp
salmonella
spp
streptococcu
spp
enterococcu
spp
staphylococcu
spp
also
occur
frequenc
success
treatment
depend
earli
effect
support
respiratori
function
correct
hypoxemia
control
system
pulmonari
inflamm
appropri
antimicrobi
therapi
unfortun
antimicrobi
select
almost
alway
empir
initi
collect
blood
cultur
sampl
initi
antimicrobi
therapi
encourag
provid
confirm
bacteri
involv
guid
futur
antimicrobi
therapi
basi
antimicrobi
sensit
pattern
transtrach
aspir
commonli
perform
neonat
foal
technic
challeng
may
worsen
foal
respiratori
distress
use
diagnost
especi
respiratori
infect
secondari
aspir
possibl
polymicrobi
mix
infect
broadspectrum
therapi
recommend
initi
often
consist
penicillin
combin
aminoglycosid
thirdgener
cephalosporin
ceftiofur
may
repres
better
choic
superior
pulmonari
penetr
pneumonia
common
foal
month
age
common
caus
death
age
group
common
etiolog
agent
bacteri
pneumonia
older
foal
streptococcu
equi
subsp
zooepidemicu
normal
upper
respiratori
commens
organ
age
group
foal
may
risk
develop
respiratori
infect
caus
decay
level
matern
immunoglobulin
conjunct
delay
endogen
immunoglobulin
product
possibl
impair
immunolog
respons
pathogen
exposur
addit
risk
factor
older
foal
includ
stress
wean
sale
prepar
transport
well
confin
crowd
dusti
condit
result
heavi
exposur
potenti
respiratori
pathogen
secondari
infect
gramneg
organ
uncommon
foal
occur
may
exhibit
poor
respons
treatment
deterior
clinic
face
treatment
viral
infect
eia
may
caus
pulmonari
inflamm
injuri
wherea
viral
infect
may
directli
impair
pulmonari
immun
respons
facilit
develop
secondari
bacteri
pneumonia
second
common
agent
pneumonia
age
group
r
equi
facult
intracellular
gramposit
coccobacillu
organ
first
isol
foal
pyogranulomat
pneumonia
sweden
origin
name
corynebacterium
equi
although
known
r
equi
sever
decad
taxonom
nomenclatur
organ
matter
ongo
debat
altern
name
prescottella
equi
prescottia
equi
recent
propos
convent
terminolog
r
equi
use
r
equi
consid
ubiquit
bacterium
worldwid
distribut
although
recent
studi
suggest
may
present
iceland
isol
capabl
caus
diseas
foal
carri
plasmid
encod
virulenceassoci
protein
vapa
although
vapa
requir
virul
alon
suffici
plasmidencod
gene
also
influenc
virul
rhodococc
pneumonia
occasion
seen
sporad
diseas
common
endem
farm
often
substanti
variat
incid
diseas
annual
basi
endem
farm
mani
one
third
foal
affect
clinic
diseas
affect
foal
may
die
like
rout
infect
foal
inhal
increas
airborn
concentr
virul
r
equi
posit
associ
develop
pneumonia
high
stock
densiti
mare
foal
also
associ
increas
incid
rhodococc
pneumonia
higher
concentr
r
equi
detect
stall
barn
oppos
pastur
paddock
could
lend
support
suggest
dusti
condit
associ
increas
incid
rhodococc
infect
r
equi
infect
rare
adult
hors
unless
suffer
form
immunodefici
given
ubiquit
natur
r
equi
environ
suggest
foal
way
uniqu
suscept
infect
organ
sever
studi
investig
immun
respons
foal
result
inconclus
clear
evid
agerel
immunodefici
render
suscept
recent
studi
investig
potenti
genet
predisposit
rhodococc
infect
intrigu
find
polymorph
transferrin
gene
associ
rhodococc
pneumonia
thoroughbr
arabian
foal
respect
recent
genet
region
chromosom
contain
gene
associ
neutrophil
function
found
posit
associ
rhodococc
pneumonia
foal
singl
nucleotid
polymorph
region
three
four
time
like
clinic
affect
herdmat
occult
natur
diseas
tremend
interest
identifi
infect
foal
earli
possibl
treatment
implement
earli
diseas
process
end
number
screen
program
earli
detect
infect
foal
investig
includ
serial
monitor
physic
examin
wbc
concentr
fibrinogen
assay
saa
concentr
quantit
fecal
vapa
pcr
test
none
proven
clinic
effect
serolog
unreward
well
although
recent
report
vapaspecif
serum
igg
measur
may
use
identifi
infect
foal
although
requir
valid
field
set
ultrasonograph
screen
program
develop
demonstr
larg
number
foal
pulmonari
lesion
absenc
clinic
sign
widespread
implement
ultrasonograph
screen
protocol
endem
farm
subclin
r
equi
infect
becom
common
form
diseas
approach
also
result
treatment
mani
foal
pulmonari
lesion
would
like
resolv
spontan
contribut
develop
macrolid
resist
clinic
evid
rhodococc
pneumonia
often
insidi
ultim
present
sign
consist
lower
respiratori
tract
infect
fever
lethargi
cough
tachypnea
dyspnea
common
clinic
sign
dyspnea
sever
nostril
flare
promin
abdomin
expiratori
effort
although
rel
rare
foal
may
present
subacut
sever
form
respiratori
diseas
consist
ard
sever
affect
foal
may
found
dead
auscult
typic
reveal
diffus
crackl
wheez
promin
larg
airway
sound
rattl
caus
accumul
exud
cranial
thorac
region
rebreath
examin
typic
necessari
promin
abnorm
lung
sound
contraind
anim
respiratori
distress
import
perform
thorough
examin
affect
foal
extrapulmonari
disord
common
common
diarrhea
ulcer
enterotyphlocol
presum
immunomedi
synov
intraabdomin
lymphaden
abscess
uveiti
arteri
blood
ga
analysi
extrem
help
assess
degre
pulmonari
dysfunct
perform
initi
intranas
oxygen
insuffl
clinic
appropri
complet
blood
count
fibrinogen
concentr
saa
concentr
help
character
sever
system
inflamm
high
wbc
count
fibrinogen
saa
concentr
although
definit
may
suggest
r
equi
infect
serial
monitor
valu
help
assess
respons
treatment
determin
durat
therapi
thorac
imag
extrem
help
stage
degre
pulmonari
inflamm
support
diagnosi
rhodococc
involv
serial
imag
studi
help
monitor
progress
diseas
respons
treatment
thorac
ultrasonographi
readili
perform
effect
detect
peripher
pulmonari
consolid
abscess
unabl
detect
axial
lesion
unless
peripher
lesion
present
despit
limit
ultrasonographi
wide
use
imag
techniqu
evalu
foal
suspect
rhodococc
pneumonia
combin
readi
avail
eas
perform
diagnost
util
abdomin
ultrasonographi
also
perform
foal
suspect
rhodococc
pneumonia
frequenc
abdomin
extrapulmonari
disord
thorac
radiograph
provid
detail
inform
regard
sever
extent
pulmonari
diseas
howev
consid
sever
affect
case
particularli
given
reason
imag
qualiti
obtain
stallsid
digit
radiograph
equip
radiograph
abnorm
observ
affect
foal
may
includ
diffus
interstiti
alveolar
pattern
tracheobronchi
lymphadenopathi
intrapulmonari
abscess
pleural
effus
score
system
develop
assess
sever
alveolar
pattern
interstiti
pattern
tracheobronchi
lymphadenopathi
pleural
effus
number
nodular
opac
cavitari
lesion
affect
foal
foal
higher
median
score
less
like
surviv
odd
ratio
confid
interv
ci
foal
lower
score
sever
alveolar
pattern
number
cavitari
lesion
associ
decreas
surviv
care
taken
avoid
overinterpret
imag
studi
especi
thorac
ultrasonographi
mani
lesion
detect
may
resolv
without
therapeut
intervent
recent
studi
endem
farm
found
foal
develop
ultrasonograph
evid
pulmonari
consolid
abscess
format
develop
clinic
appar
r
equi
pneumonia
result
concern
thorac
ultrasonograph
score
system
use
sever
prospect
studi
rhodococc
pneumonia
therapi
effort
effect
identifi
foal
requir
treatment
score
system
defin
pulmonari
abscess
focal
hypoecho
area
diamet
cm
number
abscess
identifi
record
along
diamet
abscess
diamet
individu
abscess
total
gener
total
abscess
score
centimet
foal
total
score
less
cm
cm
typic
receiv
treatment
follow
complet
imag
studi
transtrach
aspir
perform
unless
patient
unstabl
undergo
procedur
sampl
provid
import
cytolog
evid
regard
type
sever
pulmonari
inflamm
presenc
extracellular
intracellular
bacteria
sampl
also
submit
bacteri
cultur
sensit
profound
neutrophil
inflamm
degranul
neutrophil
typic
present
detect
intracellular
gramposit
coccobacilli
within
pulmonari
macrophag
strong
evid
presenc
r
equi
pcr
test
tracheal
aspir
may
also
help
confirm
rhodococc
involv
cultur
frequent
neg
even
intracellular
bacteria
seen
cytolog
examin
quantit
pcr
test
fece
recent
investig
endem
farm
found
use
diagnos
r
equi
foal
clinic
sign
pneumonia
although
result
preliminari
techniqu
may
prove
use
situat
tracheal
aspir
collect
treatment
foal
rhodococc
pneumonia
focu
address
respiratori
distress
present
treatment
infect
oxygen
insuffl
provid
possibl
anim
dyspnea
nonsteroid
antiinflammatori
therapi
may
help
control
fever
affect
anim
kept
cool
shade
area
possibl
risk
exacerb
physiolog
hyperthermia
antimicrobi
therapi
rhodococc
pneumonia
base
combin
macrolid
rifampin
year
approach
valid
recent
acvim
consensu
statement
although
erythromycin
initi
primari
macrolid
use
supplant
azithromycin
clarithromycin
varieti
reason
includ
less
frequent
administr
superior
drug
distribut
pharmacokinet
well
evid
superior
efficaci
retrospect
studi
interest
use
gamithromycin
treatment
r
equi
infect
foal
pharmacokinet
support
onceweekli
intramuscular
administr
recent
studi
report
gamithromycin
therapi
noninferior
combin
azithromycin
rifampin
although
also
report
foal
treat
gamithromycin
show
advers
reaction
consist
either
colic
hindlimb
lame
follow
drug
administr
like
caus
tissu
irrit
drug
potenti
efficaci
macrolid
tulathromycin
investig
despit
earli
report
efficaci
unaccept
pharmacokinet
subsequ
demonstr
ineffect
rifampin
use
combin
macrolid
therapi
basi
vitro
evid
synergist
effect
erythromycin
limit
evid
enhanc
treatment
efficaci
recent
studi
compar
efficaci
azithromycinrifampin
combin
azithromycin
alon
found
treatment
superior
placebo
differ
efficaci
treatment
despit
evid
efficaci
combin
call
question
interfer
rifampin
macrolid
absorpt
coadministr
still
recommend
use
rifampin
combin
macrolid
aid
minim
develop
resist
strain
combin
shown
lower
mutant
prevent
concentr
individu
macrolid
rifampin
alon
report
emerg
macrolideresist
rifampinresist
strain
r
equi
especi
endem
farm
larg
number
foal
receiv
treatment
subclin
pulmonari
lesion
identifi
survey
ultrasonograph
examin
reinforc
need
approach
inde
one
reason
question
need
treat
foal
suffer
sever
form
clinic
diseas
recent
studi
examin
treatment
efficaci
also
report
foal
untreat
control
group
recov
without
intervent
prognosi
surviv
athlet
function
foal
r
equi
pneumonia
good
respect
unfortun
odd
surviv
approxim
sevenfold
lower
foal
infect
macrolideresist
strain
tremend
interest
reduc
incid
rhodococc
infect
endem
farm
mani
year
highli
effect
approach
identifi
mainstay
prevent
mani
farm
administr
hyperimmun
plasma
despit
conflict
evid
regard
efficaci
widespread
accept
even
bestcas
scenario
protect
incomplet
despit
expens
difficulti
administr
potenti
complic
administr
hyperimmun
plasma
like
continu
use
prevent
effort
better
approach
becom
avail
chemoprophylact
strategi
investig
use
azithromycin
gallium
maltol
azithromycin
yield
conflict
result
gallium
show
evid
efficaci
prophylact
use
macrolid
discourag
howev
emerg
resist
strain
farm
larg
number
foal
receiv
drug
ultim
vaccin
repres
ideal
prevent
strategi
despit
intens
investig
effect
vaccin
yet
avail
foal
suffer
respiratori
dysfunct
respiratori
distress
may
util
use
bronchodil
increas
airway
diamet
decreas
work
breath
improv
ventil
clinic
util
approach
limit
howev
bronchoconstrict
appear
play
promin
role
ard
factor
limit
util
bronchodil
therapi
risk
result
increas
ventil
may
actual
worsen
degre
ventilationperfus
mismatch
caus
increas
ventil
area
lung
poorli
perfus
determin
whether
bronchodil
therapi
may
benefici
one
perform
bronchodil
respons
test
close
clinic
monitor
risk
worsen
hypoxemia
best
foal
alreadi
receiv
oxygen
nasal
insuffl
least
oxygen
readili
avail
case
clinic
deterior
administ
singl
dose
shortact
bronchodil
prefer
inhal
rather
system
monitor
respons
use
clinic
assess
ideal
repeat
arteri
blood
ga
analysi
patient
respond
favor
decreas
respiratori
effort
improv
arteri
oxygen
may
reason
continu
bronchodil
therapi
regard
choic
bronchodil
methylxanthin
aminophyllin
theophyllin
although
readili
avail
recommend
system
effect
narrow
therapeut
index
gener
use
aerosol
rout
prefer
target
applic
allow
use
smaller
dosag
reduc
risk
system
toxic
adrenerg
agonist
albuterol
clenbuterol
easili
administ
may
addit
benefit
includ
enhanc
mucociliari
clearanc
albuterol
inexpens
meter
dose
inhal
mdi
formul
often
use
tabl
drug
fairli
short
durat
action
hour
anticholinerg
bronchodil
ipratropium
bromid
atrov
boehring
ingelheim
longer
durat
action
albuterol
hour
use
alon
combin
combiv
boehring
ingelheim
ipratropium
avail
aerosol
prepar
either
mdi
solut
nebul
target
administr
antimicrobi
drug
respiratori
tract
interest
achiev
high
local
drug
concentr
may
allow
rapid
respons
minim
risk
system
toxic
although
control
studi
hors
lack
evid
human
medicin
use
aerosol
antimicrobi
adjunct
system
therapi
well
toler
may
improv
outcom
certain
subset
patient
although
number
antimicrobi
drug
administ
via
nebul
empir
clinic
set
drug
investig
aerosol
administr
hors
includ
ceftiofur
cefquinom
gentamicin
marbofloxacin
aerosol
administr
drug
hors
shown
achiev
high
respiratori
drug
concentr
well
toler
appear
safe
anecdot
two
wide
use
inhal
antimicrobi
hors
ceftiofur
gentamicin
tabl
varieti
devic
use
aerosol
drug
includ
jet
ultrason
nebul
recent
develop
vibrat
mesh
nebul
yield
uniform
appropri
size
aerosol
wide
varieti
drug
avail
vibrat
mesh
nebul
integr
face
mask
devic
specif
design
hors
flexineb
nortev
galway
ireland
greatli
facilit
abil
routin
deliv
aerosol
medic
clinic
field
set
goal
mechan
ventilatori
support
achiev
maintain
adequ
pulmonari
ga
exchang
reduc
work
breath
minim
patient
discomfort
distress
mechan
ventil
provid
pressur
volum
support
ensur
adequ
minut
ventil
achiev
also
provid
control
composit
inspir
gase
provid
suffici
oxygen
support
arteri
oxygen
patient
requir
mechan
ventil
typic
suffer
arteri
hypercapnia
andor
arteri
hypoxemia
treatment
hypercapnia
defin
paco
greater
mm
hg
fundament
increas
patient
alveolar
ventil
increas
rate
depth
breath
initi
therapi
clinician
use
respiratori
stimul
increas
patient
ventilatori
effort
tri
avoid
need
mechan
ventil
respiratori
stimul
therapi
unsuccess
resolv
hypercapnia
hypercapnia
sever
paco
mm
hg
one
consid
institut
mechan
ventil
earli
intervent
prefer
benefit
patient
prolong
hypercapnia
durat
requir
mechan
ventil
usual
shorter
earli
intervent
treatment
hypoxemia
defin
pao
less
mm
hg
initi
increas
fraction
inspir
oxygen
fio
provis
supplement
oxygen
intranas
insuffl
inadequ
patient
signific
hypoventil
ventilationperfus
mismatch
mechan
ventil
allow
much
higher
fio
achiev
insuffl
dramat
increas
alveolar
oxygen
tension
mechan
ventil
also
use
term
increas
minut
ventil
control
respiratori
rate
volum
recruit
alveoli
particip
ga
exchang
addit
benefit
decreas
effort
requir
respir
dramat
increas
face
pulmonari
diseas
allow
substanti
decreas
patient
energi
oxygen
need
also
eas
patient
distress
increas
patient
comfort
equin
patient
provis
mechan
ventilatori
support
indic
basic
situat
first
patient
lack
normal
respiratori
drive
obtund
comatos
neonat
foal
patient
impair
ventilatori
effort
patient
botul
type
patient
fairli
easi
ventil
lung
diseas
pulmonari
function
rel
normal
prognosi
surviv
foal
excel
mechan
ventil
institut
earli
fundament
differ
situat
present
patient
sever
pulmonari
diseas
result
respiratori
failur
foal
sever
sepsi
ard
meconium
aspir
sever
pneumonia
patient
presenc
pulmonari
diseas
result
profound
alter
pulmonari
function
primarili
form
increas
pulmonari
resist
decreas
dynam
complianc
make
patient
much
challeng
ventil
prognosi
surviv
popul
foal
much
guard
decis
initi
mechan
ventil
agon
one
concern
regard
prognosi
client
cost
potenti
complic
intimid
factor
associ
manag
ventil
unfortun
result
delay
initi
therapi
dramat
decreas
likelihood
success
outcom
develop
familiar
process
mechan
ventil
part
neonat
intens
care
team
often
result
willing
use
mechan
ventil
earlier
train
session
provid
familiar
ventil
setup
initi
set
extrem
use
pictori
guid
set
circuit
attach
patient
ppv
function
gener
posit
pressur
within
patient
airway
use
overcom
resist
airflow
aris
airway
lung
thorac
wall
invas
ppv
reli
intub
establish
airway
ga
exchang
aid
prevent
aspir
upper
respiratori
secret
reflux
stomach
content
intub
best
achiev
consciou
patient
nasal
rout
easiest
head
fulli
extend
nasotrach
tube
rang
mm
outsid
diamet
accommod
hors
foal
tube
cuf
largest
tube
pass
upper
respiratori
tract
without
trauma
use
care
taken
ensur
tip
tube
locat
cervic
portion
trachea
possibl
insert
tube
deepli
result
placement
within
mainstem
bronchu
ventil
one
lung
final
posit
tube
cuff
inflat
enough
pressur
maintain
seal
ppv
excess
cuff
pressur
caus
tracheal
injuri
necrosi
tube
anchor
patient
head
prevent
inadvert
remov
result
patient
movement
done
tie
section
umbil
tape
hub
tube
anchor
end
tape
elast
tape
bandag
place
around
muzzl
soft
cotton
halter
around
patient
head
endotrach
tube
chang
least
everi
hour
respiratori
secret
exud
accumul
within
lumen
tube
imped
ga
flow
potenti
caus
obstruct
tube
presenc
larg
amount
pulmonari
exud
may
requir
even
frequent
chang
tube
ventil
gase
must
appropri
pretreat
deliveri
patient
ensur
gase
humidifi
warm
avoid
injuri
respiratori
mucosa
achiev
activ
humidifi
typic
compon
mechan
ventil
devic
effect
humidifi
warm
larg
volum
gase
involv
unfortun
gase
tend
cool
pass
tube
ventil
patient
result
substanti
condens
rain
within
circuit
must
period
drain
effect
accentu
hospit
environment
temperatur
low
altern
passiv
humidifi
use
consist
heatmoistur
exchang
hme
filter
devic
place
ventil
circuit
patient
devic
effect
small
foal
may
adequ
foal
kg
may
need
supplement
cold
activ
humidifi
ventil
circuit
primari
limit
hme
filter
tend
clog
airway
discharg
result
obstruct
failur
mechan
ventil
reason
author
typic
use
hme
filter
short
period
time
first
initi
mechan
ventil
reli
activ
humidif
durat
ventil
set
ventil
establish
attach
patient
ventil
avoid
inadvert
overinfl
lung
although
sever
differ
ventil
mode
select
ventil
basic
set
fairli
univers
includ
fio
tidal
volum
peak
flow
breath
rate
fio
set
minimum
level
requir
maintain
adequ
pao
lower
atmospher
tidal
volum
volum
ga
deliv
machinecontrol
breath
set
peak
inspiratori
pressur
pip
exceed
cm
h
avoid
trauma
pulmonari
tissu
peak
flow
maxim
ga
flow
rate
deliv
ventil
inspiratori
phase
ventil
excess
peak
flow
rate
result
overli
rapid
inflat
lung
high
peak
airway
pressur
low
peak
flow
rate
result
overli
long
inspiratori
phase
result
loss
synchroni
ventil
especi
high
respiratori
rate
reason
initi
set
paramet
fio
tidal
volum
mlkg
mlkg
peak
flow
lmin
lmin
breath
rate
breathsmin
valu
may
requir
adjust
ventil
institut
respons
ventil
close
monitor
addit
variabl
may
control
ventil
posit
endexpiratori
pressur
peep
set
cm
h
trigger
sensit
cm
h
pressur
support
cm
h
inspir
expir
ratio
e
ratio
consid
mechan
ventil
one
encount
bewild
array
mode
ventil
ideal
mode
one
maintain
consist
adequ
tidal
volum
minut
ventil
moder
airway
pressur
synchron
patient
respiratori
effort
respond
patient
demand
allow
lowest
possibl
work
breath
discuss
limit
commonli
use
mode
mechan
ventil
simv
modif
assistcontrol
ventil
still
deliv
set
minimum
rate
mandatori
breath
rigidli
control
howev
ventil
attempt
synchron
breath
patient
inspiratori
effort
possibl
primari
advantag
mode
well
toler
patient
synchron
mandatori
breath
patient
effort
addit
simv
ensur
minimum
breath
rate
patient
variabl
respiratori
effort
exhibit
period
apnea
limit
simv
spontan
breath
support
ventil
requir
larg
degre
patient
inspiratori
effort
pressur
support
ventil
psv
allow
patient
complet
control
aspect
ventilatori
cycl
except
pressur
limit
mode
patient
breath
support
preset
assist
pressur
stop
flow
rate
decreas
set
fraction
peak
flow
end
inspir
allow
patient
determin
size
breath
inspiratori
flow
rate
substanti
decreas
work
breath
risk
psv
mandatori
minim
breath
rate
guarante
ventil
limit
simv
psv
overcom
use
simv
pressur
support
simv
provid
guarante
minim
breath
rate
ps
provid
pressur
support
patientiniti
breath
overcom
inher
resist
ventil
circuit
endotrach
tube
cpap
use
provid
posit
airway
pressur
throughout
ventilatori
cycl
pressur
provid
typic
clinicianselect
peep
level
cpap
often
combin
ps
aid
overcom
resist
circuit
decreas
work
breath
gener
desir
ventil
patient
provid
minim
ventilatori
need
patient
use
ventil
recruit
poorli
ventil
region
lung
back
particip
ga
exchang
commonli
util
recruit
maneuv
peep
function
maintain
posit
pressur
within
ventilatori
circuit
exhal
breath
prevent
alveolar
collaps
might
result
period
neg
pressur
time
presenc
peep
keep
open
alveoli
recruit
inspiratori
cycl
allow
gradual
improv
function
capac
lung
result
substanti
increas
pao
may
allow
decreas
fio
prevent
cyclic
alveolar
collaps
reopen
peep
amount
shear
stressinduc
pulmonari
injuri
may
also
decreas
use
peep
alway
benign
howev
caus
compress
intrathorac
venou
system
impair
cardiac
return
detriment
effect
cardiac
output
first
initi
mechan
ventil
reason
use
peep
patient
especi
moder
set
benefit
appear
outweigh
potenti
neg
effect
provis
mechan
ventil
dynam
process
requir
substanti
involv
clinician
supervis
ventil
setup
adjust
appropri
monitor
critic
effect
mechan
ventil
overemphas
two
import
aspect
monitor
assess
pulmonari
mechan
pulmonari
function
consid
assess
pulmonari
mechan
one
realli
analyz
interact
mechan
ventil
patient
three
import
paramet
drive
pressur
tidal
volum
tidal
airflow
primari
paramet
ventil
function
ventilatorpati
interact
pip
tidal
volum
v
paramet
interrel
increas
pressur
associ
increas
tidal
volum
normal
lung
within
normal
physiolog
limit
ventil
patient
especi
substanti
pulmonari
diseas
one
often
find
relationship
abnorm
normal
pressur
result
inadequ
tidal
volum
excess
high
pressur
requir
achiev
desir
v
continu
monitor
pip
extrem
import
sudden
decreas
may
indic
circuit
leak
ventil
failur
inadequ
ga
suppli
leak
endotrach
tube
cuff
increas
pip
may
indic
obstruct
endotrach
tube
caus
kink
accumul
exud
bronchospasm
pneumothorax
critic
aspect
monitor
involv
monitor
pulmonari
function
fundament
consist
evalu
pulmonari
ventil
form
elimin
co
pulmonari
oxygen
form
arteri
oxygen
tension
assess
pulmonari
oxygen
reli
primarili
measur
pao
fio
known
patient
normal
pulmonari
function
linear
increas
pao
increas
fio
relationship
break
presenc
pulmonari
diseas
caus
ventilationperfus
mismatch
presenc
intrapulmonari
shunt
result
perfus
poorli
ventil
region
lung
caus
pao
lower
expect
reason
target
pao
mm
hg
slightli
higher
valu
mm
hg
benefici
indic
decreas
fio
goal
use
fio
closest
room
air
achiev
desir
pao
fio
valu
associ
oxygen
toxic
respiratori
mucosa
addit
inform
deriv
knowledg
exhal
etco
concentr
measur
use
capnographi
etco
repres
paco
patient
normal
pulmonari
function
usual
valu
mm
hg
less
paco
decreas
etco
indic
decreas
pulmonari
perfus
secondari
decreas
cardiac
output
increas
pulmonari
vascular
resist
import
aspect
clinic
monitor
check
endotrach
tube
exud
accumul
tube
chang
done
least
daili
often
copiou
exud
present
increas
amount
exud
within
tube
chang
charact
exud
purul
appear
may
earli
indic
ventilatorassoci
pneumonia
vap
hemorrhag
appear
tube
exud
may
suggest
ventilatorassoci
lung
injuri
vili
worsen
pulmonari
inflamm
caus
insult
administr
mechan
ventil
inher
unnatur
unphysiolog
potenti
disrupt
normal
function
mani
bodi
system
provis
ppv
especi
form
excess
peep
potenti
substanti
decreas
venou
return
lead
impair
cardiac
output
seriou
concern
especi
critic
patient
cardiac
output
often
alreadi
impair
presenc
endotrach
tube
number
potenti
advers
effect
first
tube
caus
increas
airway
resist
long
narrow
lumen
increas
work
breath
associ
spontan
respir
second
presenc
endotrach
tube
result
bypass
normal
protect
function
upper
respiratori
tract
allow
access
respiratori
tract
pathogen
organ
infect
aris
rout
term
vap
likelihood
vap
develop
increas
prolong
durat
mechan
ventil
presenc
inflamm
secondari
process
mechan
ventil
also
increas
likelihood
vap
impair
patient
immun
function
associ
system
ill
organ
involv
vap
often
nosocomi
natur
associ
pattern
increas
resist
antimicrobi
complic
treatment
condit
aerosol
ceftazidim
shown
effect
prevent
vap
human
patient
also
attenu
proinflammatori
respons
lung
author
subject
observ
decreas
rate
vap
mechan
ventil
foal
aerosol
amikacin
nebul
ventil
circuit
start
within
hour
initi
mechan
ventil
ventilatorinduc
lung
injuri
vili
consid
inevit
clinician
goal
fundament
minim
sever
effect
three
fundament
type
vili
barotrauma
volutrauma
atelectotrauma
patient
poor
pulmonari
complianc
area
pulmonari
atelectasi
high
posit
inspiratori
pressur
may
requir
achiev
adequ
ventil
caus
overdistent
ventil
region
lung
local
volutrauma
volutrauma
result
exceed
normal
physiolog
function
residu
capac
ventil
region
lung
result
develop
pulmonari
edema
initiationamplif
local
inflammatori
respons
peep
somewhat
protect
appear
slow
develop
pulmonari
edema
unless
excess
point
contribut
overinfl
caus
harm
atelectotrauma
caus
repeat
open
close
lung
unit
tidal
ventil
essenti
repres
syndrom
lowvolum
injuri
result
initi
inflammatori
respons
appreci
lung
suscept
highand
lowvolum
injuri
appar
optim
mechan
ventil
achiev
within
fairli
narrow
rang
tidal
volum
rang
may
vari
dramat
patient
patient
discontinu
mechan
ventil
wean
challeng
part
entir
process
human
patient
phase
may
constitut
much
time
patient
mechan
ventil
arguabl
process
wean
begin
soon
patient
place
ventil
clinician
constantli
strive
identifi
minimum
level
support
requir
maintain
adequ
ventil
oxygen
minim
degre
support
one
acceler
patient
recoveri
strength
stamina
muscl
respir
minim
loss
also
increas
clinician
abil
identifi
patient
longer
requir
ventilatori
support
gradual
decreas
level
pressur
support
provid
increas
trigger
sensit
level
accomplish
progress
challeng
patient
abil
ventil
ultim
howev
determin
readi
remov
ventil
subject
one
question
answer
extub
challeng
prefer
simpli
remov
patient
ventil
leav
endotrach
tube
place
tube
caus
signific
resist
airflow
increas
patient
work
breath
intranas
oxygen
insuffl
provid
immedi
follow
tube
remov
case
unless
patient
maintain
normal
oxygen
fio
ventil
care
must
also
taken
one
fulli
prepar
immedi
reintub
patient
challeng
success
mechan
ventil
must
reinstitut
primari
endpoint
challeng
respiratori
rate
respiratori
effort
arteri
blood
ga
evalu
patient
may
fail
within
minut
other
fail
sever
hour
sever
challeng
may
requir
period
hour
day
one
certain
patient
abl
maintain
without
ventilatori
support
colic
common
present
complaint
foal
unfortun
evalu
foal
colic
frustrat
common
clinic
present
associ
acut
abdomin
pain
despit
mani
possibl
underli
etiolog
foal
typic
demonstr
abdomin
pain
adult
hors
sign
colic
foal
may
rang
nonspecif
sign
tachycardia
tachypnea
anorexia
agit
bruxism
classic
sign
abdomin
distent
recumb
roll
lie
dorsal
recumb
caus
colic
neonat
foal
includ
meconium
impact
infecti
noninfecti
enterocol
dysmotil
associ
diseas
process
small
intestin
strangul
obstruct
congenit
abnorm
intussuscept
hernia
gastric
duoden
ulcer
aerophagia
foreign
bodi
obstruct
lactos
intoler
hypox
injuri
ovarian
testicular
torsion
caus
colic
older
foal
similar
also
includ
condit
ascarid
impact
displac
pylor
duoden
strictur
abdomin
adhes
nonstrangul
obstruct
fecalith
nonintestin
pain
may
caus
clinic
sign
indistinguish
true
colic
foal
may
result
pain
thorax
liver
urogenit
tract
distent
associ
uroperitoneum
nongastrointestin
inflamm
periton
examin
foal
colic
somewhat
facilit
small
size
allow
reposit
extern
abdomin
palpat
well
thorough
ultrasonograph
examin
inabl
perform
rectal
examin
beyond
digit
palpat
frustrat
limit
howev
adult
initi
goal
colic
evalu
stabil
patient
differenti
case
requir
surgic
versu
medic
manag
although
case
colic
foal
success
manag
medic
case
prompt
surgic
intervent
requir
small
intestin
strangul
obstruct
common
presenc
diarrhea
usual
indic
medic
manag
suffici
may
present
associ
surgic
problem
unrel
pain
poorli
control
analges
strong
indic
surgic
problem
adult
sever
intestin
distent
ultrasonograph
examin
particularli
caus
fluid
mix
fluid
ga
rather
ga
alon
may
also
suggest
presenc
surgic
lesion
common
caus
intestin
obstruct
neonat
foal
meconium
impact
meconium
mixtur
glandular
secret
mucu
bile
digest
amniot
fluid
epitheli
cell
normal
expel
within
first
hour
life
follow
foal
first
feed
colostrum
feed
may
help
expuls
meconium
lax
effect
colostrum
lack
colostrum
intak
recent
studi
effect
meconium
releas
compar
foal
fed
milk
replac
meconium
pass
hour
age
like
caus
intestin
obstruct
typic
level
small
colon
pelvic
inlet
progress
intestin
abdomin
distent
develop
next
sever
hour
secondari
ga
accumul
orad
obstruct
identif
mass
meconium
may
possibl
manual
palpat
abdomen
ultrasonographi
sensit
specif
mean
identifi
meconium
obstruct
case
retrograd
contrast
radiographi
may
help
confirm
presenc
level
obstruct
rule
caus
obstruct
congenit
defect
administr
enema
use
therapeut
intervent
diagnost
test
indic
case
suspect
meconium
impact
sodium
phosphat
enema
wide
use
readi
avail
premix
human
prepar
easili
administ
care
must
taken
avoid
hyperphosphatemia
caus
excess
administr
howev
reason
type
enema
administ
twice
first
hour
life
soapi
water
enema
given
graviti
flow
also
frequent
use
likelihood
rectal
irrit
limit
efficaci
use
repeatedli
effect
type
enema
treatment
meconium
impact
acetylcystein
retent
enema
enema
prepar
use
commerci
avail
acetylcystein
nacetyllcystein
powder
sigmaaldrich
st
loui
mo
ad
g
acetylcystein
solut
g
bake
soda
ml
water
commerci
prepar
acetylcystein
enema
foal
also
avail
http
wwwscahealthcomezpassfoalenemakithtml
foal
place
later
recumb
restrain
sedat
necessari
foley
cathet
balloon
place
cm
rectum
balloon
fill
take
care
overinfl
acetylcystein
solut
infus
use
graviti
flow
volum
ml
left
within
rectum
minut
type
enema
seem
highli
irrit
procedur
repeat
mani
three
time
usual
interv
addit
treatment
help
manag
affect
foal
includ
iv
fluid
therapi
address
deficit
ongo
mainten
need
well
analges
therapi
butorphanol
administr
may
suffici
control
discomfort
mani
foal
individu
pain
may
requir
flunixin
administr
control
pain
medic
manag
pursu
case
refractori
medic
manag
may
requir
surgic
correct
meconium
impact
uncommon
sinc
introduct
acetylcystein
enema
roundworm
p
equorum
infest
common
condit
among
foal
report
preval
around
foal
show
evid
infest
clinic
sign
associ
presenc
parasit
may
includ
lethargi
anorexia
decreas
weight
gain
cough
hypoproteinemia
nasal
discharg
colic
gastrointestin
impact
occasion
ruptur
perfor
small
intestin
colic
sign
result
acut
small
intestin
obstruct
caus
larg
burden
parasit
case
colic
associ
recent
administr
anthelmint
medic
may
associ
stressor
transport
wean
hors
impact
small
intestin
caus
p
equorum
commonli
suffer
secondari
intestin
abnorm
caus
lumin
obstruct
includ
small
intestin
volvulu
intussuscept
surgic
intervent
typic
requir
prevent
intestin
ruptur
result
increas
resist
p
equorum
commonli
use
anthelmint
especi
macrocycl
lacton
seem
like
preval
condit
increas
although
congenit
defect
gastrointestin
tract
rare
must
rule
evalu
neonat
foal
colic
similar
clinic
present
meconium
impact
common
congenit
defect
atresia
colon
rectum
anu
affect
foal
typic
present
within
first
hour
life
exhibit
sign
acut
progress
colic
abdomin
distent
addit
sign
colic
tachycardia
tachypnea
recumb
roll
anorexia
tenesmu
may
note
fecal
materi
pass
meconium
stain
note
enema
fluid
administ
atresia
ani
readili
diagnos
visual
examin
digit
palpat
wherea
rectal
colon
lesion
challeng
identifi
ultrasonographi
may
use
demonstr
distent
orad
site
lesion
rare
abl
character
lesion
retrograd
contrast
radiographi
help
character
lesion
differenti
atresia
meconium
impact
colonoscopi
may
aid
diagnos
lesion
termin
colon
rectum
procedur
perform
stand
sedat
use
nbutyl
scopolamin
bromid
buscopan
boehring
ingelheim
vetmedica
inc
st
joseph
mo
shown
aid
visual
ultim
surgic
explor
may
way
definit
diagnosi
atresia
coli
made
surgic
correct
atresia
ani
straightforward
typic
success
although
anal
sphincter
function
may
normal
atresia
ani
may
accompani
penil
malform
hypospadia
also
requir
surgic
correct
surgic
resect
anastomosi
attempt
case
atresia
coli
lesion
access
outcom
poor
like
caus
addit
underli
neurolog
motil
disord
mean
condit
consid
typic
fatal
congenit
aganglionosi
overo
lethal
white
syndrom
syndrom
affect
white
american
paint
hors
foal
born
overoovero
mate
although
report
one
foal
one
solid
color
quarter
hors
parent
syndrom
occur
foal
receiv
one
copi
mutat
endothelin
receptor
b
gene
ednrb
overo
lethal
white
gene
parent
affect
foal
suffer
aganglionosi
distal
small
intestin
larg
intestin
result
lack
intestin
motil
lead
colic
recent
work
suggest
extrins
innerv
may
affect
well
foal
born
overoovero
mate
affect
care
taken
ensur
foal
simpli
suffer
meconium
impact
make
potenti
termin
decis
mutagen
separ
pcr
recent
develop
detect
ednrb
genotyp
hors
diarrhea
common
problem
foal
substanti
morbid
mortal
associ
number
potenti
pathophysiolog
mechan
mani
etiolog
make
diagnosi
manag
challeng
syndrom
involv
noninfecti
etiolog
well
bacteri
viral
protozo
parasit
etiolog
report
foal
although
mani
condit
associ
diarrhea
affect
foal
age
condit
necrot
enterocol
nec
asphyxiaassoci
enter
dysfunct
primarili
seen
neonat
wherea
other
prolif
enteropathi
seen
older
weanl
age
foal
foal
heat
diarrhea
mild
selflimit
condit
seen
foal
day
age
tempor
associ
occurr
mare
first
heat
follow
parturit
tempor
associ
impli
causat
case
foal
rais
milk
replac
also
exhibit
diarrhea
time
frame
analysi
composit
mare
milk
reveal
chang
might
precipit
develop
foal
diarrhea
affect
foal
clinic
normal
except
diarrhea
remain
bright
good
appetit
appear
like
chang
occur
within
gastrointestin
tract
relat
solid
feed
ingest
develop
fecal
microbiota
respons
addit
may
hypersecret
small
intestin
mucosa
inadequ
compens
immatur
colon
absorpt
contribut
foal
heat
diarrhea
diarrhea
foal
age
taken
lightli
howev
rapid
clinic
progress
possibl
sign
system
ill
dull
inappet
prompt
rapid
assess
sever
condit
foal
heat
diarrhea
may
warrant
medic
intervent
common
caus
diarrhea
hospit
neonat
foal
perinat
asphyxiaassoci
gastrointestin
dysfunct
affect
foal
typic
associ
risk
factor
dystocia
deliveri
cesarean
section
umbil
problem
deliveri
caus
inadequ
oxygen
immedi
postpartum
foal
may
exhibit
dysmotil
lead
ileu
gastroduoden
reflux
intoler
enter
feed
abdomin
distent
colic
diarrhea
evid
perinat
asphyxia
syndrom
may
observ
bodi
system
especi
neurolog
system
affect
foal
consid
risk
develop
sepsi
similar
present
may
observ
foal
suffer
sepsi
like
caus
presenc
sever
system
inflamm
reason
appropri
broadspectrum
antimicrobi
therapi
indic
case
anoth
condit
affect
hospit
neonat
foal
nec
syndrom
frequent
lethal
disord
affect
preterm
human
infant
associ
disrupt
intestin
barrier
lead
intestin
necrosi
multiorgan
failur
death
nec
sporad
report
foal
mani
year
appear
like
repres
underdiagnos
condit
broad
varieti
infecti
agent
includ
bacteria
also
virus
fungal
speci
associ
nec
human
although
case
report
foal
link
presenc
varieti
pathogen
bacteria
caus
nec
remain
subject
much
discuss
human
literatur
clear
primarili
infecti
condit
appear
like
pathophysiolog
truli
multifactori
involv
complex
interplay
intestin
immatur
hemodynam
instabl
inflamm
genet
factor
formula
feed
dysbiosi
clinic
present
may
similar
describ
asphyxiaassoci
disord
mention
previous
certainli
foal
may
consid
risk
nec
recent
report
foal
diagnos
nec
present
commonli
colic
diarrhea
sign
absent
major
affect
foal
abnorm
observ
associ
nec
includ
prematur
gastric
reflux
abdomin
distent
bloodi
fece
pneumonia
interestingli
author
report
found
evid
associ
c
difficil
c
perfringen
salmonella
speci
nec
diagnosi
nec
made
radiograph
ultrasonograph
evid
intramur
ga
intestin
wall
pneumatosi
intestinali
surgic
postmortem
evid
gastrointestin
necrosi
although
mani
affect
human
neonat
report
surviv
presenc
nec
associ
poor
prognosi
surviv
foal
treatment
foal
nec
critic
ill
foal
like
includ
iv
fluid
therapi
broadspectrum
antimicrobi
therapi
concern
enter
feed
may
precipit
worsen
nec
recommend
enter
feed
avoid
gener
recommend
foal
colic
ileu
reflux
parenter
nutrit
requir
enter
feed
gradual
reintroduc
human
studi
suggest
minim
enter
nutrit
approach
rather
complet
withdraw
enter
feed
use
less
ml
kg
per
day
first
sever
day
gradual
advanc
normal
intak
level
sever
day
appear
well
toler
safe
human
studi
shown
breast
milk
protect
nec
lowbirthweight
infant
reason
make
sens
use
mare
milk
feed
foal
possibl
metronidazol
therapi
may
indic
report
associ
nec
clostridi
infect
foal
although
recent
human
report
found
metronidazol
therapi
may
prevent
clinic
deterior
case
nec
caus
noninfecti
diarrhea
includ
dietari
intoler
particularli
milk
replac
fed
rather
mare
milk
result
product
use
milk
replac
poorli
digest
foal
maltodextrin
corn
syrup
oligosaccharid
glucos
polym
gastrointestin
irrit
secondari
ingest
sand
grit
dirt
may
also
result
diarrhea
caus
mechan
irrit
mucosa
common
caus
infecti
diarrhea
foal
rotaviru
detect
fece
foal
diarrhea
case
equin
coronaviru
associ
clinic
diseas
adult
hors
detect
fece
diarrheic
foal
role
viru
foal
diseas
unclear
also
detect
fece
foal
diarrhea
actual
involv
adenoviru
develop
diseas
unclear
especi
immunocompet
individu
older
report
parvoviruslik
particl
identifi
foal
diarrhea
evid
emerg
regard
potenti
pathogen
role
organ
foal
pathogenesi
rotavir
diarrhea
multifactori
organ
frequent
detect
combin
potenti
gastrointestin
pathogen
rotaviru
infect
epitheli
tip
villi
duodenum
jejunum
ileum
affect
crypt
epithelium
viru
replic
within
villou
epithelium
releas
follow
cell
lysi
result
destruct
infect
cell
desquam
villou
tip
lead
loss
normal
absorpt
capac
villi
secretori
crypt
epithelium
unharm
result
malabsorpt
like
contribut
develop
diarrhea
villou
injuri
also
result
decreas
product
disaccharidas
particularli
lactas
may
impair
digest
lactos
contribut
develop
diarrhea
osmot
mechan
factor
contribut
develop
rotavir
diarrhea
may
activ
viral
enterotoxin
inhibit
sodiumglucos
cotransport
dysregul
calcium
homeostasi
activ
enter
nervou
system
clinic
rotavir
diarrhea
often
occur
larg
comingl
group
mare
foal
affect
foal
typic
day
age
foal
initi
exhibit
anorexia
depress
quickli
progress
acut
profus
wateri
diarrhea
affect
foal
may
becom
rapidli
dehydr
frequent
develop
electrolyt
abnorm
metabol
acidosi
although
morbid
associ
rotaviru
infect
high
caus
highli
contagi
natur
viru
prognosi
surviv
good
treatment
gener
support
symptomat
iv
fluid
therapi
often
need
effect
address
fluid
electrolyt
deficit
balanc
electrolyt
replac
solut
effect
given
frequent
involv
hyponatremia
hypochloremia
sever
affect
foal
may
also
benefit
brief
period
enter
rest
day
necessit
provis
parenter
nutrit
feed
reintroduc
supplement
lactas
enzym
lactaid
mcneil
nutrit
llc
ft
washington
pa
u
one
tablet
po
everi
hour
may
help
improv
milk
digest
foal
remain
mare
nurs
reintroduc
diagnosi
rotavir
diarrhea
detect
viral
particl
use
electron
microscopi
viru
isol
enzymelink
immunosorb
assay
elisa
immunochromatographi
test
realtim
reversetranscriptas
pcr
rtpcr
immunochromatographi
test
rtpcr
rapid
simplest
perform
provid
high
sensit
specif
control
rotavir
diarrheal
outbreak
challeng
especi
crowd
environ
highli
contagi
natur
viru
persist
environ
resist
disinfect
prevent
facilit
use
matern
vaccin
associ
reduct
frequenc
sever
rotavir
diarrhea
endem
farm
condit
licens
commerci
vaccin
avail
provision
use
equin
rotaviru
vaccin
zoeti
kalamazoo
mi
primari
bacteri
agent
concern
foal
diarrhea
c
difficil
c
perfringen
discern
relationship
organ
clinic
diseas
challeng
either
organ
identifi
normal
anim
well
diseas
anim
organ
isol
significantli
frequent
foal
enterocol
healthi
foal
c
difficileassoci
diarrhea
cdad
commonli
associ
histori
antimicrobi
therapi
like
repres
primari
agent
antimicrobialassoci
diarrhea
aad
foal
spontan
case
cdad
occur
without
exposur
antimicrobi
howev
sporad
outbreak
addit
risk
factor
may
predispos
foal
cdad
includ
hospit
stress
dietari
alter
starvat
transport
nasogastr
intub
surgic
medic
treatment
clinic
cdad
quit
variabl
term
clinic
sign
sever
diseas
primari
clinic
sign
cdad
diarrhea
may
wateri
bloodi
typic
accompani
sign
system
inflamm
hypovolemia
hyperem
mucou
membran
prolong
capillari
refil
time
pyrexia
tachycardia
tachypnea
occasion
abdomin
distent
colic
unfortun
sign
nonspecif
although
cdad
may
suspect
basi
histori
clinic
present
diagnost
test
requir
confirm
diagnosi
normal
anim
may
carri
organ
often
repres
nonpathogen
strain
cultur
use
diagnosi
cdad
virul
c
difficil
depend
elabor
toxin
tcda
toxin
b
tcdb
evid
suggest
toxin
import
develop
clinic
diseas
addit
toxin
term
c
difficil
transferas
cdt
appear
play
role
virul
well
cdtproduc
strain
associ
increas
mortal
human
patient
confirm
diagnosi
cdad
base
detect
tcda
andor
tcdb
fece
affect
individu
often
perform
use
commerci
elisa
c
difficil
tox
ab
ii
techlab
inc
blacksburg
va
rtpcr
c
perfringen
also
associ
enterocol
foal
syndrom
typic
quit
sever
natur
high
mortal
rate
type
type
c
c
perfringen
implic
case
sever
form
diseas
typic
associ
type
c
affect
foal
typic
respond
treatment
c
perfringen
produc
four
major
toxin
appear
primari
one
respons
intestin
injuri
novel
toxin
netf
recent
describ
associ
sever
nec
dog
foal
risk
factor
may
includ
birth
dirt
sand
gravel
hous
stall
dri
lot
first
day
life
clinic
sign
similar
cdad
enterotoxemia
affect
foal
may
show
pronounc
sign
system
inflamm
shock
hemorrhag
diarrhea
report
case
may
transient
natur
diagnosi
c
perfringen
enterocol
challeng
organ
may
present
fece
healthi
foal
posit
fecal
cultur
combin
appropri
signal
clinic
present
may
support
howev
healthi
foal
gener
shed
low
number
organ
fecal
gram
stain
may
also
support
demonstr
larg
number
larg
gramposit
rod
spore
commerci
assay
avail
detect
fecal
enterotoxin
lack
sensit
treatment
cdad
c
perfringen
enterocol
primarili
support
natur
similar
caus
enterocol
broadspectrum
antimicrobi
coverag
indic
even
situat
aad
suspect
risk
bacteremia
secondari
bowel
wall
inflamm
injuri
metronidazol
therapi
repres
primari
specif
therapi
clostridi
infect
metronidazoleresist
strain
c
difficil
report
recent
pharmacokinet
studi
suggest
metronidazol
dose
regimen
use
foal
revis
mgkg
oral
everi
hour
newborn
foal
mgkg
oral
everi
hour
foal
age
current
recommend
mgkg
oral
everi
hour
remain
unchang
addit
therapi
may
benefit
cdad
includ
enter
administ
adsorb
ditrioctahedr
smectit
probiot
therapi
interest
posit
result
report
human
patient
limit
studi
support
efficaci
probiot
foal
diarrhea
time
number
bacteria
associ
diarrhea
foal
includ
salmonella
spp
e
coli
enterococcu
spp
aeromona
spp
bacteroid
fragili
although
causat
difficult
establish
given
diarrhea
common
clinic
abnorm
associ
sepsi
foal
import
awar
bacteri
involv
may
present
even
form
primari
enter
pathogen
one
retrospect
studi
found
foal
less
day
age
present
diarrhea
bacterem
admiss
reinforc
concern
blood
cultur
collect
routin
admiss
popul
confirm
bacteremia
also
yield
inform
regard
antimicrobi
sensit
r
equi
although
primarili
respiratori
pathogen
commonli
exhibit
extrapulmonari
involv
associ
enter
diseas
primarili
older
foal
diarrhea
ulcer
enterotyphlocol
abdomin
abscess
mesenter
lymphaden
periton
report
one
studi
foal
r
equi
infect
report
diarrhea
half
foal
diarrhea
began
follow
initi
treatment
primari
infect
equin
prolif
enteropathi
epe
infecti
diseas
affect
young
hors
primarili
foal
month
age
epe
caus
oblig
intracellular
bacterium
lawsonia
intracellulari
diseas
caus
dramat
structur
chang
mucos
epithelium
small
intestin
caus
prolifer
crypt
epitheli
cell
alter
lead
proteinlos
enteropathi
result
variabl
degre
hypoalbuminemia
hypoproteinemia
ventral
edema
lethargi
diarrhea
fever
weight
loss
colic
diagnosi
prolif
enteropathi
combin
clinic
sign
ventral
edema
clinicopatholog
abnorm
hypoalbuminemia
abdomin
ultrasonograph
examin
immunoperoxidas
monolay
assay
serolog
fecal
pcr
test
lawsonia
dna
treatment
best
accomplish
use
lipophil
antimicrobi
administ
week
tetracyclin
oxytetracyclin
doxycyclin
minocyclin
macrolid
azithromycin
clarithromycin
chloramphenicol
rifampin
use
combin
macrolid
appear
necessari
achiev
posit
clinic
respons
regard
prevent
unfortun
passiv
acquir
antibodi
demonstr
effect
occurr
subclin
clinic
epe
promis
result
regard
prevent
seen
intrarect
administr
commerci
avirul
porcin
vaccin
l
intracellulari
demonstr
result
complet
protect
epe
reduc
fecal
shed
prognosi
surviv
appropri
treatment
good
affect
anim
often
exhibit
decreas
growth
rate
result
may
slight
disadvantag
rel
peer
sever
month
recent
report
detail
sever
form
epe
associ
fatal
outcom
case
appear
unusu
pathogen
role
cryptosporidium
spp
foal
diarrhea
subject
debat
normal
foal
shown
shed
organ
sever
studi
implic
organ
sporad
outbreak
situat
although
commonli
identifi
speci
c
parvum
anoth
cryptosporidium
hors
genotyp
identifi
hors
human
calf
affect
foal
usual
exhibit
substanti
system
inflamm
diseas
typic
selflimit
profus
wateri
diarrhea
may
necessit
iv
fluid
therapi
addit
routin
support
therapi
diseas
clear
zoonot
potenti
appropri
biosecur
precaut
indic
protect
incontact
individu
inde
recent
report
detail
outbreak
human
cryptosporidiosi
veterinari
student
associ
exposur
infect
foal
equin
perinatolog
unit
diagnosi
tradit
reli
identif
oocyst
fece
use
acidfast
stain
techniqu
rtpcr
test
perform
rapid
easili
perform
immunofluoresc
assay
commerci
avail
xpect
giardiacryptosporidium
test
thermo
scientif
waltham
merifluor
cryptosporidiumgiardia
meridian
bioscienc
inc
cincinnati
oh
strongyloid
westeri
nematod
primarili
transmit
foal
transmammari
rout
although
organ
suspect
caus
diarrhea
young
foal
appear
like
clinic
diseas
would
present
parasit
present
high
number
control
typic
mean
ivermectin
administr
mare
shortli
deliveri
preval
parasit
appear
increas
perhap
relat
decreas
ivermectin
administr
foal
concern
ivermectin
resist
p
equorum
gastric
ulcer
frequent
report
foal
preval
rang
clinic
sign
associ
gastric
ulcer
foal
often
nonspecif
may
includ
diarrhea
colic
roll
restless
lie
dorsal
recumb
excess
saliv
bruxism
anorexia
reason
diagnosi
made
clinic
ground
alon
reli
gastroscop
examin
addit
confirm
presenc
gastric
ulcer
gastroscop
examin
allow
thorough
character
site
involv
sever
lesion
present
noninvas
techniqu
diagnos
gastric
ulcer
foal
interest
well
valid
would
provid
detail
inform
regard
extent
sever
gastric
ulcer
greatest
challeng
associ
diagnosi
treatment
gastric
ulcer
foal
fact
mani
anim
endoscop
evid
ulcer
show
clinic
sign
suggest
ulcer
caus
dysfunct
discomfort
therefor
clinic
signific
gastric
ulcer
foal
need
treatment
unclear
despit
fact
substanti
concern
relat
risk
intestin
perfor
secondari
progress
clinic
silent
gastric
ulcer
condit
fatal
occur
reason
prophylact
antiulc
therapi
often
administ
clinic
ill
foal
receiv
nonsteroid
therapi
efficaci
prophylact
approach
confirm
clinic
ill
foal
howev
respons
sick
foal
acidsuppress
therapi
less
consist
healthi
foal
inde
two
larg
retrospect
studi
report
preval
gastric
ulcer
postmortem
examin
hospit
foal
relat
whether
prophylact
treatment
administ
unfortun
prophylact
acid
suppress
may
associ
risk
human
studi
document
increas
risk
pneumonia
cdad
nonicu
hospit
patient
treat
acidsuppress
drug
protonpump
inhibitor
ppi
potent
inhibitor
acid
suppress
histamin
antagonist
reason
ppi
appear
associ
greater
risk
complic
human
icu
patient
appear
increas
risk
pneumonia
differ
overal
mortal
associ
acid
suppress
use
ppi
associ
increas
risk
cdad
recent
multicent
studi
found
use
acidsuppress
therapi
hospit
foal
associ
increas
risk
undifferenti
diarrhea
cdad
togeth
concern
suggest
use
avoid
treatment
limit
foal
document
diseas
requir
treatment
pathophysiolog
gastric
ulcer
foal
like
complex
multifactori
may
differ
squamou
glandular
mucos
region
stomach
within
stomach
constant
interplay
protect
factor
aggress
factor
protect
factor
maintain
healthi
gastric
mucosa
promot
mucos
blood
flow
mucu
bicarbon
product
prostaglandin
product
promot
epitheli
growth
factor
epitheli
cell
restitut
gastric
affer
innerv
gastroduoden
motil
aggress
factor
includ
gastric
acid
bile
salt
pepsin
numer
enzym
act
induc
potenti
gastric
epitheli
injuri
gastric
acid
product
highli
variabl
neonat
foal
intragastr
environ
often
alkalin
seem
like
ulcer
result
commonli
suppress
protect
factor
rather
excess
acid
product
perinat
hypoxia
system
ill
administr
nonsteroid
antiinflammatori
medic
may
lead
gastric
mucos
hypoxia
ischemia
impair
local
protect
factor
predispos
patient
mucos
ulcer
ulcer
may
occur
squamou
mucosa
glandular
mucosa
may
extend
involv
duodenum
andor
esophagu
clinic
syndrom
associ
ulcer
includ
subclin
clinic
signific
ulcer
perfor
ulcer
gastroduoden
ulcer
syndrom
gdu
scheme
perhap
expand
includ
gastroesophag
ulcer
although
commonli
associ
reflux
esophag
secondari
gdusinduc
delay
gastric
empti
classif
ulcer
subclin
clinic
may
challeng
base
sole
number
sever
lesion
identifi
gastroscop
evalu
instead
must
involv
consider
histori
clinic
sign
associ
find
diagnosi
perfor
may
also
difficult
base
gastroscop
assess
alon
sometim
benign
surfac
appear
lesion
reason
abdomin
ultrasonographi
abdominocentesi
import
confirm
presenc
perfor
diagnosi
gdu
base
gastroscop
evalu
combin
presenc
one
sign
gastric
ulcer
list
previous
although
sign
gastricoutflow
obstruct
ptyalism
bruxism
typic
common
diagnosi
gdu
commonli
seen
foal
month
age
often
associ
unthrifti
potbelli
appear
foal
small
rel
peer
ultrasonograph
examin
indic
foal
suspect
suffer
gdu
allow
noninvas
assess
gastric
duoden
distent
gastric
distent
present
nasogastr
tube
pass
extract
fluid
facilit
gastroscop
evalu
gastroscop
abnorm
commonli
observ
gdu
includ
esophag
gastric
squamou
glandular
ulcer
pylor
ulcer
pylor
strictur
examin
duodenum
usual
possibl
presenc
pylor
strictur
treatment
affect
foal
challeng
requir
intens
manag
frequent
gastric
decompress
requir
parenter
nutrit
typic
necessari
inabl
foal
eat
support
care
includ
iv
fluid
antimicrobi
analges
also
indic
acidsuppress
therapi
requir
usual
accompani
gastroprotect
prokinet
although
medic
manag
may
help
resolv
delay
gastric
empti
mani
affect
foal
sever
fibrosi
constrict
pyloru
duodenum
necessit
surgic
correct
goal
surgic
correct
bypass
pyloru
proxim
duodenum
typic
involv
gastrojejunostomi
surgeri
challeng
success
like
depend
earli
intervent
surgic
expertis
appropri
postop
care
report
surgic
outcom
improv
time
recent
report
demonstr
surviv
hospit
discharg
longterm
surviv
cornerston
treatment
gastric
ulcer
foal
acidsuppress
drug
primarili
drug
cimetidin
ranitidin
ppi
omeprazol
tabl
acidsuppress
effect
variabl
less
dramat
seen
ppi
drug
may
suppress
acid
product
suffici
facilit
ulcer
heal
consist
pronounc
acidsuppress
effect
ppi
omeprazol
drug
becom
mainstay
gastric
ulcer
therapi
hors
dose
foal
challeng
label
form
specif
design
use
foal
product
market
use
adult
measur
volum
basi
administ
oral
bodi
weightappropri
dosag
foal
iv
formul
omeprazol
readili
avail
administr
foal
take
medic
oral
iv
pharmacokinet
ppi
pantoprazol
determin
foal
treatment
includ
mucos
adher
sucralf
oral
antacid
aluminum
hydroxid
magnesium
sucralf
dissoci
acid
environ
stomach
sucros
octasulf
aluminum
hydroxid
sucros
octasulf
bind
ulcer
mucosa
decreas
tissu
exposur
hydrochlor
acid
may
also
interfer
activ
peptic
enzym
sucralf
appear
safe
well
toler
like
repres
safer
approach
ulcer
prevent
hospit
neonat
foal
compar
use
ppi
prostaglandin
analog
misoprostol
use
effort
enhanc
ulcer
heal
increas
epitheli
mucou
secret
bicarbon
secret
mucos
blood
flow
misoprostol
may
also
enhanc
epitheli
repair
via
closur
tight
junction
follow
epitheli
restitut
denud
region
mucosa
abnorm
involv
urogenit
tract
common
foal
congenit
acquir
natur
acquir
condit
may
occur
secondari
infecti
toxic
traumat
iatrogen
caus
presenc
urogenit
disord
may
repres
primari
diseas
process
may
occur
secondari
diseas
process
case
present
sign
may
directli
associ
urogenit
disord
often
case
present
nonspecif
sign
depress
poor
bodi
condit
clinicopatholog
evalu
may
normal
case
involv
impair
renal
function
urin
retent
typic
associ
azotemia
electrolyt
abnorm
azotemia
often
present
elev
serum
creatinin
concentr
chronic
insidi
condit
elev
blood
urea
nitrogen
bun
may
promin
serum
electrolyt
abnorm
may
includ
hyponatremia
hypochloremia
hyperkalemia
metabol
acidosi
also
common
urinalysi
normal
foal
demonstr
hyposthenuria
produc
dilut
urin
specif
graviti
less
foal
renal
dysfunct
may
hyposthenur
isosthenur
specif
graviti
concentr
hypersthenur
urin
specif
graviti
depend
natur
dysfunct
transient
proteinuria
typic
birth
resolv
first
day
life
normal
foal
cast
present
congenit
urinari
tract
disord
quit
rare
foal
renal
dysplasia
hypoplasia
commonli
report
famili
breed
predisposit
demonstr
condit
hors
utero
exposur
therapeut
drug
toxin
may
caus
renal
dysplasia
report
renal
dysplasia
foal
born
mare
treat
equin
protozo
myeloenceph
pyrimethamin
trimethoprim
sulfonamid
folic
acid
vitamin
e
renal
dysplasia
hypoplasia
may
repres
incident
find
foal
young
adult
hors
present
evalu
problem
azotemia
typic
present
unless
renal
function
impair
least
substanti
reserv
renal
function
normal
present
case
bilater
renal
involv
urin
retent
suffer
acuteonchron
diseas
like
associ
clinic
clinicopatholog
find
consist
renal
insuffici
patient
unilater
involv
often
remain
asymptomat
wherea
treatment
renal
dysplasia
hypoplasia
usual
unreward
bilater
renal
involv
present
pollakiuria
dysuria
stranguria
incontin
may
observ
renal
dysplasiahypoplasia
commonli
associ
condit
ectop
uret
ectop
uret
may
associ
urin
scald
caus
urinari
incontin
surgic
intervent
often
challeng
option
address
case
ectop
uret
reloc
ureter
open
primari
intervent
hematuria
uncommonli
associ
congenit
urogenit
disord
may
present
associ
renal
arterioven
malform
congenit
abnorm
bladder
suspect
case
uroperitoneum
evid
true
congenit
origin
lack
hors
speci
umbil
hernia
may
present
birth
usual
small
resolv
without
intervent
larger
hernia
typic
cm
size
may
requir
surgic
repair
rush
perform
procedur
long
hernia
remain
easili
reduc
inguin
hernia
may
also
present
birth
also
typic
small
easili
reduc
conserv
medic
manag
consist
frequent
repeat
reduct
bandag
maintain
reduct
often
success
resolv
small
hernia
larger
inguin
hernia
may
allow
substanti
herniat
small
intestin
often
requir
surgic
repair
accumul
urin
within
periton
caviti
repres
one
common
urogenit
condit
young
foal
involv
mani
hospit
neonat
case
observ
within
first
day
life
associ
bladder
wall
ruptur
common
site
bladder
wall
failur
dorsal
wall
believ
case
occur
parturit
propos
etiolog
fetu
full
bladder
ruptur
intens
pressur
occur
transit
birth
canal
obstruct
urin
outflow
via
urachu
deliveri
may
contribut
high
intravesicular
pressur
theori
support
anecdot
report
bladder
distent
identifi
fetal
ultrasonograph
examin
foal
subsequ
develop
bladder
ruptur
birth
may
sex
predilect
bladder
ruptur
colt
overrepres
case
present
shortli
birth
case
develop
later
seem
differ
sex
case
uroperitoneum
associ
primari
bladder
ruptur
howev
ureter
tear
urach
ruptur
also
result
uroperitoneum
although
ureter
tear
initi
result
urin
accumul
retroperiton
space
typic
progress
uroperitoneum
sever
day
urach
ruptur
may
associ
infect
necrosi
umbil
remnant
reason
foal
may
present
slightli
later
foal
bladder
ruptur
diagnosi
uroperitoneum
made
basi
histori
physic
examin
clinic
patholog
ultrasound
examin
clinic
sign
associ
uroperitoneum
may
vari
base
site
leakag
affect
foal
often
present
depress
weak
sign
hypovolemia
difficult
differenti
foal
suffer
neonat
sepsi
inde
mani
affect
foal
may
suffer
sepsi
addit
uroperitoneum
rate
clinic
sign
develop
often
associ
size
defect
associ
rate
urin
leakag
periton
space
small
defect
bladder
retroperiton
ureter
leakag
often
becom
clinic
obviou
sever
day
week
post
foal
foal
uroperitoneum
present
ventral
edema
although
dramat
foal
umbil
trauma
associ
subcutan
urin
leakag
foal
retroperiton
urin
accumul
may
present
stranguria
develop
uroperitoneum
foal
urethr
defect
often
demonstr
substanti
subcutan
edema
perin
region
foal
uroperitoneum
present
abdomin
distent
abdomin
discomfort
otherwis
good
physic
condit
palpat
ballott
abdomen
may
aid
detect
fluid
accumul
within
periton
caviti
classic
clinicopatholog
present
foal
uroperitoneum
azotemia
increas
serum
creatinin
less
reliabl
bun
azotemia
typic
accompani
hyperkalemia
hyponatremia
hypochloremia
metabol
acidosi
hyperkalemia
caus
reabsorpt
substanti
amount
potassium
wherea
hyponatremia
hypochloremia
caus
reabsorpt
water
urin
within
abdomen
chang
like
pronounc
milkbas
diet
foal
milk
contain
rel
high
concentr
potassium
meql
rel
low
sodium
meql
hyperkalemia
potenti
lifethreaten
possibl
fatal
bradyarrhythmia
electrocardiogram
ecg
perform
foal
uroperitoneum
hyperkalemia
caus
typic
ecg
find
hyperkalemia
progress
peak
wave
shorten
qt
interv
lengthen
pr
interv
loss
p
wave
follow
widen
qr
complex
potenti
lead
cardiac
arrest
death
potenti
cardiac
sequela
associ
hyperkalemia
includ
thirddegre
atrioventricular
block
ventricular
fibril
ventricular
prematur
contract
classic
pattern
electrolyt
abnorm
typic
observ
howev
hospit
foal
develop
uroperitoneum
treat
iv
fluid
therapi
balanc
electrolyt
solut
ultrasonograph
examin
use
ancillari
diagnost
test
evalu
uroperitoneum
one
confirm
presenc
free
fluid
within
periton
space
one
also
assess
degre
fluid
accumul
investig
possibl
site
urin
leakag
free
fluid
within
abdomen
typic
hypoecho
mildli
hyperecho
numer
loop
small
intestin
intraabdomin
structur
may
suspend
free
fluid
contain
within
abdomen
dorsal
bladder
wall
common
site
bladder
ruptur
area
thoroughli
investig
case
free
margin
defect
readili
observ
import
rememb
may
one
site
urin
leakag
howev
either
bladder
potenti
involv
urachu
uret
urethra
although
ultrasound
examin
typic
less
use
evalu
ureter
urethr
defect
import
perform
complet
examin
urinari
tract
detect
defect
kidney
uret
might
miss
bladder
urachu
examin
contrast
radiographi
may
requir
identifi
site
leakag
bladder
urachu
definit
confirm
uroperitoneum
requir
abdominocentesi
creatinin
diffus
poorli
across
semiperm
periton
membran
creatinin
concentr
periton
fluid
least
twofold
higher
creatinin
concentr
serum
abdominocentesi
diagnost
import
techniqu
therapeut
techniqu
allow
drainag
accumul
urin
periton
caviti
remov
fluid
aid
control
hyperkalemia
minim
potassium
absorpt
periton
caviti
drainag
also
decreas
pressur
exert
diaphragm
thorac
caviti
aid
resolut
tachypnea
dyspnea
respiratori
distress
abdominocentesi
perform
teat
cannula
stainless
bitch
cathet
indwel
type
cathet
foley
mushroomtip
periton
cathet
approach
minim
risk
trauma
abdomin
viscera
allow
safe
manipul
mainten
cathet
abdomen
drain
care
taken
administ
appropri
fluid
therapi
drainag
abdomen
avoid
hypovolemia
result
remov
thirdspac
fluid
drainag
continu
surgic
repair
perform
prematur
discontinu
simpli
allow
reaccumul
urin
within
abdomen
although
medic
manag
describ
treatment
uroperitoneum
primarili
surgic
site
urin
leakag
must
identifi
address
surgic
repair
remov
correct
hypovolemia
electrolyt
disturb
surgeri
import
minim
risk
anesthet
complic
critic
disturb
hyperkalemia
risk
cardiac
disturb
hyperkalemia
address
administr
iv
fluid
contain
potassium
isoton
hypoton
salin
solut
commonli
use
dextros
typic
ad
fluid
rate
aid
lower
serum
potassium
concentr
encourag
movement
potassium
extracellular
intracellular
compart
sever
case
administr
exogen
insulin
ukg
may
necessari
substanti
reduc
serum
potassium
concentr
sodium
bicarbon
therapi
may
aid
lower
serum
potassium
concentr
may
help
address
concurr
hyponatrem
metabol
acidosi
administr
calcium
glucon
may
also
help
decreas
neg
effect
hyperkalemia
recent
report
suggest
frequenc
anesthet
complic
surgic
correct
uroperitoneum
less
common
previous
report
perhap
less
sever
electrolyt
disturb
better
preoper
stabil
use
safer
inhal
anesthet
primarili
isofluran
prognosi
surviv
foal
uncompl
uroperitoneum
secondari
bladder
ruptur
good
wherea
prognosi
foal
suffer
ureter
urethr
disord
less
favor
delay
identif
affect
foal
presenc
concurr
diseas
especi
sepsi
result
worsen
prognosi
surviv
umbilicu
repres
primari
channel
exchang
nutrient
oxygen
dam
fetu
primari
outlet
fetal
urin
umbil
cord
consist
two
arteri
carri
poorli
oxygen
blood
away
fetal
heart
one
vein
carri
rel
better
oxygen
blood
placenta
toward
fetal
heart
urachu
connect
fetal
urinari
bladder
allanto
caviti
follow
secondstag
parturit
umbilicu
narrow
separ
point
cm
bodi
wall
typic
within
minut
mare
foal
undisturb
small
amount
neonat
blood
loss
may
occur
normal
follow
separ
cord
minim
volum
ceas
within
minut
mare
stand
soon
prematur
separ
umbil
cord
umbil
cord
damag
may
occur
subcutan
ruptur
urachu
result
substanti
accumul
urin
tissu
abdomin
wall
like
requir
surgic
resect
umbil
remnant
follow
separ
placenta
umbil
structur
immedi
becom
vestigi
normal
foal
umbil
remnant
atrophi
first
month
life
one
common
umbil
disord
patent
urachu
urach
remnant
open
urin
drain
extern
environ
although
may
occur
immedi
follow
cord
separ
typic
seen
sever
day
birth
often
associ
umbil
infect
system
ill
associ
stress
handl
involv
manag
sick
foal
may
also
predispos
patient
resumpt
patenc
patent
urachu
may
present
simpli
moist
extern
umbil
remnant
may
associ
stream
flow
urin
urin
scald
abdomin
wall
medial
aspect
hindlimb
may
occur
secondarili
import
ultrasound
examin
perform
case
determin
whether
intern
abnorm
umbil
remnant
infect
associ
patent
urachu
conserv
manag
consist
topic
cleans
extern
umbilicu
close
monitor
develop
infect
often
suffici
although
complet
resolut
may
take
day
week
case
infecti
compon
suspect
appropri
system
antimicrobi
therapi
indic
chemic
cauteri
use
silver
nitrat
stick
often
use
may
acceler
closur
urach
remnant
especi
earli
mild
case
excess
use
silver
nitrat
may
result
local
tissu
necrosi
howev
may
precipit
develop
infect
conserv
manag
fail
surgic
excis
umbil
remnant
indic
rare
problem
need
address
urgent
especi
foal
suffer
system
ill
diseas
process
umbil
remnant
infect
also
common
take
sever
form
affect
foal
may
appear
clinic
normal
may
exhibit
sign
system
inflamm
fever
leukocytosi
hyperfibrinogenemia
elev
saa
infect
extern
umbil
structur
result
local
abscess
format
present
swell
inflamm
often
discharg
area
extern
umbilicu
becom
local
invas
involv
bodi
wall
extern
umbil
abscess
often
treat
establish
drainag
combin
appropri
system
antimicrobi
therapi
intern
umbil
remnant
infect
occur
three
distinct
umbil
structur
urachu
infect
urachu
call
urach
umbil
arteri
infect
umbil
arteri
call
omphaloarter
umbil
vein
infect
umbil
vein
call
omphalophleb
tradit
thought
umbil
remnant
infect
occur
secondari
extern
contamin
umbilicu
ascend
migrat
bacteria
like
true
case
reason
import
practic
appropri
routin
clean
disinfect
extern
remnant
excess
cleans
treatment
caustic
agent
may
actual
increas
risk
ascend
infect
moder
key
possibl
bacteremia
occur
secondari
umbil
infect
result
seed
site
infect
remot
structur
especi
synovi
structur
growth
plate
frequent
associ
presenc
umbil
remnant
infect
although
umbil
structur
may
repres
primari
site
infect
also
possibl
umbil
remnant
infect
actual
develop
secondari
system
ill
bacteremia
rather
secondari
extern
contamin
ultrasonograph
examin
umbil
remnant
well
describ
perform
readili
either
linear
curv
probe
use
frequenc
mhz
although
higher
qualiti
imag
obtain
linear
probe
four
umbil
structur
urachu
vein
pair
arteri
readili
imag
extern
remnant
cours
bodi
wall
intern
pair
umbil
arteri
found
ventral
later
urachu
bladder
cours
caudal
deep
toward
origin
iliac
arteri
thickwal
structur
diamet
less
mm
although
arteri
may
still
observ
pulsat
young
foal
contract
immobil
hour
age
lumen
may
fill
clot
blood
case
urachu
extend
apex
bladder
outward
umbil
stump
lumen
typic
collaps
difficult
appreci
transvers
view
urachu
umbil
arteri
taken
apex
bladder
normal
measur
less
mm
total
diamet
umbil
vein
cours
cranial
site
extern
umbilicu
liver
locat
along
midlin
close
abdomin
wall
vein
thinwal
structur
may
contain
anecho
fluid
within
lumen
vein
measur
less
mm
diamet
infect
involv
structur
typic
manifest
fill
lumen
materi
variabl
echogen
thicken
wall
increas
overal
size
structur
thorough
assess
import
multipl
structur
may
involv
infecti
process
treatment
umbil
remnant
infect
medic
surgic
natur
medic
manag
gener
prefer
treatment
appropri
broadspectrum
antimicrobi
often
success
resolv
infect
prolong
treatment
sever
week
durat
ongo
ultrasonograph
monitor
requir
ensur
complet
resolut
case
suffer
combin
umbil
remnant
infect
infect
site
clinician
may
feel
sens
urgenc
surgic
remov
umbil
remnant
stress
gener
anesthesia
abdomin
surgeri
may
counterproduct
stabil
patient
institut
antimicrobi
therapi
surgeri
may
benefici
case
broadspectrum
antimicrobi
therapi
indic
prefer
use
oral
medic
need
prolong
therapi
case
presenc
ga
within
intern
structur
ultrasonograph
examin
fetid
order
repres
indic
addit
metronidazol
treatment
regimen
case
refractori
medic
therapi
surgic
excis
affect
intern
umbil
remnant
indic
thorough
ultrasonograph
examin
preoper
help
develop
surgic
plan
may
reveal
area
infect
deep
umbil
arteri
vein
may
abl
surgic
remov
continu
medic
manag
may
indic
situat
marsupi
umbil
vein
arteri
perform
allow
extern
drainag
possibl
lavag
infect
structur
acut
kidney
injuri
acut
renal
failur
acut
kidney
injuri
occur
foal
secondari
system
diseas
toxin
exposur
postren
obstruct
common
etiolog
system
diseas
previous
term
vasomotor
nephropathi
although
actual
pathophysiolog
involv
case
well
understood
appear
like
complex
interact
among
system
cardiovascular
respons
local
vasomotor
tone
system
local
inflammatori
mediat
microvascular
dysfunct
local
renal
tissu
respons
result
decreas
renal
function
decreas
renal
function
may
repres
selfprotect
respons
kidney
decreas
energi
oxygen
demand
within
kidney
may
help
improv
tissu
surviv
recoveri
common
toxic
caus
renal
injuri
foal
iatrogen
naturenam
aminoglycosid
antimicrobi
oxytetracyclin
administ
treatment
tendon
contractur
nonsteroidalassoci
renal
injuri
rel
uncommon
foal
like
drug
commonli
use
foal
time
although
may
chang
increas
use
nsaid
foal
caus
toxininduc
renal
injuri
hemoglobin
releas
ni
myoglobin
releas
myopathi
commonli
white
muscl
diseas
postren
obstruct
rare
foal
primarili
associ
congenit
abnorm
diagnosi
acut
kidney
injuri
complic
poor
sensit
commonli
use
biomark
renal
functionnam
serum
creatinin
bun
substanti
renal
reserv
like
substanti
injuri
occur
time
chang
marker
detect
clinic
bun
insensit
limit
use
evalu
acut
kidney
injuri
foal
one
concern
substanti
simultan
increas
bun
serum
creatinin
observ
serum
creatinin
despit
poor
sensit
remain
best
biomark
renal
function
foal
although
tremend
interest
identifi
sensit
biomark
renal
function
none
yet
character
foal
interpret
serum
creatinin
concentr
neonat
foal
complic
spuriou
hypercreatininemia
caus
placent
insuffici
neonat
hypoxia
although
foal
present
spuriou
hypercreatininemia
similar
elev
serum
creatinin
concentr
compar
foal
present
acut
renal
failur
serum
creatinin
concentr
foal
spuriou
hypercreatininemia
typic
decreas
within
hour
initi
treatment
normal
hour
effect
way
improv
sensit
serum
creatinin
becom
critic
evalu
chang
serum
concentr
even
though
valu
may
remain
within
publish
normal
rang
elev
littl
mgdl
baselin
may
indic
decreas
renal
function
serum
creatinin
may
elev
preren
caus
present
import
evalu
serum
creatinin
concentr
frequent
assess
respons
therapi
detect
upward
trend
earli
possibl
given
limit
serum
creatinin
concentr
marker
renal
function
specif
glomerular
filtrat
rate
gfr
may
help
case
obtain
accur
assess
gfr
exogen
marker
iohexol
valid
foal
iohexol
assay
readili
avail
endogen
creatinin
clearanc
actual
fairli
simpl
perform
foal
indwel
urinari
cathet
urin
collect
system
involv
obtain
baselin
serum
sampl
creatinin
determin
simultan
empti
urin
collect
bag
follow
time
urin
collect
least
sever
hour
ideal
hour
end
time
second
serum
sampl
obtain
serum
creatinin
measur
volum
urin
collect
accur
measur
repres
sampl
urin
collect
creatinin
determin
endogen
creatinin
clearanc
calcul
use
formula
report
valu
endogen
creatinin
clearanc
normal
foal
mlmin
per
kilogram
urinalysi
help
detect
acut
kidney
injuri
interpret
challeng
tempor
chang
composit
neonat
urin
influenc
fluid
therapi
treatment
urin
constitu
urin
specif
graviti
normal
hyposthenur
foal
well
hydrat
increas
appropri
foal
dehydr
isosthenuria
specif
graviti
may
indic
loss
renal
function
serial
determin
may
requir
confirm
inabl
kidney
dilut
concentr
urin
chang
hydrat
statu
proteinuria
normal
present
first
hour
life
absent
unless
renal
injuri
urin
alkalin
mild
spuriou
proteinuria
may
observ
dipstick
examin
sick
foal
often
acid
urin
make
less
issu
interpret
adult
examin
enzymuria
advoc
earli
indic
renal
injuri
foal
primarili
regard
urin
transferas
ggt
assess
use
ggttocreatinin
ratio
urin
ggturin
creatinin
correct
dilut
effect
elev
urin
ggt
creatinin
ratio
suggest
proxim
tubular
injuri
test
good
specif
unfortun
elev
ggt
creatinin
ratio
expect
foal
receiv
system
aminoglycosid
therapi
magnitud
increas
well
correl
degre
renal
injuri
treatment
acut
renal
failur
primarili
support
natur
effort
made
remov
exposur
potenti
initi
caus
acut
kidney
injuri
possibl
fluid
therapi
typic
indic
correct
exist
dehydr
hypovolemia
induc
diuresi
care
monitor
urin
output
indic
sure
patient
oligur
anur
placement
urinari
cathet
urin
collect
system
extrem
help
regard
may
difficult
achiev
ambulatori
patient
readili
accomplish
recumb
foal
urin
output
normal
foal
approxim
mlkg
per
hour
valu
increas
respons
fluid
therapi
monitor
in
versu
out
routin
perform
goal
least
two
third
fluid
intak
excret
achiev
fluid
overload
like
develop
urin
output
inadequ
restor
normovolemia
correct
system
hypotens
diuret
therapi
indic
furosemid
appear
safe
well
toler
addit
loop
diuret
effect
furosemid
may
actual
lessen
renal
metabol
demand
suppress
tubuloglomerular
feedback
recommend
dose
furosemid
rang
mgkg
iv
q
h
mgkg
everi
minut
hour
cri
also
use
foal
base
dose
regimen
develop
adult
hors
start
load
dose
mgkg
iv
follow
mgkg
per
hour
cri
furosemid
ineffect
osmot
diuret
use
dmso
commonli
administ
foal
suspect
suffer
ne
addit
free
radic
scaveng
effect
osmot
diuret
effect
mannitol
use
potent
osmot
diuret
dosag
gkg
iv
solut
minut
medic
therapi
effect
renal
replac
therapi
dialysi
consid
hemodialysi
gold
standard
therapi
perform
foal
rare
avail
equin
patient
expens
lack
access
appropri
equip
although
typic
less
effect
hemodialysi
periton
dialysi
thorac
dialysi
perform
foal
much
feasibl
clinic
set
critic
ill
foal
undergo
sever
physiolog
stress
bodi
respond
stress
complex
integr
seri
neuroendocrin
humor
adapt
direct
toward
support
critic
hemodynam
immun
metabol
function
hpa
axi
sympatheticadrenomedullari
axi
hypothalamicpituitarythyroid
hpt
axi
somatotrop
axi
critic
import
respons
activ
hpa
axi
lead
increas
secret
corticotropinreleas
hormon
crh
arginin
vasopressin
avp
paraventricular
nucleu
hypothalamu
crh
primari
stimulu
product
secret
acth
anterior
pituitari
wherea
avp
act
synergist
crh
increas
acth
secret
acth
secret
system
circul
interact
cell
zona
fasciculata
adren
gland
subsequ
produc
cortisol
cortisol
store
adren
gland
releas
system
circul
immedi
produc
unbound
free
cortisol
biolog
activ
normal
adult
state
vast
major
cortisol
circul
bound
cortisol
bind
globulin
cbg
much
smaller
amount
bound
albumin
foal
shown
much
greater
free
cortisol
fraction
birth
day
age
adult
hors
human
infant
birth
month
age
increas
free
cortisol
fraction
associ
local
system
inflamm
bound
cortisol
releas
cbg
neutrophil
elastas
concentr
activ
cortisol
also
regul
tissu
level
action
two
isoform
enzym
dehydrogenas
primarili
gener
activ
cortisol
inact
cortison
wherea
primarili
convert
activ
cortisol
inact
cortison
unbound
cortisol
reach
tissu
diffus
enter
cell
bind
intracellular
glucocorticoid
receptor
gr
cortisolgr
complex
transloc
nucleu
abl
exert
genom
regul
gene
transcript
nongenom
proteinprotein
effect
critic
ill
cortisol
import
support
cardiovascular
function
regul
immun
respons
increas
avail
glucos
energi
sourc
varieti
approach
use
assess
function
hpa
axi
health
diseas
includ
determin
neutrophil
lymphocyt
ratio
basal
serum
cortisol
concentr
basal
serum
acth
concentr
acthcortisol
ratio
acth
stimul
test
measur
abil
adren
gland
produc
cortisol
delta
cortisol
number
challeng
associ
hpa
axi
assess
howev
first
activ
respons
hpa
axi
highli
dynam
rapid
chang
short
period
time
substanti
variat
even
hourtohour
basi
second
challeng
measur
total
serum
cortisol
concentr
reflect
biolog
activ
free
portion
determin
activ
free
cortisol
fraction
technic
challeng
timeconsum
readili
avail
clinic
set
third
concentr
cortisol
circul
provid
inform
relat
concentr
cortisol
tissu
intracellular
level
activ
fourth
challeng
acth
stimul
test
either
high
low
dose
may
repres
accur
assess
hpa
axi
function
critic
ill
final
may
substanti
variat
among
cortisol
assay
render
extrem
difficult
compar
result
studi
use
differ
assay
call
question
use
specif
valu
serum
cortisol
indic
hpa
axi
function
dysfunct
matur
hpa
axi
function
equin
fetu
occur
late
gestat
last
day
birth
continu
first
sever
week
life
result
foal
deliv
prematur
often
suffer
inadequ
hpa
axi
function
manifest
inappropri
low
serum
cortisol
concentr
despit
increas
serum
acth
concentr
find
indic
decreas
respons
acth
level
adren
gland
support
fact
prematur
foal
also
show
impair
respons
acth
stimul
test
neutrophil
lymphocyt
ratio
note
rossdal
et
al
easili
determin
surrog
marker
basal
cortisol
concentr
foal
ratio
suggest
impair
hpa
axi
function
prematur
foal
wherea
ratio
associ
adequ
hpa
function
term
foal
normal
term
foal
also
show
evid
incomplet
hpa
axi
develop
howev
exhibit
impair
respons
endogen
acth
lowand
highdos
acth
stimul
test
compar
adult
hors
follow
birth
serum
cortisol
acth
concentr
peak
first
hour
life
gradual
declin
hour
level
lower
normal
seen
adult
hors
correl
hpa
axi
dysfunct
equin
prematur
led
earli
interest
area
equin
medicin
littl
work
done
area
past
decad
renew
interest
primarili
result
extens
work
done
human
regard
role
hpa
axi
critic
ill
concept
rel
adrenocort
insuffici
rai
develop
defin
inadequ
cortisol
respons
degre
ill
rai
consid
transient
revers
condit
associ
exagger
proinflammatori
respons
condit
sepsi
ard
sever
trauma
potenti
mechan
rai
includ
suppress
hpa
axi
level
hypothalamu
pituitari
adren
gland
rai
associ
number
studi
increas
risk
death
critic
ill
human
patient
subsequ
studi
use
corticosteroid
supplement
demonstr
trend
toward
decreas
mortal
improv
vasopressor
respons
support
concept
rai
critic
ill
diagnosi
rai
remain
challeng
howev
wide
rang
diagnost
criteria
use
differ
studi
wide
accept
criteria
random
total
serum
cortisol
mgdl
delta
cortisol
mgdl
follow
acth
stimul
sever
studi
perform
healthi
foal
character
normal
hpa
axi
function
popul
substanti
agerel
chang
basal
cortisol
concentr
found
normal
agebas
rang
report
unfortun
rapid
chang
time
high
variabl
singl
cortisol
measur
mean
applic
basal
cortisol
concentr
clinic
marker
rai
recommend
time
respons
lowand
highdos
acth
stimul
test
also
examin
although
dosag
acth
vari
among
studi
consist
pattern
agerel
differ
respons
acth
profound
respons
observ
immedi
birth
agerel
refer
rang
lowdos
pair
lowand
highdos
acth
stimul
test
report
sever
studi
perform
clinic
ill
foal
determin
whether
rai
occur
septic
foal
first
report
transient
adren
insuffici
septic
foal
publish
foal
report
low
basal
serum
cortisol
concentr
inadequ
respons
highdos
acth
stimul
test
gold
et
al
report
septic
foal
higher
mean
cortisol
acth
concentr
normal
foal
septic
foal
also
higher
acthcortisol
ratio
normal
foal
castagnetti
et
al
report
nonsurviv
septic
foal
higher
acth
acthcortisol
ratio
admiss
healthi
foal
surviv
septic
foal
interestingli
wong
et
al
report
differ
baselin
cortisol
acth
concentr
acthcortisol
ratio
normal
clinic
ill
foal
small
number
foal
studi
exhibit
low
baselin
cortisol
acth
concentr
inadequ
respons
acth
stimul
suggest
rai
howev
hurcomb
et
al
report
acth
cortisol
avp
concentr
increas
septic
foal
compar
sick
nonsept
foal
normal
foal
also
found
acth
cortisol
avp
concentr
higher
sick
nonsept
foal
healthi
foal
septic
foal
studi
exhibit
low
normal
serum
cortisol
concentr
despit
increas
acth
concentr
consid
suggest
rai
hart
et
al
examin
popul
hospit
foal
agematch
popul
healthi
foal
found
hospit
foal
inappropri
low
baselin
cortisol
concentr
inadequ
respons
highdos
acth
stimul
signific
correl
observ
inadequ
respons
highdos
acth
stimul
shock
mod
hospit
foal
well
correl
decreas
surviv
subset
septic
foal
armeng
et
al
report
nonsurviv
septic
foal
higher
cortisol
concentr
acthcortisol
ratio
surviv
foal
although
report
examin
role
peripher
tissu
corticosteroid
resist
develop
circi
foal
recent
studi
perform
adult
hors
sir
found
decreas
gr
bind
affin
associ
nonsurviv
trend
toward
increas
acth
cortisol
ratio
investig
role
peripher
tissu
corticosteroid
resist
foal
may
warrant
variabl
seen
equin
studi
mirror
challeng
observ
human
medicin
appli
basal
cortisol
concentr
result
highand
lowdos
acth
stimul
test
diagnosi
rai
use
baselin
cortisol
concentr
acth
stimul
test
longer
recommend
human
critic
care
patient
similarli
current
consensu
regard
appropri
diagnost
featur
condit
foal
difficulti
increas
appreci
possibl
determin
actual
activ
cortisol
tissu
level
new
term
develop
human
medicin
circi
circi
inadequ
cellular
corticosteroid
activ
sever
patient
ill
current
recommend
human
medicin
regard
diagnosi
circi
base
clinic
criteria
rather
diagnost
test
patient
hypotens
refractori
fluid
replac
vasopressor
therapi
suspect
suffer
circi
treat
hydrocortison
posit
respons
hydrocortison
therapi
potenti
support
diagnosi
circi
littl
inform
avail
regard
treatment
foal
may
suffer
circi
result
multipl
studi
human
patient
demonstr
lowdos
corticosteroid
therapi
septic
shock
associ
improv
hemodynam
decreas
requir
vasopressor
therapi
clear
surviv
benefit
associ
intervent
base
experi
human
medicin
appear
reason
reserv
corticosteroid
therapi
foal
circi
suspect
demonstr
fluidrefractori
vasopressorresist
hypotens
potenti
role
corticosteroid
replac
therapi
may
support
recent
studi
regard
factor
associ
nonsurviv
foal
ne
studi
report
persist
hypotens
requir
vasopressor
andor
inotrop
therapi
significantli
associ
nonsurviv
recommend
corticosteroid
therapi
foal
necess
base
primarili
recommend
deriv
human
medicin
specif
therapeut
protocol
investig
foal
current
human
recommend
use
physiolog
dosag
hydrocortison
approach
close
mimic
normal
corticosteroid
dynam
rather
use
high
supraphysiolog
dosag
longact
drug
like
prednisolon
dexamethason
cours
taper
dosag
hydrocortison
mgkgday
divid
q
h
iv
healthi
foal
report
potenti
benefici
antiinflammatori
effect
without
appar
advers
effect
innat
immun
daili
endogen
product
cortisol
pharmacokinet
hydrocortison
studi
neonat
foal
determin
appropri
dosag
hydrocortison
foal
suspect
circi
might
rang
mgkg
per
day
slightli
lower
dosag
divid
two
four
iv
bolus
per
day
current
recommend
human
medicin
sinc
suggest
reason
hydrocortison
dosag
foal
may
mgkg
per
day
divid
four
six
iv
bolus
per
day
appropri
durat
therapi
unknown
foal
human
shown
earli
withdraw
hydrocortison
therapi
deleteri
prolong
treatment
day
subsequ
taper
dosag
recommend
product
thyroid
hormon
regul
hypothalamu
releas
thyrotropinreleas
hormon
trh
pituitari
portal
system
trh
stimul
thyrotrop
anterior
pituitari
releas
thyroidstimul
hormon
tsh
system
circul
tsh
regul
synthesi
releas
thyroid
hormon
thyroid
gland
thyroid
hormon
store
within
thyroid
gland
precursor
thyroglobulin
cleav
produc
triiodothyronin
thyroxin
influenc
tsh
enter
system
circul
circul
thyroid
hormon
bound
thyroid
bind
globulin
protein
includ
albumin
minim
activ
essenti
serv
prohormon
convert
primari
activ
form
thyroid
hormon
tissu
level
unbound
free
thyroid
hormon
transport
cell
bind
thyroid
hormon
receptor
nucleu
subsequ
influenc
gene
transcript
effect
thyroid
hormon
extens
primarili
involv
increas
metabol
rate
enhanc
cardiovascular
function
thermogenesi
assess
hpt
function
reli
primarili
measur
tsh
andor
measur
basal
thyroid
hormon
concentr
free
free
revers
approach
complic
agerel
chang
hormon
concentr
occur
newborn
foal
well
myriad
influenc
nonthyroid
factor
measur
circul
concentr
also
poorli
reflect
activ
hormon
tissu
level
stimul
test
difficult
lack
readi
avail
trh
tsh
practic
clinic
set
newborn
foal
thyroid
hormon
concentr
substanti
higher
birth
adult
hors
elev
concentr
gradual
decreas
adult
level
sever
month
time
studi
measur
tsh
neonat
foal
found
concentr
elev
instead
similar
level
seen
adult
hors
suggest
hpt
axi
differ
foal
perhap
increas
activ
tsh
increas
receptor
sensit
tsh
alter
hpt
axi
may
account
rapid
growth
foal
first
month
life
high
neonat
thermogen
capac
dysfunct
hpt
axi
describ
neonat
foal
caus
congenit
hypothyroid
prematur
system
ill
syndrom
congenit
hypothyroid
dysmatur
syndrom
first
describ
neonat
foal
western
canada
syndrom
associ
thyroid
hyperplasia
goiter
increas
gestat
length
dysmatur
numer
musculoskelet
abnorm
includ
flexur
limb
deform
ruptur
common
digit
extensor
tendon
incomplet
ossif
cuboid
bone
mandibular
prognath
incomplet
closur
abdomin
wall
syndrom
also
suspect
associ
abort
case
thyroid
hormon
level
affect
foal
may
low
normal
respons
tsh
stimul
consist
decreas
although
etiolog
unknown
syndrom
suspect
associ
exposur
caus
agent
epidemiolog
investig
suggest
increas
dietari
nitrat
intak
exposur
mustard
plant
could
involv
potenti
risk
factor
could
includ
inadequ
iodin
selenium
intak
prognosi
surviv
affect
foal
poor
surviv
like
suffer
varieti
orthoped
abnorm
render
unsound
congenit
hypothyroid
also
report
foal
whose
dam
suffer
dietari
iodin
defici
excess
affect
foal
typic
exhibit
promin
goiter
utero
exposur
foal
endophyt
coenophialum
infect
fescu
associ
clinic
sign
hypothyroid
birth
decreas
circul
concentr
prematur
foal
exhibit
hypothyroid
substanti
lower
thyroid
hormon
concentr
compar
healthi
fullterm
foal
may
analog
syndrom
transient
hypothyroxinemia
prematur
describ
prematur
human
infant
one
report
describ
prematur
term
hospit
foal
lower
concentr
compar
healthi
term
foal
wherea
prematur
foal
lower
concentr
either
group
term
foal
presenc
system
ill
also
associ
hypothyroid
prematur
term
foal
term
sick
euthyroid
syndrom
nonthyroid
ill
syndrom
nti
nti
well
describ
human
dog
cat
increas
evid
occur
adult
hors
foal
nti
sick
foal
character
primarili
low
concentr
mechan
underli
nti
thought
associ
proinflammatori
state
associ
ill
may
also
relat
decreas
feed
intak
fast
induc
nti
healthi
human
propos
phenomenon
may
repres
appropri
benefici
respons
critic
ill
least
acut
stage
may
requir
therapeut
intervent
beyond
address
primari
diseas
previous
discuss
matur
endocrin
system
foal
incomplet
birth
develop
continu
week
month
parturit
also
case
system
regul
energi
metabol
foal
system
complex
involv
neuroendocrin
cortisol
vasopressin
thyroid
hormon
somatotrop
growth
hormon
gh
insulinlik
growth
sympathoadren
epinephrin
norepinephrin
pancreat
insulin
glucagon
respons
well
signal
deriv
fat
store
leptin
adiponectin
gastrointestin
tract
ghrelin
somatotrop
axi
stimul
hypothalam
releas
growth
hormonereleas
hormon
inhibit
releas
somatostatin
somatotrop
cell
anterior
pituitari
respond
signal
increas
decreas
releas
gh
effect
gh
primarili
mediat
produc
liver
similar
effect
insulin
regul
blood
glucos
concentr
decreas
hepat
gluconeogenesi
stimul
uptak
util
storag
glucos
secret
gh
stimul
ghrelin
neg
feedback
control
leptin
sympathoadren
respons
stimul
physiolog
stress
hypoglycemia
lead
releas
epinephrin
adren
gland
metabol
effect
epinephrin
increas
energi
substrat
avail
inhibit
pancreat
insulin
secret
increas
glucagon
secret
interf
effect
insulin
tissu
stimul
hepat
glycogenolysi
increas
lipolysi
pancreat
hormon
insulin
glucagon
critic
mediat
blood
glucos
concentr
insulin
produc
cell
respons
hyperglycemia
glucagon
produc
cell
respons
hypoglycemia
insulin
multitud
effect
primarili
focus
lower
blood
glucos
concentr
includ
increas
glucos
uptak
insulindepend
tissu
muscl
adipos
tissu
increas
glycogen
synthesi
increas
fat
synthesi
decreas
gluconeogenesi
lipolysi
glucagon
act
opposit
insulin
primarili
function
increas
blood
glucos
concentr
increas
glycogenolysi
gluconeogenesi
well
increas
lipolysi
adipokin
leptin
involv
control
appetit
increas
seen
follow
ingest
meal
increas
total
bodi
fat
wherea
adiponectin
neg
correl
total
bodi
fat
activ
similar
glucagon
ghrelin
mainli
act
increas
feed
intak
stimul
gh
secret
hypoglycemia
common
find
critic
ill
equin
neonat
perhap
limit
endogen
energi
store
decreas
enter
intak
care
taken
interpret
blood
glucos
concentr
neonat
foal
howev
typic
rel
low
blood
glucos
concentr
matern
blood
glucos
immedi
postpartum
period
especi
first
nurs
hypoglycemia
repeatedli
associ
increas
risk
nonsurviv
critic
ill
foal
although
differ
diagnost
criteria
use
defin
hypoglycemia
studi
report
holli
et
al
associ
sever
hypoglycemia
risk
nonsurviv
increas
mgdl
cutoff
mgdl
associ
increas
odd
surviv
discharg
time
ci
one
studi
percentag
survivor
lower
among
foal
blood
glucos
valu
mgdl
compar
foal
blood
glucos
concentr
mgdl
second
studi
howev
found
clinic
relev
pattern
alter
blood
glucos
concentr
compar
septic
sick
nonsept
neonat
foal
healthi
control
septic
foal
slightli
lower
median
blood
glucos
concentr
control
remain
within
normal
refer
rang
treatment
hypoglycemia
sick
foal
critic
import
document
address
immedi
provis
nutrit
support
either
enter
andor
parenter
appropri
individu
case
see
later
section
nutrit
support
foal
hyperglycemia
common
critic
ill
foal
well
one
studi
report
foal
demonstr
hyperglycemia
admiss
similar
rate
hypoglycemia
studi
report
extrem
hyperglycemia
mgdl
associ
increas
risk
nonsurviv
similar
situat
report
human
neonat
adult
hors
acut
abdomin
diseas
interestingli
barsnick
et
al
report
differ
find
septic
foal
highest
blood
glucos
concentr
mgdl
studi
surviv
insulin
resist
may
play
role
develop
hyperglycemia
although
mani
factor
may
contribut
develop
hyperglycemia
discuss
previous
increas
insulin
concentr
associ
mortal
critic
ill
foal
might
indic
insulin
resist
sever
affect
individu
insulin
resist
appear
common
featur
critic
ill
foal
howev
sick
nonsept
septic
foal
exhibit
normal
insulin
sensit
studi
investig
phenomenon
tremend
interest
debat
human
medicin
regard
therapeut
intervent
control
hyperglycemia
critic
ill
tight
regul
blood
glucos
concentr
mgdl
initi
advoc
human
medicin
approach
shown
deleteri
frequent
hypoglycemia
result
insulin
administr
permiss
approach
recommend
blood
glucos
concentr
maintain
mgdl
approach
attempt
avoid
requir
aggress
insulin
therapi
minim
hypoglycem
episod
also
recogn
stress
hyperglycemia
normal
physiolog
respons
import
maxim
energi
deliveri
noninsulindepend
tissu
brain
intestin
red
blood
cell
kidney
primari
goal
avoid
sever
hypoglycemia
exce
renal
threshold
foal
like
mgdl
insulin
therapi
may
requir
accomplish
goal
variou
regimen
describ
includ
intermitt
bolu
administr
continu
rate
iv
infus
see
later
section
nutrit
support
foal
institut
insulin
therapi
taken
lightli
requir
frequent
monitor
blood
glucos
concentr
rapid
intervent
avoid
hypoglycemia
stabl
blood
glucos
level
achiev
may
take
sever
hour
finetun
indic
alter
energi
regul
investig
foal
includ
triglycerid
tg
nonesterifi
fatti
acid
nefa
gh
leptin
glucagon
although
understand
role
factor
equin
neonat
critic
ill
still
develop
studi
give
valuabl
insight
complex
involv
provid
indic
potenti
benefit
assay
variabl
barsnick
et
al
report
septic
foal
higher
glucagon
tg
concentr
healthi
foal
found
differ
leptin
concentr
group
lower
leptin
concentr
associ
mortal
studi
howev
later
studi
barsnick
et
al
found
septic
foal
higher
ghrelin
gh
tg
concentr
lower
glucos
concentr
compar
healthi
foal
find
like
relat
inanit
neg
energi
balanc
sick
nonsept
foal
studi
higher
gh
tg
lower
concentr
observ
healthi
foal
gh
ratio
higher
septic
sick
nonsept
foal
healthi
foal
highest
nonsurvivor
find
indic
somatotrop
axi
resist
clinic
ill
foal
panzani
et
al
report
concentr
differ
healthi
sick
foal
increas
time
group
wherea
nefa
concentr
higher
sick
foal
time
point
armeng
et
al
also
report
nefa
concentr
higher
sick
foal
healthi
foal
found
differ
tg
concentr
group
although
direct
intervent
somatotrop
axi
appear
indic
find
support
import
correct
neg
energi
balanc
exist
mani
critic
ill
foal
common
type
immunodefici
disord
hors
ftpi
failur
foal
ingest
absorb
adequ
immunoglobulin
colostrum
critic
import
foal
essenti
agammaglobulinem
birth
inabl
macromolecul
transfer
across
diffus
epitheliochori
equin
placenta
dam
fetu
ftpi
regard
import
risk
factor
develop
infect
death
foal
within
first
month
life
incid
ftpi
estim
ftpi
occur
sever
mechan
includ
failur
foal
ingest
adequ
volum
colostrum
earli
neonat
period
loss
colostrum
ingest
prematur
lactat
low
colostr
immunoglobulin
concentr
inadequ
absorpt
colostrum
neonat
gastrointestin
tract
time
colostrum
ingest
critic
import
abil
neonat
gastrointestin
tract
absorb
macromolecul
maxim
birth
rapidli
declin
first
hour
life
diagnosi
ftpi
made
clinic
ground
requir
determin
foal
serum
igg
concentr
within
first
hour
life
gold
standard
assay
quantif
immunoglobulin
quantif
singl
radial
immunodiffus
assay
test
requir
prolong
incub
period
render
littl
util
clinic
set
number
type
rapid
screen
test
avail
estim
foal
igg
concentr
includ
glutaraldehyd
coagul
zinc
sulfat
turbid
turbidimetr
immunoassay
latex
agglutin
enzym
immunoassay
test
well
serum
globulin
tp
concentr
ultim
decis
regard
test
use
base
consider
test
accuraci
time
requir
cost
eas
implement
sever
studi
indic
serum
globulin
concentr
use
estim
igg
concentr
appear
cutoff
point
must
establish
individu
clinic
laboratori
variat
test
methodolog
enzym
immunoassay
test
wide
use
accept
diagnost
perform
screen
test
high
sensit
combin
simpl
perform
rapid
result
interpret
result
igg
test
subject
tremend
interest
past
year
point
confus
differ
diagnost
criteria
differ
test
methodolog
use
time
recent
report
support
tradit
cutoff
valu
mgdl
indic
adequ
transfer
passiv
immun
atpi
found
larg
popul
hospit
foal
valu
mgdl
proport
associ
mortal
studi
also
report
regress
equat
could
use
estim
serum
igg
concentr
serum
tp
albumin
globulin
concentr
good
diagnost
perform
igg
estim
may
help
situat
specif
test
serum
igg
concentr
readili
avail
treatment
ftpi
depend
extent
clinic
statu
foal
foal
environ
foal
known
suspect
ingest
inadequ
amount
colostrum
earli
enter
administr
matern
bank
colostrum
may
effect
howev
treatment
assum
result
atpi
monitor
serum
igg
still
indic
clinic
normal
foal
examin
home
farm
environ
may
requir
treatment
igg
valu
mgdl
partial
ftpi
wherea
valu
less
mgdl
complet
ftpi
repres
ground
treatment
foal
show
sign
clinic
ill
examin
hospit
environ
igg
valu
less
mgdl
indic
treatment
treatment
consist
provid
igg
supplement
often
accomplish
iv
administr
equin
plasma
test
result
typic
avail
time
period
enter
supplement
would
like
effect
dosag
iv
plasma
administr
base
sever
foal
deficit
precis
tremend
variabl
igg
content
commerci
equin
plasma
clinic
practic
administr
l
plasma
reason
expect
provid
approxim
increas
serum
igg
unless
plasma
higher
igg
concentr
use
difficult
administ
enough
plasma
complet
normal
serum
igg
sever
affect
foal
risk
volum
overload
well
expens
treatment
maximum
initi
dosag
plasma
typic
l
import
monitor
effect
treatment
repeat
measur
serum
igg
ensur
treatment
requir
especi
sever
affect
clinic
ill
foal
may
ongo
catabol
igg
associ
system
ill
ni
common
caus
icteru
newborn
foal
immunogenet
disord
foal
red
blood
cell
destroy
preform
matern
antir
blood
cell
antibodi
ingest
colostrum
matern
antibodi
produc
respons
exposur
mare
foreign
red
blood
cell
antigen
sever
possibl
rout
includ
placent
patholog
allow
exposur
fetal
red
blood
cell
gestat
exposur
foal
red
blood
cell
parturit
blood
transfus
administ
mare
blood
group
incompat
mare
foal
caus
foal
inherit
blood
group
antigen
sire
mare
possess
incompat
like
commonli
caus
multitud
equin
blood
group
antigen
estim
incid
yet
report
incid
ni
thoroughbr
standardbr
major
blood
group
antigen
strongli
immunogen
condit
exposur
blood
group
factor
strongli
immunogen
factor
aa
system
factor
qa
q
system
histor
factor
associ
major
case
ni
recent
report
document
involv
alloantigen
perhap
result
enhanc
abil
detect
factor
differ
breed
composit
local
hors
popul
incid
ni
mule
much
higher
hors
estim
high
presenc
foal
donkeyspecif
red
blood
cell
antigen
donkey
factor
hors
lack
foal
affect
ni
typic
born
clinic
normal
begin
show
clinic
sign
within
day
birth
although
interv
long
day
report
clinic
sign
ni
result
anemia
tissu
hypoxia
includ
progress
lethargi
weak
tachypnea
tachycardia
affect
foal
initi
pale
mucou
membran
subsequ
develop
icteru
although
peracut
case
foal
may
die
exhibit
icteru
diseas
progress
foal
becom
dyspneic
seizurelik
activ
may
occur
potenti
caus
kernicteru
case
sever
hyperbilirubinemia
pigmenturia
may
present
caus
sever
hemolysi
affect
foal
anem
although
magnitud
anemia
may
mask
concurr
hemoconcentr
present
although
foal
present
hematocrit
anemia
sever
hematocrit
low
report
thrombocytopenia
may
present
well
find
appear
common
mule
foal
venou
blood
ga
analysi
reveal
decreas
venou
oxygen
concentr
satur
caus
increas
oxygen
extract
tissu
level
metabol
acidosi
caus
lactic
acidosi
caus
anaerob
tissu
metabol
result
increas
lactat
product
hyperbilirubinemia
primarili
caus
increas
indirect
bilirubin
concentr
consist
featur
although
increas
direct
bilirubin
concentr
seen
affect
anim
potenti
caus
hepat
injuri
secondari
hypoxia
iron
toxic
associ
bilirubin
accumul
increas
sdh
concentr
also
associ
sever
anemia
hematocrit
foal
ni
support
hepatocellular
injuri
occur
sever
affect
foal
hemoglobinemia
hemoglobinuria
pronounc
pigment
nephropathi
result
acut
renal
failur
occur
sever
affect
case
diagnosi
often
made
base
signal
histori
clinic
sign
confirm
import
caus
hemolyt
anemia
neonat
foal
includ
dic
associ
sepsi
bacteriainduc
hemolysi
iatrogen
caus
incompat
transfus
blood
plasma
definit
diagnosi
made
demonstr
presenc
antibodi
mare
colostrum
serum
direct
foal
red
blood
cell
antigen
done
use
agglutin
lytic
test
lytic
test
regard
reliabl
hemolyt
crossmatch
mare
serum
foal
red
blood
cell
use
exogen
complement
consid
test
choic
identif
specif
red
blood
cell
factor
involv
also
accomplish
test
panel
red
cell
repres
known
blood
group
despit
limit
agglutin
test
commonli
use
readili
perform
provid
rapid
result
crossmatch
mare
serum
foal
red
blood
cell
without
addit
exogen
complement
agglutin
rather
hemolysi
endpoint
less
sensit
hemolyt
crossmatch
direct
antiglobulin
coomb
test
use
demonstr
presenc
antibodi
surfac
foal
red
blood
cell
test
lack
sensit
readili
perform
test
jaundic
foal
agglutin
jfa
test
simpl
provid
rapid
result
jfa
test
perform
use
red
blood
cell
foal
colostrum
mare
agglutin
endpoint
unfortun
jfa
test
lack
sensit
specif
use
prevent
ni
rather
diagnosi
affect
foal
treatment
ni
dictat
sever
anemia
associ
clinic
sign
moder
affect
foal
primarili
requir
support
care
exercis
restrict
close
monitor
stress
avoid
handl
foal
foal
present
less
hour
age
withheld
nurs
risk
antibodi
ingest
pass
time
interv
difficult
assess
accur
exceed
hour
wane
matern
antibodi
content
milk
decreas
gastrointestin
absorpt
foal
serial
monitor
jfa
test
use
desir
assess
declin
matern
alloantibodi
milk
confirm
introduct
nurs
safe
foal
need
provid
nutrit
support
time
period
readili
perform
use
indwel
feed
tube
igg
supplement
colostrum
anoth
mare
frozen
plasma
necessari
ensur
adequ
passiv
transfer
despit
concern
literatur
withhold
colostrum
appear
deleteri
effect
gastrointestin
develop
foal
iv
fluid
therapi
help
support
cardiovascular
function
tissu
perfus
well
ensur
diuresi
minim
potenti
nephrotox
effect
hemoglobin
fluid
therapi
administ
conserv
howev
avoid
hemodilut
particularli
sever
affect
foal
plasma
exchang
success
use
treat
foal
affect
sever
hyperbilirubinemia
secondari
ni
treatment
indic
affect
foal
show
evid
shock
caus
tissu
hypoxia
becom
like
foal
profoundli
low
hematocrit
base
hematocrit
read
alon
decis
treat
case
may
support
find
persist
progress
tachycardia
tachypnea
demonstr
decreas
mix
venou
oxygen
tension
treatment
foal
direct
restor
oxygencarri
capac
blood
improv
tissu
oxygen
deliveri
intranas
oxygen
insuffl
readili
perform
may
limit
benefit
oxygen
satur
typic
advers
affect
way
improv
oxygen
deliveri
transfus
red
blood
cell
damag
matern
alloantibodi
transfus
red
blood
cell
like
persist
foal
circul
day
goal
transfus
provid
support
foal
produc
suffici
red
blood
cell
support
ideal
situat
known
aa
qa
neg
univers
donor
could
use
difficult
identifi
commonli
avail
case
mare
repres
logic
donor
red
blood
cell
wash
remov
alloantibodi
present
serum
transfus
foal
effect
way
wash
matern
red
blood
cell
centrifug
often
readili
avail
serial
graviti
sediment
anticoagul
matern
red
blood
cell
use
steril
isoton
salin
remov
discard
supernat
readili
perform
reason
effect
requir
substanti
period
time
sever
hour
foal
clinic
statu
may
deterior
report
administr
polymer
bovin
hemoglobin
oxyglobin
biopur
corpor
cambridg
altern
form
bolster
oxygen
transport
capac
appeal
product
shelfstabl
requir
delay
administr
report
provid
conflict
evid
regard
potenti
safeti
approach
administr
bovin
hemoglobin
associ
poor
outcom
instanc
unclear
result
product
administ
result
case
select
sever
affect
foal
like
select
receiv
therapi
blood
transfus
use
volum
blood
administ
foal
kept
minimum
administr
greater
l
blood
associ
develop
hepat
failur
reinforc
concern
find
administr
addit
unit
blood
shown
increas
odd
nonsurviv
time
effect
treatment
ni
prevent
blood
type
mare
perform
breed
fulli
character
mare
blood
group
mare
lack
factor
aa
andor
qa
would
consid
risk
becom
sensit
futur
test
identifi
specif
alloantibodi
produc
mare
produc
niaffect
foal
use
combin
blood
type
sire
predict
futur
risk
rare
done
howev
simpler
perform
jfa
test
time
foal
born
foal
allow
nurs
perform
manner
jfa
test
reason
diagnost
neg
result
support
allow
foal
nurs
absenc
jfa
test
result
foal
born
mare
previou
foal
affect
ni
consid
high
risk
foal
muzzl
birth
allow
nurs
first
hour
life
although
clinic
affect
foal
like
receiv
adequ
passiv
transfer
immunoglobulin
foal
depriv
matern
colostrum
prevent
measur
must
receiv
immunoglobulin
form
pool
colostrum
administ
enter
fresh
frozen
plasma
administ
intraven
neonat
alloimmun
thrombocytopenia
nait
neonat
alloimmun
neutropenia
nan
appear
rare
equin
report
hors
mule
foal
syndrom
ulcer
dermat
thrombocytopenia
neutropenia
also
describ
foal
possibl
incid
condit
underappreci
howev
neutropenia
thrombocytopenia
common
find
critic
ill
patient
secondari
number
mechan
pathophysiolog
nait
nan
similar
ni
affect
foal
ingest
matern
alloantibodi
direct
antigen
platelet
neutrophil
result
destruct
remov
circul
diagnosi
condit
base
demonstr
persist
thrombocytopenia
neutropenia
absenc
diseas
process
might
caus
abnorm
bacteri
sepsi
foal
affect
nait
may
appear
clinic
normal
may
exhibit
petechi
hemorrhag
prolong
bleed
venipunctur
site
foal
nan
typic
clinic
normal
predispos
secondari
bacteri
infect
may
lead
exhibit
clinic
sign
local
system
inflamm
confirm
clinic
diagnosi
requir
demonstr
antibodi
bound
patient
platelet
nait
neutrophil
nan
direct
fluoresc
antibodi
test
elisa
immunoradiometr
test
flow
cytometri
use
confirm
diagnosi
treatment
nait
support
case
although
whole
blood
plateletrich
plasma
transfus
administ
foal
exhibit
clinic
bleed
diathesi
support
care
indic
foal
nan
although
recombin
human
granulocyt
colonystimul
factor
administ
effort
increas
endogen
neutrophil
product
foal
affect
nait
especi
nan
appear
increas
risk
secondari
bacteri
infect
appropri
broadspectrum
antimicrobi
therapi
indic
condit
ultim
selflimit
offend
alloantibodi
consum
elimin
circul
use
immunosuppress
therapi
propos
appear
indic
condit
hepat
disord
uncommon
foal
wide
rang
possibl
etiolog
true
hepat
failur
rare
hepat
dysfunct
common
disord
detect
diagnosi
hepat
diseas
foal
challeng
clinic
sign
nonspecif
often
relat
primari
diseas
process
nonspecif
sign
includ
anorexia
depress
fever
weight
loss
abdomin
pain
icteru
may
present
specif
hepat
dysfunct
may
secondari
anorexia
intravascular
extravascular
hemolysi
sepsi
sever
system
ill
sever
hepat
involv
one
may
observ
follow
cn
sign
bleed
disord
edema
ascit
diarrhea
dermat
definit
diagnosi
requir
clinicopatholog
examin
consist
serum
enzym
activ
conjug
unconjug
bilirubin
minimum
potenti
includ
serum
bile
acid
serum
ammonia
prothrombin
time
addit
biochem
abnorm
may
support
specif
hepat
diseas
includ
hypoglycemia
metabol
acidosi
low
bun
polycythemia
ultrasonograph
examin
also
help
allow
assess
hepat
parenchyma
may
allow
detect
structur
abnorm
hepat
biopsi
although
rare
perform
foal
may
use
diagnosi
treatment
plan
prognost
interpret
biochemistri
profil
challeng
young
foal
activ
hepat
enzym
paramet
substanti
differ
normal
seen
adult
hors
tabl
serum
alkalin
phosphatas
alp
activ
show
strike
elev
compar
adult
valu
much
greater
first
week
life
primarili
caus
bone
metabol
rapidli
declin
first
month
life
gradual
decreas
adult
rang
month
age
serum
ggt
activ
transient
increas
second
week
life
return
normal
adult
rang
month
age
ast
concentr
increas
slightli
first
week
life
remain
similar
adult
valu
sdh
glutam
dehydrogenas
gldh
valu
differ
significantli
age
serum
bile
acid
concentr
also
increas
birth
gradual
decreas
normal
adult
rang
first
week
life
neonat
hyperbilirubinemia
well
document
foal
primarili
associ
increas
total
bilirubin
concentr
elev
gradual
resolv
valu
typic
within
normal
adult
rang
first
week
life
direct
bilirubin
concentr
low
birth
increas
normal
adult
rang
first
day
life
serum
enzym
liver
specificnam
sdh
gldh
ggtare
greatest
util
evalu
foal
hepat
dysfunct
compar
nonspecif
enzym
alp
ast
ggt
liver
biliari
tract
specif
wherea
sdh
gldh
hepatocellular
origin
tyzzer
diseas
enterohepat
syndrom
affect
foal
day
age
associ
rapid
onset
septic
shock
death
usual
within
hour
onset
clinic
sign
primari
manifest
diseas
peracut
bacteri
hepat
diseas
well
describ
foal
numer
case
document
unit
state
countri
past
year
caus
agent
tyzzer
diseas
c
piliform
soiland
manureborn
gramneg
pleomorph
motil
sporeform
rodshap
oblig
intracellular
bacterium
epidemiolog
poorli
understood
diseas
affect
adult
hors
like
adult
carrier
contamin
environ
subsequ
fecalor
transmiss
risk
factor
diseas
includ
season
time
greater
risk
march
april
foal
born
young
mare
year
age
nonresid
mare
also
increas
risk
possibl
lack
previou
exposur
lead
poor
colostr
antibodi
product
result
inadequ
passiv
immun
foal
tyzzer
diseas
often
affect
otherwis
healthi
foal
affect
individu
especi
younger
foal
may
simpli
found
dead
foal
present
aliv
clinic
sign
often
nonspecif
includ
lethargi
anorexia
dehydr
icteru
fever
colic
diarrhea
seizur
follow
rapid
onset
recumb
weak
coma
death
antemortem
diagnosi
difficult
typic
base
signal
histori
clinic
sign
clinicopatholog
find
pcr
test
may
use
earli
specif
diagnosi
result
may
avail
within
use
time
frame
rapid
progress
diseas
clinicopatholog
examin
typic
demonstr
sever
leukopenia
left
shift
thrombocytopenia
mark
hypoglycemia
sever
metabol
acidosi
elev
serum
fibrinogen
elev
total
indirect
direct
bilirubin
concentr
hepatocellular
enzym
ast
sdh
markedli
increas
ggt
alp
typic
within
normal
limit
ultrasonograph
examin
liver
reveal
mark
hepatomegali
increas
echogen
hepat
parenchyma
possibl
enhanc
vascular
pattern
treatment
extrem
difficult
sever
acut
natur
diseas
prognosi
regard
grave
howev
report
success
treatment
three
suspect
one
confirm
case
diseas
treatment
consist
antimicrobi
therapi
penicillin
ampicillin
combin
aminoglycosid
well
fluid
therapi
correct
electrolyt
acidbas
disord
parenter
nutrit
support
appropri
support
care
bacteria
c
piliform
caus
hepat
diseas
commonli
associ
sever
system
inflamm
bacteremia
case
typic
present
primari
hepat
diseas
foal
typic
present
septic
critic
ill
foal
find
hepat
involv
secondari
actinobacillu
spp
equi
subsp
zooepidemicu
report
involv
acut
bacteri
hepat
young
foal
spirochet
bartonella
hensela
recent
associ
sever
suppur
cholangiohepat
foal
success
treat
trimethoprimsulfamethoxazol
rifampin
along
sadenosylmethionin
pentoxifyllin
potenti
antifibrot
antioxid
effect
leptospirosi
associ
jaundic
death
foal
leptospira
interrogan
serovar
pomona
appear
rare
caus
hepat
diseas
neonat
foal
ascend
cholangiohepat
bile
duct
obstruct
associ
duoden
stenosi
result
sever
gastroduoden
ulcer
diseas
gdud
effect
surgic
bypass
procedur
describ
foal
suffer
delay
gastric
empti
associ
gdud
prognosi
foal
hepat
involv
appear
guard
equin
herpesviru
infect
nearterm
fetu
result
deliveri
nonviabl
foal
suffer
hepat
respiratori
andor
gastrointestin
diseas
affect
foal
born
prematur
sever
icter
initi
examin
clinicopatholog
examin
typic
demonstr
sever
leukopenia
caus
neutropenia
lymphopenia
may
sever
seen
septic
foal
hyperbilirubinemia
may
present
although
magnitud
hyperbilirubinemia
may
less
one
might
expect
base
profound
icteru
observ
clinic
increas
usual
observ
serum
activ
hepat
enzym
surpris
given
sever
hepat
necrosi
detect
postmortem
examin
although
hepat
involv
promin
affect
foal
death
usual
caus
overwhelm
respiratori
diseas
within
day
birth
treatment
acyclovir
associ
improv
surviv
one
report
although
valacyclovir
may
repres
superior
choic
given
superior
bioavail
drug
adult
hors
oral
administr
hepat
lipidosi
hepat
lipidosi
occur
secondari
hyperlipemia
neonat
foal
appear
common
miniatur
breed
hypertriglyceridemia
mgdl
typic
develop
consequ
neg
energi
balanc
result
inanit
anorexia
caus
primari
diseas
process
unresolv
may
progress
hyperlipemia
characterist
grossli
lipem
serum
fat
accumul
liver
proceed
rapidli
result
hepat
lipidosi
hepat
enzym
activ
may
increas
consist
observ
clinic
sign
hepat
lipidosi
may
refer
primari
diseas
process
includ
sever
depress
seizur
blind
ventral
edema
treatment
direct
toward
resolv
primari
diseas
process
correct
neg
energi
balanc
parenter
nutrit
insulin
therapi
often
critic
facilit
resolut
hyperlipemia
allow
administr
adequ
amount
parenter
nutrit
ni
common
caus
hyperbilirubinemia
foal
hepat
diseas
may
develop
hepatocellular
injuri
result
excess
bilirubin
accumul
anem
hypoxia
andor
iron
toxicosi
total
direct
bilirubin
ast
alp
sdh
activ
may
increas
foal
ni
foal
lowest
present
pack
cell
volum
tend
highest
sdh
valu
suggest
hepat
injuri
present
time
present
one
studi
report
foal
receiv
multipl
blood
transfus
l
time
like
develop
hepat
failur
receiv
smaller
volum
blood
product
thought
multipl
blood
transfus
may
caus
iron
overload
lead
iron
toxic
administr
deferoxamin
mesyl
iron
chelat
shown
decreas
hepat
iron
accumul
healthi
foal
receiv
blood
transfus
although
use
drug
foal
ni
report
result
studi
suggest
administr
deferoxamin
foal
ni
start
blood
administr
may
benefici
decreas
ironassoci
hepat
injuri
iron
toxic
oral
administr
iron
fumar
welldescrib
caus
hepat
injuri
foal
greatest
risk
toxic
associ
iron
administr
foal
first
suckl
presum
caus
presenc
protect
factor
colostrum
milk
decreas
hepatotox
iron
administ
nurs
begun
iron
administ
birth
colostrum
ingest
clinic
sign
typic
manifest
within
day
primarili
associ
hepatoencephalopathi
seizur
profound
depress
head
press
ataxia
abnorm
behavior
common
icteru
usual
present
time
onset
neurolog
sign
clinicopatholog
examin
typic
reveal
elev
bilirubin
ggt
alp
sdh
well
increas
ammonia
concentr
glycogen
storag
diseas
type
iv
fatal
recess
inherit
defici
glycogen
branch
enzym
describ
quarter
hors
foal
clinic
sign
associ
diseas
variabl
rang
stillbirth
progress
weak
transient
flexur
limb
deform
persist
recumb
seizur
respiratori
cardiac
failur
affect
foal
leukopen
typic
elev
ast
ggt
activ
addit
elev
creatin
kinas
ck
caus
muscl
patholog
genet
lesion
singl
base
nonsens
mutat
glycogen
branch
enzym
encod
gene
one
studi
report
approxim
fetal
earli
neonat
death
quarter
horserel
breed
homozyg
mutant
allel
suggest
syndrom
clinic
relev
impact
reproduct
effici
breed
persist
hyperammonemia
associ
encephalopathi
describ
morgan
foal
month
age
affect
foal
exhibit
acut
onset
clinic
sign
shortli
wean
includ
coma
blind
seizur
hepat
enzym
may
mildli
elev
hepat
patholog
modest
blood
ammonia
level
extrem
high
affect
foal
syndrom
thought
relat
inherit
disord
hepat
ammonia
metabol
possibl
amino
acid
metabol
defect
may
resembl
hhh
syndrom
human
although
foal
may
surviv
first
encephalopath
crisi
syndrom
consid
fatal
may
end
termin
hemolyt
crisi
syndrom
congenit
hepat
fibrosi
describ
swiss
franchesmontagn
swiss
frieberg
breed
onset
clinic
sign
sudden
affect
foal
jaundic
encephalopath
abdomin
distent
colic
fever
tachypnea
also
common
leukocytosi
caus
neutrophilia
increas
ggt
alp
serum
bile
acid
valu
report
histopatholog
demonstr
diffus
bridg
portal
fibrosi
numer
small
irregular
bile
duct
sometim
cystic
portosystem
shunt
infrequ
congenit
anomali
foal
allow
shunt
blood
directli
portal
circul
system
circul
shunt
locat
intraor
extrahepat
may
singl
multipl
number
clinic
sign
encephalopathi
often
develop
foal
week
age
diagnosi
base
signal
particularli
age
onset
presenc
encephalopath
sign
normal
serum
hepat
enzym
activ
mark
elev
serum
ammonia
confirm
diagnosi
may
possibl
use
hepat
ultrasonographi
bubblegram
studi
involv
inject
ml
agit
salin
spleen
monitor
rapid
appear
bubbl
via
simultan
echocardiographi
ct
posit
contrast
portographi
transrect
portoscintigraphi
may
also
use
confirm
diagnosi
success
surgic
repair
use
band
techniqu
provid
progress
occlus
describ
muscular
disord
polysaccharid
storag
myopathi
pssm
first
describ
quarter
hors
relat
breed
paint
appaloosa
hors
recogn
draft
warmblood
light
hors
breed
well
pssm
character
abnorm
glycogen
accumul
skelet
muscl
associ
muscl
damag
follow
exert
exercis
syndrom
associ
incomplet
penetr
autosom
domin
mutat
gene
encod
skelet
muscl
glycogen
synthas
enzym
mutat
identifi
hors
breed
although
highli
variabl
frequenc
quarter
hors
belgian
highest
report
preval
pssm
rare
report
foal
remain
subclin
especi
foal
stall
confin
indic
presenc
syndrom
may
increas
serum
ck
activ
unless
foal
undergo
period
exert
activ
affect
concurr
diseas
typic
diseas
recogn
affect
individu
matur
enough
put
train
work
clinic
sign
may
rang
muscl
sore
gait
abnorm
warmblood
progress
weak
muscl
atrophi
draft
breed
wherea
quarter
hors
may
suffer
acut
exert
rhabdomyolysi
diagnosi
adult
depend
muscl
biopsi
may
diagnost
use
foal
genet
test
prefer
daili
pastur
exercis
appropri
feed
balanc
lowstarch
fatsuppl
diet
foal
dam
like
benefici
manag
affect
foal
glycogen
branch
enzym
defici
repres
import
caus
stillbirth
earli
neonat
death
quarter
hors
paint
breed
syndrom
caus
mutat
gene
result
sever
impair
glucos
homeostasi
clinic
present
variabl
foal
born
aliv
weak
hypotherm
although
often
respond
posit
assist
nurs
bottlefe
intermitt
hypoglycemia
seizur
may
develop
unless
nurs
regularli
clinic
sign
includ
fever
tachypnea
tachycardia
nonspecif
spectrum
clinic
sign
difficult
differenti
foal
suffer
neonat
sepsi
respiratori
failur
sudden
death
occur
even
mild
moder
exercis
clinicopatholog
evalu
may
reveal
leukopenia
intermitt
hypoglycemia
persist
elev
ck
ast
ggt
activ
despit
support
care
condit
ultim
fatal
foal
succumb
week
report
surviv
beyond
week
age
genet
test
avail
diagnosi
diseas
nutrit
myodegener
nmd
noninflammatori
degen
diseas
primarili
seen
foal
less
day
age
affect
skelet
well
cardiac
muscl
associ
low
serum
selenium
vitamin
e
concentr
primari
defici
vitamin
e
selenium
appear
mare
reason
nmd
commonli
seen
area
seleniumdefici
soil
forag
grain
area
includ
northeastern
northwestern
midatlant
great
lake
region
unit
state
clinic
present
nmd
acut
subacut
subacut
form
associ
muscular
weak
wherea
acut
form
associ
rapidli
progress
weak
lead
recumb
death
within
day
dysphagia
common
find
subacut
form
relat
involv
muscl
involv
prehens
mastic
swallow
may
contribut
develop
ftpi
aspir
pneumonia
sever
affect
foal
typic
involv
myocardium
respiratori
musculatur
contribut
cardiovascular
respiratori
failur
lead
death
diagnosi
nmd
base
clinic
sign
combin
increas
muscl
enzym
activ
ck
ast
decreas
blood
selenium
decreas
glutathion
peroxidas
activ
respons
vitamin
e
selenium
treatment
profound
electrolyt
abnorm
may
present
includ
hyperkalemia
hyponatremia
hypochloremia
hypocalcemia
hyperkalemia
potenti
contribut
cardiac
arrest
sever
affect
foal
myoglobinuria
may
present
pigment
nephropathi
lead
develop
acut
renal
failur
muscl
biopsi
may
support
nmd
definit
antemortem
diagnosi
requir
assess
vitamin
e
selenium
concentr
glutathion
peroxidas
activ
postmortem
examin
consist
reveal
bilater
symmetr
myodegener
dri
appear
pale
discolor
affect
muscl
treatment
requir
support
care
iv
fluid
therapi
correct
hypovolemia
electrolyt
derang
metabol
acidosi
diuresi
dysphag
foal
requir
nutrit
support
either
indwel
nasogastr
feed
tube
parenter
vitamin
e
selenium
supplement
essenti
treatment
affect
foal
tabl
inject
form
selenium
also
contain
vitamin
e
insuffici
concentr
requir
foal
also
receiv
inject
oral
vitamin
e
although
initi
prognosi
guard
foal
regain
abil
stand
favor
prognosi
prevent
nmd
aid
ensur
mare
adequ
dietari
vitamin
e
selenium
intak
prophylact
parenter
administr
vitamin
e
selenium
newborn
foal
endem
area
presenc
document
focal
system
bacteri
infect
septic
arthriti
pneumonia
enterocol
mening
umbil
remnant
infect
repres
clear
indic
use
antimicrobi
therapi
foal
unfortun
clinic
situat
alway
straightforward
risk
septicemia
compromis
neonat
foal
often
better
make
assumpt
bacteri
infect
present
rather
risk
allow
patient
deterior
await
confirm
diagnosi
situat
bacteri
infect
like
suspect
aggress
therapi
includ
antimicrobi
indic
although
risk
associ
antimicrobi
therapi
primarili
aad
risk
greatli
outweigh
risk
associ
withhold
antimicrobi
therapi
patient
sepsi
secondari
bacteri
infect
earli
appropri
empir
antimicrobi
therapi
shown
reduc
mortal
human
patient
suffer
septic
shock
although
publish
evid
lack
clinic
experi
neonat
foal
support
conclus
well
implement
antimicrobi
therapi
one
must
consid
basic
pharmacolog
concept
first
concept
whether
antimicrobi
select
appropri
like
target
therapi
understand
one
must
concept
drug
mechan
action
relat
differ
class
bacteria
inher
suscept
second
drug
deliv
rout
deliveri
like
achiev
therapeut
concentr
drug
affect
site
key
factor
profoundli
affect
abil
effect
deliv
antimicrobi
site
infect
failur
take
account
preclud
effect
treatment
physic
pharmacolog
characterist
differ
antimicrobi
interact
variou
tissu
also
signific
influenc
effici
efficaci
treatment
bacteri
infect
consider
also
given
rout
administr
frequenc
dose
particularli
treatment
administ
lay
personnel
owner
achiev
therapeut
concentr
site
infect
challeng
especi
drug
cross
epitheli
barrier
cn
eye
lung
biliari
etc
drug
highli
lipid
solubl
tend
distribut
fulli
tissu
wherea
watersolubl
drug
tend
distribut
primarili
within
extracellular
water
penetr
epithelia
poorli
presenc
inflamm
allow
increas
tissu
permeabl
epitheli
barrier
howev
resolut
inflamm
allow
epitheli
restitut
may
limit
abil
watersolubl
drug
maintain
therapeut
respiratori
concentr
heal
progress
recurr
infect
may
result
pharmacodynam
characterist
differ
antimicrobi
also
impact
decis
regard
rout
frequenc
administr
two
fundament
class
drug
timedepend
concentrationdepend
antimicrobi
efficaci
timedepend
antimicrobi
requir
concentr
site
infect
maintain
minimum
inhibitori
concentr
mic
much
treatment
interv
possibl
timedepend
drug
benefit
intramuscular
oral
administr
slower
absorpt
yield
lower
serum
concentr
therapeut
concentr
typic
maintain
longer
period
time
use
cri
deliveri
timedepend
drug
yield
optim
pharmacokinet
feasibl
hospit
environ
use
electron
infus
pump
efficaci
concentrationdepend
drug
requir
high
peak
serum
concentr
maxim
efficaci
greater
time
mic
aminoglycosid
requir
high
concentr
throughout
treatment
interv
compound
benefit
iv
topic
administr
achiev
high
peak
concentr
prolong
treatment
interv
also
import
rememb
foal
differ
adult
hors
number
way
may
impact
choic
antimicrobi
therapi
first
foal
substanti
greater
total
bodi
water
content
adult
hors
typic
requir
dosag
watersolubl
drug
increas
exampl
dose
aminoglycosid
often
increas
much
foal
compar
dose
adult
compens
increas
volum
distribut
also
neonat
foal
complet
matur
hepat
renal
system
especi
first
week
life
may
result
impair
elimin
certain
drug
metabol
elimin
rout
differ
type
toxic
associ
antimicrobi
use
foal
must
also
consideredfor
exampl
risk
arthropathi
associ
administr
fluoroquinolon
rapidli
grow
cartilag
tissu
advantag
design
foal
antimicrobi
therapi
oral
administ
antimicrobi
effect
absorb
foal
compar
adult
allow
wider
use
rout
addit
foal
appear
reduc
risk
aad
like
yet
fulli
transit
hindgut
ferment
last
antimicrobi
use
foal
costprohibit
adult
hors
total
dose
requir
henc
cost
foal
much
less
common
isol
encount
vari
somewhat
base
specif
site
infect
predispos
factor
associ
infect
howev
look
retrospect
studi
isol
bacterem
neonat
foal
pattern
becom
appar
past
year
common
bacteria
isol
blood
cultur
infect
foal
gramneg
organ
gramposit
organ
isol
infect
foal
repres
less
isol
typic
present
mix
infect
gramneg
organ
although
varianc
pattern
bacteria
isol
foal
may
result
region
differ
appear
recent
increas
percentag
gramposit
isol
occur
sever
studi
report
increas
number
gramposit
isol
rang
total
isol
tempor
chang
pattern
isol
highlight
need
consid
like
pathogen
present
formul
initi
empir
antimicrobi
plan
base
recent
report
e
coli
remain
common
isol
follow
enterococcu
spp
actinobacillu
spp
streptococci
staphylococcu
spp
enterobact
spp
unfortun
also
tempor
chang
pattern
antimicrobi
suscept
observ
bacteria
isol
bacterem
foal
although
may
debat
drive
forc
behind
chang
pattern
antimicrobi
sensit
doubt
phenomenon
real
earlier
report
mention
presenc
isol
resist
multipl
antimicrobi
recent
report
demonstr
substanti
number
multidrugresist
mdr
organ
isol
definit
vari
somewhat
among
refer
gener
speak
mdr
organ
display
resist
three
core
antimicrobi
sensit
panel
recent
studi
human
medicin
character
common
problemat
mdr
organ
eskap
group
includ
enterococcu
faecium
staphylococcu
aureu
klebsiella
pneumonia
acinetobact
baumanii
pseudomona
aeruginosa
enterobact
spp
group
pathogen
respons
major
nosocomi
infect
human
hospit
routin
escap
current
use
antimicrobi
drug
increas
preval
mdr
organ
requir
antimicrobi
use
judici
appropri
limit
spread
organ
risk
associ
organ
also
reinforc
need
perform
appropri
cultur
sampl
blood
synovi
fluid
csf
bodi
caviti
effus
etc
sure
pathogen
involv
tailor
antimicrobi
therapi
appropri
antibiot
bind
penicillin
bind
protein
interf
bacteri
cell
wall
synthesi
lead
format
defect
cell
wall
osmot
unstabl
cell
death
usual
result
cell
lysi
drug
includ
penicillin
synthet
penicillin
cephalosporin
carbapenem
modif
basic
penicillin
cephalosporin
molecul
confer
differ
antimicrobi
activ
seen
synthet
penicillin
thirdgener
cephalosporin
exhibit
increas
gramneg
spectrum
increas
stabil
may
also
achiev
seen
carbapenem
drug
timedepend
antimicrobi
must
present
tissu
concentr
greater
mic
throughout
prefer
dosag
interv
effect
penicillin
g
commonli
use
antimicrobi
equin
medicin
exhibit
good
efficaci
mani
gramposit
organ
anaerob
limit
gramneg
spectrum
penicillin
g
exhibit
good
synergi
aminoglycosid
antimicrobi
make
use
drug
combin
therapi
approach
procain
penicillin
administ
intramuscularli
wherea
aqueou
solut
sodium
potassium
penicillin
administ
intraven
tabl
procain
penicillin
g
readili
avail
inexpens
requir
repeat
intramuscular
inject
make
less
desir
use
neonat
foal
minim
muscl
mass
potassium
sodium
penicillin
substanti
expens
procain
penicillin
daili
cost
basi
commonli
use
hospit
foal
readi
venou
access
report
administ
potassium
sodium
penicillin
iv
cri
provid
favor
pharmacokinet
timedepend
compound
toxic
low
penicillin
primarili
associ
advers
reaction
inadvert
iv
intraarteri
inject
intramuscular
prepar
procain
penicillin
g
like
repres
advers
reaction
procain
rather
penicillin
although
anaphylact
reaction
report
ampicillin
amoxicillin
synthet
penicillin
exhibit
better
activ
gramneg
bacteria
improv
outer
cell
wall
penetr
suffer
loss
efficaci
compar
penicillin
g
regard
suscept
gramposit
bacteria
ampicillin
wide
use
altern
penicillin
treatment
neonat
sepsi
typic
combin
amikacin
drug
occasion
use
foal
includ
antipseudomon
penicillin
carbapenem
drug
exhibit
superior
gramneg
spectrum
action
primarili
use
case
aminoglycosid
administ
treatment
pathogen
resist
aminoglycosid
use
drug
restrict
case
document
infect
involv
suscept
mdr
organ
commonli
use
antipseudomon
penicillin
ticarcillin
typic
combin
clavulan
acid
clavulan
acid
caus
irrevers
timedepend
inactiv
mani
enhanc
activ
ticarcillin
organ
produc
enzym
imipenem
carbapenem
antimicrobi
use
foal
treatment
mdr
infect
imipenem
use
combin
cilastatin
slow
renal
elimin
imipenem
allow
decreas
frequenc
dose
cephalosporin
tradit
group
gener
accord
order
discoveri
spectrum
action
firstgener
drug
exhibit
primarili
gramposit
spectrum
wherea
subsequ
gener
increas
gramneg
spectrum
correspond
decreas
gramposit
spectrum
fourthgener
drug
consid
truli
broad
spectrum
primari
cephalosporin
administ
hors
ceftiofur
thirdgener
drug
exhibit
fairli
broad
spectrum
emphasi
toward
gramneg
coverag
spectrum
activ
ceftiofur
often
use
sole
therapi
initi
treatment
foal
rel
safeti
ceftiofur
foal
foster
approach
allow
clinician
avoid
use
combin
therapi
includ
aminoglycosid
unfortun
recent
studi
document
frequent
resist
ceftiofur
organ
isol
foal
appear
trend
toward
increas
resist
time
especi
among
gramneg
enter
bacteria
use
ceftiofur
sodium
cri
also
investig
appear
yield
suitabl
pharmacokinet
ceftiofur
also
avail
sustainedreleas
form
contain
ccfa
subcutan
administr
ccfa
yield
appropri
pharmacokinet
highli
suscept
bacteria
foal
selflimit
diarrhea
report
foal
treat
ccfa
appear
clinic
problem
associ
drug
repeat
subcutan
dose
ccfa
mgkg
interv
four
dose
report
maintain
appropri
therapeut
concentr
foal
cephalosporin
may
util
foal
cefquinom
ceftriaxon
cefpodoxim
proxetil
cefotaxim
ceftazidim
cefepim
cefquinom
fourthgener
cephalosporin
label
europ
treatment
foal
septicemia
caus
e
coli
avail
unit
state
time
cefquinom
dose
mgkg
iv
intramuscularli
everi
hour
suscept
pathogen
higher
dose
mgkg
iv
everi
hour
indic
deal
pathogen
higher
mic
valu
cefpodoxim
proxetil
thirdgener
drug
administ
oral
unfortun
expens
drug
render
limit
util
case
cefepim
fourthgener
drug
use
manag
mdr
infect
aminoglycosid
continu
constitut
major
compon
equin
clinician
armamentarium
despit
welldescrib
potenti
nephrotox
primari
reason
aminoglycosid
bactericid
exhibit
primarili
gramneg
spectrum
demonstr
good
synergi
antimicrobi
bacteri
penetr
aminoglycosid
part
oxygendepend
transport
process
partial
accomplish
passiv
diffus
depend
oxygendriven
transport
render
anaerob
resist
aminoglycosid
role
passiv
diffus
lead
depend
high
tissu
concentr
drug
achiev
high
intracellular
concentr
rout
administr
andor
dosag
schedul
associ
high
peak
concentr
site
infect
extendedinterv
dose
associ
improv
clinic
respons
prolong
treatment
interv
decreas
risk
nephrotox
still
demonstr
clinic
efficaci
caus
prolong
bacteri
kill
even
aminoglycosid
concentr
drop
mic
target
organ
phenomenon
term
postantibiot
effect
use
extend
interv
dose
also
demonstr
lessen
develop
acquir
adapt
antimicrobi
resist
caus
high
peak
concentr
achiev
period
time
drug
mic
neonat
foal
reduc
rate
drug
clearanc
necessit
prolong
treatment
interv
clearanc
increas
adult
level
within
first
week
life
also
greater
volum
distribut
compar
adult
necessit
substanti
higher
dosag
achiev
desir
peak
serum
concentr
recent
studi
examin
pharmacokinet
gentamicin
foal
indic
gentamicin
dose
mgkg
iv
everi
hour
foal
less
week
age
wherea
lower
dose
mgkg
iv
everi
hour
estim
adequ
foal
week
age
older
unpredict
aminoglycosid
pharmacokinet
sick
foal
recommend
therapeut
drug
monitor
perform
ensur
adequ
peak
serum
concentr
achiev
well
appropri
trough
concentr
peak
serum
concentr
typic
monitor
minut
administr
iv
dose
trough
concentr
monitor
immedi
subsequ
dose
approach
effect
may
lack
sensit
detect
impair
clearanc
drug
addit
time
sampl
collect
result
assay
avail
administr
next
dose
may
delay
adjust
dosag
interv
indic
altern
approach
obtain
serum
sampl
minut
hour
drug
administr
allow
estim
drug
clearanc
time
manner
allow
rapid
adjust
therapeut
protocol
potenti
sulfa
compound
common
equin
medicin
broad
spectrum
oral
rout
administr
afford
drug
exhibit
timedepend
pharmacodynam
effect
consid
bactericid
potenti
sulfa
distribut
well
tissu
toxic
commonli
associ
disturb
gastrointestin
flora
associ
develop
coliti
although
drug
appropri
initi
therapi
septic
foal
organ
document
suscept
use
quit
effect
tetracyclin
bacteriostat
broad
spectrum
possess
activ
wide
varieti
bacteria
protozoa
well
mycoplasma
rickettsia
compound
time
depend
natur
commonli
use
compound
oxytetracyclin
minocyclin
toxic
report
disturb
gastrointestin
flora
adult
appear
rare
foal
tetracyclin
primarili
elimin
via
urinari
tract
risk
toxic
anim
renal
insuffici
larg
dosag
oxytetracyclin
administ
foal
suffer
tendon
contractur
repeat
injudici
administr
associ
nephrotox
rapid
iv
inject
oxytetracyclin
associ
collaps
hors
perhap
caus
chelat
calcium
blood
reason
oxytetracyclin
administ
mgkg
slowli
iv
twice
daili
usual
dilut
l
normal
salin
administ
minut
doxycyclin
longer
wide
use
decreas
avail
increas
expens
minocyclin
come
widespread
use
hors
superior
pharmacokinet
compar
doxycyclin
much
reason
cost
treatment
although
pharmacokinet
studi
perform
foal
minocyclin
empir
administ
adult
dosag
macrolid
erythromycin
azithromycin
clarithromycin
consid
bacteriostat
broad
spectrum
action
accumul
tissu
particularli
lung
primari
applic
treatment
rhodococc
pneumonia
foal
macrolid
elimin
hepat
metabol
affect
pharmacokinet
drug
metabol
system
erythromycin
administr
foal
rhodococc
pneumonia
associ
frequent
hyperthermia
diarrhea
drug
longer
use
purpos
area
unit
state
azithromycin
clarithromycin
commonli
use
macrolid
foal
time
rifampin
therapi
typic
administ
conjunct
macrolid
treatment
rhodococc
pneumonia
potenti
synergist
effect
combin
clarithromycinrifampin
shown
effect
erythromycinrifampin
azithromycinrifampin
treatment
rhodococc
pneumonia
despit
decad
clinic
experi
support
efficaci
combin
macrolid
rifampin
recent
evid
coadministr
rifampin
macrolid
substanti
inhibit
macrolid
absorpt
current
recommend
support
continu
use
macroliderifampin
combin
treatment
rhodococc
pneumonia
foal
recent
interest
use
macrolid
gamithromycin
foal
drug
exhibit
favor
pharmacokinet
foal
follow
onceweekli
intramuscular
inject
also
shown
noninferior
combin
azithromycin
rifampin
treatment
rhodococc
pneumonia
foal
rifamycin
rifampin
macrocycl
antibiot
use
primarili
foal
adjunct
therapi
macrolid
treatment
rhodococc
pneumonia
combin
antibiot
treatment
abscess
never
use
alon
risk
rapidli
develop
antimicrobi
resist
addit
use
rifampin
treatment
rhodococc
infect
report
effect
treatment
staphylococc
infect
chloramphenicol
wide
distribut
tissu
wide
spectrum
action
includ
gramposit
gramneg
bacteria
well
rickettsia
mycoplasma
anaerob
halflif
chloramphenicol
short
timedepend
drug
requir
frequent
dose
interv
human
health
concern
regard
possibl
chloramphenicolassoci
nondosedepend
fatal
aplast
anemia
made
illeg
use
drug
food
anim
past
year
result
minim
use
drug
low
level
resist
chloramphenicol
mani
type
bacteria
creat
potenti
import
role
chloramphenicol
treatment
mdr
organ
intriguingli
usag
chloramphenicol
propos
human
patient
infect
mdr
organ
despit
risk
aplast
anemia
regardless
potenti
risk
aplast
anemia
human
handl
chloramphenicol
necessit
thorough
client
educ
dispens
drug
avoid
contact
aerosol
drug
direct
contact
mucou
membran
anim
toxic
appear
rare
associ
revers
irrevers
bone
marrow
suppress
florfenicol
close
relat
chloramphenicol
associ
aplast
anemia
human
label
use
food
anim
administr
florfenicol
adult
hors
associ
acut
coliti
contraind
report
foal
anecdot
report
success
clinic
use
florfenicol
foal
dose
interv
howev
recent
pharmacokinet
studi
suggest
shorter
treatment
interv
hour
may
appropri
fluoroquinolon
fluoroquinolon
rel
broad
spectrum
excel
activ
gramneg
organ
minim
activ
streptococci
bactericid
exhibit
excel
tissu
penetr
fluoroquinolon
exhibit
peak
concentrationdepend
bactericid
effect
prolong
postantibiot
effect
similar
aminoglycosid
result
given
rel
high
dose
decreas
frequenc
enrofloxacin
wide
use
fluoroquinolon
hors
use
contraind
foal
advers
effect
cartilag
matur
marbofloxacin
use
foal
appear
safe
although
control
studi
perform
confirm
clinic
impress
metronidazol
metronidazol
nitroimidazol
antimicrobi
highli
effect
anaerob
organ
limit
anaerob
spectrum
antimicrobi
use
foal
metronidazol
commonli
use
anaerob
involv
suspect
confirm
foal
recent
pharmacokinet
studi
found
agedepend
influenc
metronidazol
kinet
foal
suggest
rang
dosag
cours
first
week
life
aerosol
administr
antimicrobi
demonstr
achiev
high
concentr
antimicrobi
respiratori
mucos
surfac
minim
develop
system
side
effect
potenti
advantag
deliv
medic
lower
respiratori
tract
aerosol
includ
decreas
total
dose
administ
avoid
system
side
effect
rapid
onset
action
administr
antimicrobi
aerosol
limit
howev
includ
potenti
problem
drug
deliveri
pulmonari
irrit
well
expens
requir
equip
time
requir
administr
sever
antimicrobi
investig
aerosol
administr
hors
includ
gentamicin
ceftiofur
cefquinom
marbofloxacin
gentamicin
ceftiofur
well
toler
administ
aerosol
fluid
therapi
foal
one
fundament
dilemma
face
clinician
evalu
sick
foal
whether
fluid
therapi
indic
determin
answer
question
one
must
consid
varieti
indic
fluid
therapi
common
indic
correct
volum
deplet
dehydr
indic
fluid
therapi
correct
specif
electrolyt
imbal
provis
colloid
support
correct
acidbas
disord
restor
oxygencarri
capac
provis
immunoglobulin
mani
case
one
indic
present
one
must
care
assess
patient
chang
clinic
statu
time
may
result
one
new
indic
fluid
therapi
aris
even
other
may
resolv
next
question
regard
fluid
therapi
type
fluid
patient
need
choic
fluid
composit
depend
multipl
variabl
includ
primari
goal
fluid
therapi
well
patientspecif
routespecif
practic
consider
clinician
must
determin
appropri
rout
administr
fluid
therapi
individu
patient
may
also
factor
decisionmak
process
regard
type
fluid
administ
amount
fluid
therapi
administ
must
also
determin
primarili
base
patient
fluid
deficit
need
mainten
replac
ongo
loss
anticip
durat
therapi
difficult
assess
formul
treatment
plan
repres
import
factor
decid
fluid
administ
potenti
cost
client
fluid
therapi
final
clinician
must
develop
plan
monitor
ongo
fluid
therapi
determin
fluid
therapi
longer
requir
first
challeng
patient
evalu
accur
assess
hydrat
statu
typic
paramet
use
assess
clinic
hydrat
physic
examin
mucou
membran
color
capillari
refil
time
jugular
refil
time
puls
qualiti
temperatur
extrem
mental
statu
urin
product
fundament
repres
indic
perfus
rather
hydrat
import
distinct
given
situat
cardiogen
vasodilatori
shock
wellhydr
patient
present
extrem
poor
perfus
term
dehydr
actual
refer
situat
total
bodi
deficit
pure
water
clinic
sign
commonli
use
assess
dehydr
increas
skin
turgor
tacki
mucou
membran
sunken
eye
unfortun
skin
turgor
difficult
assess
foal
recent
studi
adult
hors
indic
also
reliabl
estim
clinic
hydrat
statu
popul
insight
hydrat
statu
gain
measur
urin
specif
graviti
properli
hydrat
foal
rang
valu
greater
indic
foal
retain
water
like
adequ
hydrat
urin
output
anoth
use
paramet
hard
gaug
foal
continu
monitor
normal
foal
urin
least
everi
hour
accur
assess
urin
output
possibl
foal
urinari
cathet
place
allow
urin
collect
measur
urin
output
greater
approxim
two
third
total
fluid
intak
includ
iv
infus
enter
fluid
feed
hypotens
consid
mean
arteri
pressur
map
less
mm
hg
may
indic
hypovolemia
also
result
decreas
cardiac
output
excess
venou
capacit
hypotens
patient
respond
volum
replac
addit
therapi
form
vasopressor
andor
inotrop
indic
see
later
section
inotrop
vasopressor
therapi
attempt
determin
whether
hypovolemia
dehydr
present
help
consid
fluid
distribut
within
bodi
neonat
foal
substanti
higher
total
bodi
water
tbw
content
adult
hors
respect
tbw
present
two
primari
compart
intracellular
fluid
icf
ecf
ecf
subdivid
interstiti
fluid
plasma
volum
neonat
foal
ecf
icf
repres
approxim
half
tbw
plasma
volum
repres
approxim
one
fourth
ecf
tbw
primarili
determin
total
bodi
sodium
content
close
relat
sodium
concentr
within
ecf
compart
regul
ingest
elimin
sodium
decreas
plasma
sodium
concentr
hyponatremia
indic
rel
excess
free
water
andor
decreas
total
bodi
sodium
content
kidney
respond
elimin
water
retain
sodium
restor
normal
sodium
concentr
tbw
content
increas
plasma
sodium
concentr
repres
loss
free
water
stimul
thirst
lead
water
ingest
correct
tbw
deficit
determin
patient
need
fluid
next
challeng
determin
type
fluid
administ
mani
choic
fluid
fall
three
broad
categori
crystalloid
colloid
oxygencarri
solut
crystalloid
solut
contain
electrolyt
nonelectrolyt
dextros
capabl
diffus
capillari
wall
interstitium
wherea
colloid
solut
contain
larger
molecul
readili
diffus
tend
remain
within
vascular
lumen
oxygencarri
solut
contain
either
red
blood
cell
substanc
capabl
deliv
oxygen
lung
tissu
major
situat
appropri
fluid
crystalloid
solut
solut
classifi
base
tonic
rel
normal
plasma
isoton
hyperton
hypoton
isoton
electrolytecontain
fluid
littl
influenc
icf
volum
expand
ecf
volum
expand
circul
blood
volum
fluid
contain
larg
amount
sodium
substanti
amount
fluid
retain
bodi
unless
kidney
excret
sodium
water
togeth
sodium
overload
result
hypernatremia
associ
increas
mortal
sever
ill
human
patient
addit
substanti
sodium
content
isoton
electrolyt
solut
typic
substanti
chlorid
content
well
pronounc
isoton
salin
contain
meql
sodium
chlorid
tabl
although
sodium
content
slightli
supraphysiolog
chlorid
content
dramat
greater
present
normal
plasma
patient
renal
elimin
chlorid
impair
adequ
deal
high
chlorid
load
excess
chlorid
administr
associ
develop
hyperchlorem
metabol
acidosi
inflamm
hypotens
advers
renal
outcom
human
patient
physiolog
fluid
lactat
ringer
solut
lr
plasmalyt
normosolr
contain
lower
concentr
chlorid
close
mimick
normal
serum
concentr
dextros
water
except
rule
isoton
crystalloid
fluid
contain
electrolyt
primarili
use
replac
total
bodi
water
deficit
hyperton
crystalloid
fluid
higher
electrolyt
concentr
plasma
fewer
indic
use
commonli
use
hyperton
crystalloid
hyperton
salin
primarili
use
expand
circul
blood
volum
effect
result
shift
fluid
interstiti
space
circul
transient
rapid
diffus
sodium
load
circul
interstitium
commonli
use
hyperton
crystalloid
hyperton
sodium
bicarbon
typic
administ
correct
metabol
acidosi
provid
sodium
without
accompani
chlorid
solut
directli
address
strong
ion
acidosi
hyponatrem
metabol
acidosi
less
use
address
type
metabol
acidosi
lactic
acidosi
care
must
taken
administ
solut
foal
depress
ventil
increas
carbon
dioxid
product
potenti
worsen
respiratori
acidosi
hypoton
crystalloid
solut
contain
much
less
sodium
chlorid
isoton
replac
fluid
help
lower
sodium
load
decreas
risk
water
retent
edema
format
lower
chlorid
load
decreas
risk
hyperchlorem
metabol
acidosi
reason
hypoton
crystalloid
solut
use
mainten
fluid
therapi
less
need
electrolyt
replac
need
provis
water
use
resuscit
fluid
lr
normosolrplasmalyt
mainten
therapi
foal
associ
develop
hypernatremia
hyperchloremia
reinforc
concern
patient
mainten
fluid
therapi
often
reduc
dietari
intak
increas
need
potassium
supplement
mainten
fluid
accordingli
higher
concentr
potassium
concern
administr
hypoton
fluid
could
caus
red
blood
cell
lysi
reason
mainten
fluid
often
dextros
ad
bring
tonic
solut
appropri
physiolog
rang
follow
administr
dextros
metabol
impact
fluid
shift
within
bodi
use
dextros
water
repres
altern
hypoton
crystalloid
fluid
mainten
therapi
foal
solut
contribut
sodium
load
electrolyt
problemat
ongo
need
electrolyt
caus
renal
gastrointestin
insens
loss
reason
use
alon
typic
combin
isoton
polyion
crystalloid
solut
provid
replac
electrolyt
deficit
well
ongo
loss
colloid
fluid
contain
rel
larg
molecul
less
readili
abl
diffus
across
capillari
membran
allow
exert
colloid
oncot
pressur
within
circul
result
fluid
shift
interstitium
vasculatur
expand
circul
blood
volum
colloid
also
aid
retain
fluid
administ
within
vasculatur
longer
period
time
would
possibl
crystalloid
alon
commonli
use
colloid
solut
fresh
frozen
equin
plasma
contain
albumin
primari
colloid
albumin
physiolog
colloid
also
rel
small
size
diffus
interstiti
fluid
space
exert
colloid
effect
potenti
exacerb
develop
edema
blood
anoth
natur
colloid
addit
colloid
effect
albumin
contain
blood
benefit
provid
red
blood
cell
improv
oxygencarri
capac
tissu
oxygen
deliveri
anoth
solut
oxygencarri
capac
ultrapurifi
polymer
bovin
hemoglobin
product
colloid
effect
primari
reason
product
would
use
polymer
hemoglobin
use
appar
clinic
efficaci
foal
hors
dose
mlkg
product
current
avail
unit
state
avail
europ
oxyglobin
dechra
veterinari
product
shrewsburi
uk
synthet
colloid
hetastarch
pentastarch
shelfstabl
requir
collect
thaw
administr
make
use
critic
ill
patient
synthet
colloid
typic
less
expens
frozen
equin
plasma
also
may
provid
longlast
colloid
effect
albumin
concern
synthet
colloid
especi
hetastarch
may
interfer
coagul
especi
patient
sever
system
inflamm
may
alreadi
suffer
subclin
coagul
dysfunct
newgener
hetastarch
prepar
lower
molecular
weight
lower
degre
molar
substitut
may
improv
safeti
profil
even
greater
concern
recent
evid
human
medicin
resuscit
hetastarch
solut
may
associ
increas
risk
acut
kidney
injuri
mortal
although
studi
address
concern
veterinari
patient
recommend
hetastarch
solut
use
patient
demonstr
need
colloid
therapi
potenti
combin
equin
plasma
rather
primari
resuscit
fluid
sole
colloid
hetastarch
solut
administ
dose
mlkg
cumul
dose
restrict
mlkg
next
challeng
determin
rout
fluid
administ
patient
physiolog
rout
enter
rout
easi
overlook
util
rout
especi
hospit
patient
gener
gut
work
use
least
whatev
compon
fluid
therapi
appropri
enter
administr
limit
volum
deliv
rate
fluid
absorb
render
limit
util
critic
ill
patient
may
use
deliv
mainten
fluid
therapi
enter
therapi
may
also
less
expens
practic
field
set
treat
less
sever
compromis
patient
iv
administr
achiev
rapid
result
allow
rapid
administr
larg
amount
fluid
commonli
use
rout
administr
critic
ill
patient
iv
access
associ
risk
primarili
catheterassoci
complic
thrombophleb
air
embolu
aspir
neither
subcutan
intraperiton
fluid
administr
well
toler
equin
patient
rout
administr
rare
use
practic
consider
relat
abil
administ
fluid
therapi
may
impact
decis
iv
access
challeng
establish
sick
neonat
foal
especi
field
set
although
overthestylet
cathet
commonli
use
difficult
place
hypotens
foal
suscept
kink
displac
caus
foal
movement
frequent
handl
cathet
best
use
shortterm
fluid
administr
normotens
foal
commonli
use
overthestylet
cathet
made
teflon
irrit
vein
materi
polyurethan
overthestylet
cathet
also
avail
mila
intern
inc
erlang
ky
arrow
teleflex
inc
wayn
pa
overthewir
cathet
although
slightli
complex
regard
placement
easier
use
hypotens
patient
easier
maintain
longer
period
time
cathet
typic
made
polyurethan
less
thrombogen
teflon
silicon
overthewir
cathet
least
thrombogen
rare
use
foal
overthewir
cathet
also
avail
longer
length
cm
overthestylet
cathet
cm
help
critic
ill
foal
place
almost
deep
central
venou
line
potenti
decreas
risk
vascular
irrit
associ
deliveri
hyperton
solut
irrit
medic
multiplelumen
overthewir
cathet
avail
help
critic
ill
patient
allow
parenter
nutrit
medic
deliv
separ
cathet
lumen
one
use
iv
fluid
administr
downsid
multilumen
cathet
primarili
larg
outer
diamet
make
challeng
place
may
increas
risk
cathet
site
vascular
complic
enter
administr
fluid
achiev
use
nasogastr
tube
approach
primarili
use
administr
dose
fluid
requir
repeatedli
pass
tube
may
repres
stress
intervent
leav
nasogastr
tube
place
also
problemat
local
irrit
within
pharynx
interfer
voluntari
drink
eat
repeat
enter
administr
anticip
seriou
consider
given
placement
indwel
enter
feed
tube
fr
cm
mila
intern
inc
erlang
ky
small
outer
diamet
tube
allow
ongo
voluntari
intak
feed
water
one
tube
place
make
simpl
administ
multipl
small
bolus
enter
fluid
milk
minim
patient
stress
discuss
enter
feed
found
section
nutrit
support
foal
later
chapter
clinician
must
also
determin
volum
fluid
administ
durat
fluid
therapi
factor
must
consid
determin
amount
fluid
administ
volum
need
mainten
normal
bodili
function
magnitud
exist
fluid
deficit
ongo
loss
potenti
associ
diseas
process
diarrhea
reflux
well
insens
loss
sweat
design
fluid
therapi
plan
import
consid
mainten
fluid
plan
separ
replac
fluid
plan
includ
replac
exist
deficit
ongo
loss
type
fluid
use
purpos
typic
differ
inadvert
use
mainten
fluid
replac
vice
versa
deleteri
patient
calcul
mainten
fluid
requir
foal
approach
two
way
tradit
approach
base
accept
valu
mlkg
per
hour
mlkgday
mainten
fluid
requir
primari
problem
approach
repres
broad
rang
fluid
rate
may
result
fluid
overload
close
monitor
second
approach
determin
mainten
fluid
requir
propos
base
hollidaysegar
formula
provid
drier
conserv
rate
fluid
administr
calcul
follow
first
kg
bodi
weight
mlkg
per
day
fluid
administ
mlkg
per
day
kilogram
kg
bodi
weight
mlkg
per
day
kilogram
bodi
weight
kg
foal
calcul
yield
mainten
rate
mlday
mlh
equat
mlkg
per
hour
formul
fluid
plan
forget
incorpor
fluid
sourc
may
administ
foal
includ
enter
feed
well
fluid
given
drug
infus
parenter
nutrit
easi
overlook
addit
sourc
yet
may
constitut
signific
proport
daili
fluid
intak
consider
design
mainten
fluid
regimen
ongo
need
electrolyt
particularli
sodium
potassium
isoton
replac
solut
administ
mainten
purpos
hypernatremia
hyperchloremia
like
complic
solut
also
contain
inadequ
amount
potassium
mainten
use
hypoton
crystalloid
mainten
solut
therefor
appropri
recommend
daili
rate
sodium
supplement
foal
less
meqkg
unless
increas
renal
sodium
loss
administr
mainten
solut
plasmalyt
mlkg
per
hour
provid
approxim
meqkg
per
day
sodium
import
rememb
foal
like
receiv
sourc
sodium
form
drug
infus
cathet
flush
solut
parenter
nutrit
plasma
synthet
colloid
regard
potassium
daili
mainten
requir
quit
substanti
foal
nurs
milk
contain
high
level
potassium
supplement
potassium
meqkg
per
day
reason
start
point
hypoton
mainten
solut
plasmalyt
contain
substanti
potassium
replac
solut
meql
vs
meql
respect
still
insuffici
neonat
foal
supplement
requir
addit
potassium
chlorid
meql
hypoton
mainten
solut
reason
start
point
supplement
care
taken
administ
fluid
amount
potassium
supplement
high
rate
howev
administr
potassium
rate
greater
meqkg
per
hour
may
result
cardiac
complic
caus
hyperkalemia
use
clinic
perfus
indic
mention
previous
mucou
membran
color
capillari
refil
time
jugular
refil
time
heart
rate
puls
qualiti
one
deriv
rough
estim
degre
clinic
dehydr
tabl
approach
yield
estim
dehydr
rang
valu
use
calcul
estim
fluid
deficit
exampl
foal
clinic
estim
dehydr
requir
l
fluid
kg
kg
fluid
replac
deficit
clinicopatholog
test
aid
refin
estim
fluid
deficit
variabl
pack
cell
volum
total
plasma
protein
concentr
urin
specif
graviti
bun
concentr
serum
creatinin
concentr
serum
lactat
concentr
potenti
provid
use
insight
tabl
pack
cell
volum
increas
hypovolemia
may
show
less
mark
elev
dehydr
total
protein
concentr
typic
increas
hypovolemia
dehydr
well
marker
may
lack
sensit
patient
hypoalbuminemia
andor
hypoglobulinemia
urin
specif
graviti
fairli
sensit
marker
dehydr
clinic
use
bun
creatinin
concentr
indic
hypovolemia
decreas
perfus
rather
dehydr
bun
creatinin
rel
insensit
marker
decreas
perfus
especi
bun
begin
increas
substanti
decreas
gfr
serum
lactat
concentr
may
sensit
marker
perfus
also
elev
respons
impair
tissu
oxygen
util
decreas
hepat
lactat
clearanc
measur
central
venou
pressur
cvp
use
assess
foal
fluid
statu
techniqu
somewhat
technic
challeng
feasibl
limit
equip
foal
catheter
overthewir
cathet
placement
cathet
tip
fairli
central
cathet
use
determin
approxim
cvp
foal
later
recumb
ingo
fluid
therapi
stop
measur
taken
water
manomet
electron
pressur
transduc
use
zero
posit
manomet
set
approxim
height
base
heart
manomet
prime
steril
heparin
salin
open
iv
cathet
slight
fluctuat
pressur
observ
respir
measur
taken
approxim
mean
rang
determin
exist
fluid
deficit
made
deficit
fluid
replac
plan
formul
use
isoton
replac
fluid
lr
normosolr
plasmalyt
appropri
purpos
previous
discuss
rememb
deficit
therapi
given
addit
ongo
mainten
fluid
support
describ
earlier
rather
simpli
divid
calcul
fluid
deficit
administ
set
period
time
ie
l
hour
use
administ
bolus
replac
fluid
mlkg
eg
l
foal
minut
reassess
patient
statu
determin
whether
bolus
requir
foal
may
requir
replac
calcul
deficit
care
taken
exceed
total
dose
unless
compel
clinic
reason
indic
ongo
loss
excess
administr
bolu
fluid
therapi
associ
worsen
outcom
human
patient
greater
mlkg
fluid
replac
requir
patient
remain
hypotens
consid
nonrespons
fluid
therapi
initi
inotrop
andor
vasopressor
therapi
serious
consid
see
next
section
inotrop
vasopressor
therapi
reassess
patient
hydrat
statu
respons
fluid
therapi
involv
use
paramet
discuss
earlier
serial
measur
critic
process
replac
therapi
intend
address
patient
ongo
fluid
loss
determin
magnitud
loss
art
scienc
difficult
measur
mani
clinic
situat
foal
urinari
cathet
place
assess
renal
loss
entir
empir
base
frequenc
urin
perceiv
volum
assess
gastrointestin
loss
similar
natur
wherea
loss
caus
sweat
extrem
difficult
estim
fluid
use
replac
loss
isoton
balanc
replac
solut
fluid
lost
rout
accompani
electrolyt
loss
well
foal
appear
urin
defec
normal
obvious
sweat
addit
replac
fluid
indic
foal
increas
loss
associ
system
one
add
intermitt
bolus
mlkg
replacementtyp
fluid
address
estim
loss
monitor
ongo
fluid
therapi
import
requir
frequent
assess
ensur
goal
fluid
therapi
individu
patient
achiev
avoid
develop
advers
outcom
fluid
overload
repeat
assess
clinic
indic
hydrat
statu
perfus
readili
perform
extrem
valuabl
monitor
fluid
therapi
normal
paramet
evid
therapeut
efficaci
hemodynam
factor
volum
deplet
low
cardiac
output
inappropri
vasodil
lead
system
hypotens
may
result
organ
hypoperfus
reduct
perfus
pressur
potenti
deleteri
consequ
gastrointestin
renal
system
tissu
perfus
support
provis
iv
fluid
address
hypovolemia
improv
venou
return
heart
provid
adequ
preload
support
cardiac
output
fluid
replet
alway
first
intervent
use
affect
foal
although
mani
foal
suffer
hypotens
respond
well
iv
fluid
administr
subset
case
nonrespons
fluid
requir
addit
blood
pressur
support
treatment
inotrop
vasopressor
may
indic
case
increas
cardiac
contractil
afterload
respect
administr
agent
requir
foal
hospit
environ
close
monitor
hemodynam
function
avail
electron
infus
pump
provid
accur
cri
blood
pressur
monitor
absolut
essenti
accomplish
direct
arteri
cathet
indirect
oscillometr
tail
cuff
mean
situat
indirect
approach
use
placement
mainten
arteri
cathet
foal
extrem
challeng
although
data
obtain
direct
measur
superior
technic
challeng
render
approach
impract
indirect
techniqu
ideal
affect
tail
cuff
size
placement
inaccur
provid
accept
accuraci
clinic
use
particularli
monitor
trend
map
time
challeng
determin
point
patient
requir
addit
blood
pressur
support
human
patient
exceed
critic
lower
level
map
regard
mm
hg
vital
maintain
cerebr
coronari
renal
blood
flow
major
goal
manag
critic
ill
foal
therefor
maintain
map
mm
hg
although
level
necessarili
indic
adequ
tissu
perfus
appar
advantag
achiev
higher
map
may
actual
deleteri
alter
distribut
blood
flow
result
decreas
perfus
tissu
critic
use
indic
tissu
perfus
includ
heart
rate
mentat
central
venou
oxygen
tension
urin
output
acidbas
statu
trend
blood
lactat
concentr
suggest
neonat
foal
may
differ
physiolog
respons
hypotens
adult
hors
implement
inotrop
vasopressor
therapi
advis
start
lowest
end
dosag
rang
tabl
monitor
respons
therapi
increas
dosag
imposs
predict
respons
individu
patient
short
halflif
agent
mean
respons
therapi
assess
quickli
often
littl
minut
reinforc
need
continu
patient
reevalu
dobutamin
posit
inotrop
commonli
use
treat
hypotens
neonat
foal
often
repres
firstlin
drug
choic
tabl
agonist
increas
myocardi
contractil
therefor
cardiac
output
via
action
receptor
concurr
stimul
receptor
may
also
produc
peripher
splanchnic
vasodil
vasodilatori
effect
may
unproduct
result
decreas
system
vascular
resist
map
mean
dobutamin
may
ideal
choic
singl
agent
treatment
fluidrefractori
hypotens
reason
dobutamin
normal
use
combin
vasopressor
human
patient
posit
benefit
vasodilatori
effect
dobutamin
may
improv
splanchnic
perfus
use
concurr
vasopressor
increas
myocardi
contractil
dobutamin
also
increas
myocardi
oxygen
demand
problemat
patient
alreadi
impair
oxygen
deliveri
concern
dobutamin
stimul
receptor
caus
tachycardia
arrhythmia
especi
higher
dose
dopamin
tradit
use
firstlin
agent
human
veterinari
medicin
exhibit
dosedepend
stimul
wide
varieti
receptor
dopaminerg
activ
low
dose
activ
moder
dose
activ
high
dose
stimul
dopaminerg
receptor
lowdos
dopamin
increas
renal
splanchnic
perfus
although
proven
benefici
prevent
organ
failur
human
patient
higher
dose
dopamin
increas
cardiac
contractil
vasoconstrict
heart
rate
tend
increas
map
unfortun
vasopressor
respons
dopamin
less
pronounc
less
consist
achiev
norepinephrin
inotrop
effect
dopamin
compar
dobutamin
hypotens
human
neonat
dopamin
less
effect
restor
blood
flow
high
dose
greater
dopamin
caus
pulmonari
venou
vasoconstrict
reduc
splanchnic
perfus
reason
dopamin
much
less
commonli
use
human
equin
critic
care
norepinephrin
primarili
receptor
agonist
also
limit
effect
norepinephrin
induc
arteri
venou
vasoconstrict
result
increas
map
effect
circul
blood
volum
venou
return
preload
minim
increas
heart
rate
stroke
volum
despit
histor
concern
regard
potenti
splanchnic
hypoperfus
norepinephrin
regard
firstlin
pressor
agent
hypotens
human
patient
current
human
guidelin
recommend
administr
norepinephrin
sole
agent
initi
dobutamin
ad
hypoperfus
persist
despit
adequ
map
norepinephrin
report
effect
increas
map
urin
output
hypotens
foal
nonrespons
fluid
administr
dobutamin
therapi
anoth
studi
compar
effect
norepinephrin
alon
combin
norepinephrin
dobutamin
control
treatment
salin
infus
norepinephrin
norepinephrinedobutamin
increas
arteri
blood
pressur
system
vascular
resist
decreas
heart
rate
cardiac
index
compar
salin
effect
observ
renal
function
norepinephrinedobutamin
result
higher
arteri
pressur
norepinephrin
alon
combin
therapi
approach
commonli
use
treatment
foal
refractori
hypotens
recent
year
human
medicin
avp
antidiuret
hormon
gain
popular
manag
vasodilatori
shock
cardiac
arrest
despit
concern
regard
potenti
splanchnic
hypoperfus
higher
dosag
concern
regard
splanchnic
hypoperfus
deserv
consider
effect
observ
high
dose
vasopressin
studi
examin
effect
dobutamin
norepinephrin
vasopressin
healthi
anesthet
foal
induc
hypotens
although
vasopressin
myriad
effect
involv
numer
receptor
pathway
control
blood
pressur
primarili
vasoconstrict
via
action
receptor
vasopressin
stronger
vasoconstrict
effect
larg
arteriol
norepinephrin
may
explain
effect
even
patient
refractori
standard
catecholamin
therapi
vasopressin
also
shown
posit
interact
hydrocortison
therapi
treatment
refractori
shock
human
use
treatment
vasodilatori
shock
vasopressin
shown
decreas
heart
rate
improv
overal
hemodynam
lead
reduct
inotrop
requir
recent
human
metaanalysi
determin
vasopressin
therapi
human
patient
septic
shock
safe
use
wean
patient
catecholamin
associ
decreas
mortal
consensu
human
medicin
appear
vasopressin
reason
secondlin
choic
vasopressor
patient
exhibit
posit
respons
norepinephrin
therapi
anecdot
report
use
vasopressin
secondlin
vasopressor
equin
critic
care
one
refer
collin
et
al
indic
vasopressin
begun
use
firstlin
therapi
foal
fluidrefractori
hypotens
time
one
publish
report
regard
vasopressin
therapi
clinic
ill
foal
report
effect
norepinephrin
vasopressin
cardiovascular
respons
fluid
balanc
compar
group
foal
hypotens
refractori
fluid
therapi
dobutamin
eighteen
foal
treat
vasopressin
wherea
foal
receiv
norepinephrin
six
foal
vasopressin
group
fail
respond
norepinephrin
therapi
withdrawn
initi
vasopressin
therapi
sever
ill
pronounc
similar
group
mean
lactat
mmoll
vasopressin
group
mmoll
norepinephrin
group
two
group
also
similar
sepsi
score
admiss
mean
vasopressin
group
norepinephrin
group
vasopressin
administr
associ
signific
increas
map
urin
output
well
signific
decreas
heart
rate
wherea
norepinephrin
administr
associ
signific
increas
map
overal
surviv
rate
studi
like
reflect
sever
system
diseas
present
popul
foal
evidenc
admiss
sepsi
score
lactat
concentr
consist
previou
report
institut
surviv
rate
foal
present
lactat
concentr
greater
mmoll
report
author
report
also
describ
increas
use
vasopressin
firstlin
therapi
foal
refractori
hypotens
pressor
agent
includ
epinephrin
phenylephrin
strong
adrenerg
receptor
agonist
neg
effect
splanchnic
renal
perfus
epinephrin
catecholamin
potent
activ
receptor
epinephrin
increas
map
increas
cardiac
output
vascular
tone
human
patient
regard
first
altern
combin
norepinephrin
dobutamin
howev
epinephrin
associ
hyperglycemia
hypokalemia
lipolysi
tachycardia
decreas
splanchnic
perfus
increas
lactat
concentr
increas
platelet
aggreg
phenylephrin
potent
activ
cardiac
effect
mediat
effect
constrict
peripher
arteri
vasculatur
phenylephrin
primarili
util
patient
arrhythmia
result
dobutamin
andor
norepinephrin
administr
littl
applic
equin
neonat
critic
care
although
vasopressor
per
se
lowdos
hydrocortison
therapi
shown
improv
respons
vasopressor
shorten
durat
vasopressor
therapi
human
shock
patient
mechan
respons
effect
unclear
appear
associ
primari
corticosteroid
insuffici
rather
appear
corticosteroid
therapi
directli
result
improv
vasopressor
respons
peripher
vessel
hydrocortison
rais
blood
volum
increas
vascular
tone
enhanc
endotheli
reactiv
vasopressor
thorough
discuss
hydrocortison
replac
therapi
found
previou
section
endocrin
disord
antiinflammatori
indic
antiinflammatori
therapi
foal
numer
often
compound
use
regul
fever
local
inflamm
reduc
patient
discomfort
situat
requir
control
system
inflamm
well
primari
class
antiinflammatori
use
foal
nsaid
consist
drug
inhibit
arachidon
acid
synthesi
via
cox
inhibit
drug
typic
exhibit
antipyret
antiinflammatori
analges
effect
also
sever
drug
nsaid
group
effect
pathway
arachidon
acid
metabol
second
class
antiinflammatori
drug
corticosteroid
steroid
antiinflammatori
drug
said
drug
potent
dosedepend
antiinflammatori
immunosuppress
effect
typic
littl
antipyret
analges
activ
situat
primari
goal
analgesia
one
use
nsaid
opioid
drug
provid
analgesia
without
concern
regard
gastrointestin
renal
toxic
associ
mani
nsaid
although
commonli
use
young
foal
altern
analges
ketamin
lidocain
may
benefici
manag
older
foal
sever
refractori
pain
nsaid
includ
nonspecif
cox
inhibitor
phenylbutazon
flunixin
meglumin
select
inhibitor
ketoprofen
drug
like
meloxicam
firocoxib
nonspecif
cox
inhibit
associ
side
effect
includ
gastrointestin
ulcer
renal
injuri
phenylbutazon
associ
experiment
clinic
toxic
foal
appear
narrow
therapeut
index
popul
addit
difficult
administ
appropri
dosag
phenylbutazon
foal
small
size
composit
form
phenylbutazon
avail
reason
phenylbutazon
rare
use
foal
flunixin
meglumin
howev
given
parenter
appropri
dosag
demonstr
safe
foal
even
administ
sever
week
support
clinic
experi
flunixin
meglumin
primarili
use
foal
sever
system
inflamm
sever
discomfort
persist
fever
import
note
metabol
elimin
nsaid
impair
neonat
foal
potenti
requir
increas
dose
prolong
dose
interv
reason
recommend
nonspecif
cox
inhibitor
use
caution
clinic
ill
neonat
foal
particularli
foal
sever
system
inflamm
hypovolemia
potenti
gastric
ulcer
theori
drug
like
ketoprofen
carprofen
safer
use
foal
select
phenylbutazon
flunixin
although
peerreview
evid
support
claim
reduc
toxic
drug
use
foal
appar
safeti
pharmacokinet
ketoprofen
studi
foal
dosag
treatment
interv
recommend
report
greater
adult
hors
tabl
ibuprofen
also
studi
foal
found
safe
administ
day
publish
report
pharmacokinet
carprofen
foal
mostli
highli
nsaid
studi
hors
foal
meloxicam
firocoxib
firocoxib
demonstr
greatest
degre
specif
firocoxib
favor
pharmacokinet
report
safe
foal
administ
oral
iv
rout
firocoxib
demonstr
effect
musculoskelet
viscer
pain
hors
analges
efficaci
firocoxib
assess
foal
anecdot
seem
firocoxib
may
effect
musculoskelet
pain
viscer
pain
scientif
evalu
meloxicam
market
equin
use
europ
current
label
smallanim
use
unit
state
meloxicam
pharmacokinet
safeti
evalu
foal
evid
gastrointestin
renal
toxic
detect
interestingli
meloxicam
elimin
rapidli
foal
adult
hors
quit
differ
found
nsaid
reason
author
studi
recommend
meloxicam
dose
everi
hour
foal
rather
hour
addit
cox
inhibitor
sever
antiinflammatori
drug
use
foal
may
applic
dipyron
metamizol
wide
use
hors
analges
antipyret
antispasmod
drug
clinic
appear
safe
use
singl
dose
foal
abdomin
pain
acetaminophen
use
littl
hors
concern
potenti
hepatotox
recent
report
suggest
drug
may
safe
effect
analges
although
dipyron
acetaminophen
cox
inhibitori
effect
pathway
consid
primarili
respons
drug
therapeut
effect
current
hypothesi
drug
act
primarili
pathway
includ
serotonerg
opioid
cannabinoid
system
dipyron
acetaminophen
sometim
combin
tradit
nsaid
achiev
enhanc
analges
effect
limit
report
regard
approach
hors
addit
nsaid
drug
may
exhibit
antiinflammatori
effect
pentoxifyllin
dmso
pentoxifyllin
phosphodiesteras
inhibitor
shown
widerang
antiinflammatori
effect
frequent
use
adult
hors
suffer
sever
system
inflamm
although
pharmacokinet
pentoxifyllin
known
foal
use
foal
adult
dosag
dmso
free
radic
scaveng
wide
use
hors
foal
suffer
sever
local
system
inflamm
despit
rel
lack
evid
efficaci
administ
intraven
appropri
dilut
dmso
appear
safe
frequent
administ
foal
suspect
suffer
ne
although
tradit
antiinflammatori
antimedi
polymyxin
b
sometim
use
foal
sir
capabl
bind
circul
endotoxin
inhibit
upregul
inflammatori
respons
recent
studi
perform
healthi
foal
experiment
induc
endotoxemia
found
administr
polymyxin
b
ukg
iv
everi
hour
attenu
clinic
clinicopatholog
effect
endotoxemia
polymyxin
b
potenti
nephrotox
howev
caution
indic
consid
util
therapi
critic
ill
hypovolem
foal
administr
said
foal
frequent
indic
restrict
clinic
syndrom
overwhelm
local
system
inflamm
must
control
foal
interstiti
pneumonia
ali
ard
said
therapi
critic
downregul
pulmonari
inflamm
restor
pulmonari
function
repres
primari
pharmacolog
therapi
condit
syndrom
discuss
detail
previou
section
respiratori
disord
sever
ill
foal
suffer
circi
associ
poor
clinic
outcom
syndrom
discuss
detail
previou
section
immunolog
disord
cortisol
replac
therapi
use
small
dose
hydrocortison
administ
frequent
may
provid
antiinflammatori
physiolog
benefit
circiaffect
foal
appear
interfer
function
innat
immun
system
primari
goal
therapi
analgesia
independ
antiinflammatori
effect
number
altern
therapi
avail
shortterm
analgesia
adrenerg
agonist
xylazin
detomidin
commonli
use
effect
control
sever
pain
limit
drug
profound
sedat
decreas
gastrointestin
motil
altern
one
could
consid
use
opioid
agonist
agonistantagonist
butorphanol
opioid
agonistantagonist
commonli
use
drug
readili
avail
safe
administ
limit
butorphanol
primarili
caus
substanti
sedat
last
short
period
time
given
bolu
administ
butorphanol
cri
allow
much
stabl
analges
effect
may
lessen
sed
effect
opioid
agonist
tramadol
fentanyl
rare
use
foal
could
util
manag
chronic
sever
musculoskelet
pain
lidocain
local
anesthet
administ
system
cri
provid
effect
analgesia
especi
viscer
pain
associ
sed
effect
caus
neurolog
sign
given
excess
rate
recent
studi
lidocain
administr
foal
achiev
lower
system
concentr
adult
hors
appear
safe
clinic
effect
ketamin
dissoci
agent
commonli
use
induct
andor
mainten
gener
anesthesia
report
analges
effect
administ
lower
dose
cri
develop
appropri
nutrit
plan
treat
sick
foal
challeng
one
must
ensur
foal
adequ
energi
nutrient
basal
metabol
immun
function
ideal
growth
well
straightforward
process
number
calori
requir
foal
calcul
follow
determin
volum
appropri
nutrientcontain
solut
administr
nutrit
sourc
appropri
rout
unfortun
energi
requir
sick
foal
well
understood
vari
among
patient
addit
abil
foal
appropri
metabol
nutrient
provid
guarante
age
degre
ill
impact
foal
abil
produc
metabol
hormon
well
abil
tissu
respond
hormon
stimul
anoth
difficulti
aris
energi
content
mare
milk
easili
determin
exact
formul
substitut
artifici
milk
replac
alway
known
ultim
burden
fall
clinician
formul
best
plan
possibl
inform
hand
ensur
foal
close
monitor
ensur
goal
nutrit
plan
met
risk
complic
minim
foal
nutrit
requir
dietari
composit
chang
substanti
transit
neonat
weanl
requir
care
consider
foal
stage
growth
formul
nutrit
plan
birth
foal
transit
continu
suppli
nutrient
provid
dam
via
placenta
intermitt
absorpt
ingest
nutrient
time
metabol
neonat
longer
abl
depend
matern
glucos
concentr
maintain
normoglycemia
pancrea
assum
respons
regul
glucos
homeostasi
dramat
alter
energi
metabol
alway
occur
smoothli
foal
possess
limit
energi
reserv
form
glycogen
fat
result
hypoglycemia
occur
frequent
even
normal
neonat
foal
clinic
ill
foal
risk
profound
hypoglycemia
depriv
energi
intak
even
hour
calor
requir
normal
foal
sizabl
need
support
high
basal
metabol
need
also
maintain
rate
growth
much
bodi
weight
per
day
neonat
period
mean
neonat
calor
requir
great
kilocalori
per
kg
bodi
weight
per
day
kcalkgday
decreas
gradual
around
kcalkg
per
day
week
age
kcalkg
per
day
month
age
recent
studi
suggest
actual
energi
requir
foal
month
age
may
less
valu
measur
given
term
foal
bodi
weight
import
realiz
energi
requir
per
kilogram
decreas
foal
bodi
weight
increas
thu
total
calor
requir
increas
age
initi
energi
sourc
foal
mare
milk
substanti
greater
lactos
content
cow
milk
lower
milk
fat
content
dri
matter
basi
mare
milk
averag
sugar
protein
fat
respect
compar
sugar
protein
fat
respect
cow
milk
mare
milk
therefor
deriv
energi
content
carbohydr
appropri
endogen
product
insulin
pancreat
cell
requir
foal
metabol
util
carbohydr
appropri
matur
pancreat
function
occur
late
gestat
fetal
foal
depend
normal
rise
fetal
circul
cortisol
concentr
occur
final
day
gestat
preparturi
cortisol
rise
critic
mani
aspect
readi
foal
birth
term
endocrin
function
well
respiratori
cardiovascular
function
follow
birth
gradual
matur
endocrin
respons
ingest
carbohydr
shown
normal
newborn
poni
foal
demonstr
impair
glucos
clearanc
follow
administr
exogen
glucos
first
day
life
suggest
degre
insulin
resist
day
age
foal
demonstr
increas
rate
glucos
clearanc
respons
remain
lower
seen
normal
adult
equin
gradual
matur
may
appropri
respons
chang
composit
mare
milk
colostrum
contain
littl
lactos
volum
milk
ingest
less
first
day
life
subsequ
day
start
earli
second
day
life
foal
begin
ingest
small
amount
hay
grass
grain
time
ingest
matern
fece
like
provid
initi
microbi
flora
requir
support
digest
feed
unlik
grain
roughag
thoroughli
digest
sever
week
age
point
foal
begin
gradual
transit
milkbas
diet
foragebas
diet
amount
milk
produc
mare
peak
around
month
lactat
begin
steadi
declin
continu
time
wean
necessit
foal
begin
reli
ingest
solid
food
increas
proport
nutrit
requir
time
foal
hindgut
function
increas
like
fulli
function
around
month
age
age
month
foal
receiv
less
total
nutrit
requir
form
milk
allow
fairli
easi
dietari
transit
wean
occur
foal
hindgut
function
increas
corollari
shift
primari
energi
substrat
carbohydr
absorb
small
intestin
volatil
fatti
acid
absorb
larg
intestin
evalu
sick
neonat
foal
one
must
alway
rememb
diseas
process
work
foal
may
origin
utero
matern
ill
matern
malnutrit
matern
toxin
exposur
placent
placent
insuffici
potenti
profoundli
influenc
develop
matur
fetal
metabol
studi
investig
role
restrict
uterin
environ
fetal
develop
demonstr
lifelong
impair
growth
develop
affect
foal
convers
provis
luxuri
utero
environ
lead
enhanc
growth
rate
year
age
influenc
matern
diet
import
diet
high
solubl
carbohydr
fed
mare
late
gestat
contribut
decreas
insulin
sensit
foal
day
age
clear
potenti
lifelong
effect
metabol
function
secondari
prenat
program
effect
potenti
contribut
develop
metabol
diseas
later
life
prenat
program
may
affect
neonat
foal
abil
appropri
metabol
nutrient
clinic
set
foal
compromis
placent
environ
potenti
exhibit
insulin
resist
carbohydr
intoler
previous
discuss
late
gestat
rise
fetal
cortisol
critic
final
matur
energi
metabol
mani
foal
deliv
prematur
fail
undergo
rise
fetal
cortisol
concentr
therefor
unabl
respond
normal
chang
metabol
occur
birth
hypoglycemia
complic
decreas
endogen
energi
reserv
impair
nurs
caus
concurr
weak
depress
andor
difficulti
stand
common
problem
foal
follow
success
deliveri
nutrient
enter
parenter
rout
foal
like
intoler
carbohydr
caus
impair
endogen
insulin
product
may
suffer
profound
hyperglycemia
foal
suffer
system
inflamm
associ
septicemia
may
also
exhibit
hyperglycemia
caus
insulin
resist
carbohydr
intoler
manag
foal
may
requir
lipidcontain
parenter
nutrit
solut
andor
administr
exogen
insulin
achiev
adequ
calor
input
attempt
determin
true
calor
need
clinic
ill
foal
one
greatest
challeng
design
nutrit
strategi
histor
believ
critic
ill
creat
hypermetabol
situat
patient
increas
energi
need
caus
increas
tissu
energi
consumpt
energi
requir
sick
foal
appear
great
thought
howev
reduct
overal
metabol
rate
decreas
activ
level
combin
temporari
reduct
growth
rate
indirect
calorimetri
test
clinic
ill
neonat
foal
shown
rest
energi
requir
kcalkg
per
day
one
third
energi
requir
grow
activ
normal
foal
foal
recov
energi
requir
gradual
increas
approxim
kcalkg
per
day
similar
energi
requir
agematch
control
foal
manag
critic
ill
neonat
foal
may
prefer
pursu
hypocalor
approach
one
endeavor
prevent
foal
enter
sever
catabol
state
accept
nutrit
need
patient
may
met
approach
address
fact
aggress
nutrit
support
result
overfeed
risk
may
easili
outweigh
possibl
benefit
provid
nutrit
support
excess
carbohydr
administr
lead
increas
gener
carbon
dioxid
worsen
hypercapnia
foal
compromis
respiratori
function
excess
carbohydr
deliveri
also
caus
hyperglycemia
consid
proinflammatori
stimulu
associ
worsen
outcom
human
critic
ill
overfeed
protein
result
increas
protein
catabol
result
potenti
andor
develop
azotemia
excess
administr
lipid
may
result
hypertriglyceridemia
contrast
risk
overfeed
littl
evid
human
patient
shortterm
sever
day
hypocalor
nutrit
support
result
worsen
outcom
compar
regimen
design
meet
patient
metabol
need
evid
suggest
approach
especi
regard
mainten
appropri
control
blood
glucos
level
associ
decreas
rate
complic
improv
outcom
first
step
develop
nutrit
plan
involv
select
rout
nutrient
deliveri
provid
nutrit
support
enter
rout
gener
prefer
two
reason
first
natur
physiolog
sound
mean
nutrient
deliveri
second
intestin
mucosa
partial
depend
product
digest
energi
nutrient
thorough
evalu
gastrointestin
function
need
institut
enter
nutrit
support
includ
abdomin
auscult
check
gastric
reflux
possibl
abdomin
radiograph
ultrasonograph
examin
evalu
bowel
dimens
motil
foal
evid
gastrointestin
dysfunct
gastric
reflux
bowel
distent
increas
bowel
wall
thick
ileu
unlik
toler
enter
feed
conserv
approach
enter
feed
also
indic
prematur
immatur
foal
may
incomplet
develop
gastrointestin
tract
foal
perinat
asphyxia
syndrom
may
intoler
enter
feed
caus
ileu
dysfunct
result
intestin
ischem
injuri
mare
milk
prefer
substrat
enter
feed
highli
digest
obvious
provid
correct
balanc
nutrient
normal
growth
develop
commerci
mare
milk
replac
use
recogn
product
bovin
origin
lower
digest
compar
mare
milk
increas
risk
intestin
dysfunct
associ
enter
feed
semiskim
fat
cow
milk
gl
dextros
equival
ml
dextros
solut
per
liter
ad
use
mare
milk
mare
milk
replac
unavail
foal
unabl
nurs
mare
may
fed
bottl
bowl
nasogastr
feed
tube
mani
sick
recumb
foal
weak
andor
uncoordin
suckl
reflex
therefor
milk
administ
feed
tube
use
smallbor
indwel
tube
feed
small
volum
frequent
interv
eg
everi
minut
prefer
repeat
passag
nasogastr
tube
interv
largebolu
feed
may
overwhelm
digest
capac
repeat
passag
stomach
tube
unnecessari
stress
foal
anoth
advantag
smallbor
indwel
tube
interfer
voluntari
feed
water
intak
therefor
tube
may
left
place
foal
transit
feed
mare
feed
tube
insert
foal
sternal
recumb
correct
placement
within
esophagu
confirm
radiographi
endoscopi
tube
may
fasten
extern
nare
sutur
feed
import
check
tube
still
place
reflux
foal
sternal
recumb
stand
fed
milk
administ
graviti
flow
follow
small
amount
clean
water
flush
tube
tube
cap
feed
prevent
aspir
air
feed
tube
replac
everi
day
reduc
risk
gastrointestin
tract
infect
suggest
initi
rate
milk
deliveri
mlkg
bodi
weight
per
hour
mlh
foal
tabl
provid
l
milk
foal
first
hour
enter
support
dextrosecontain
fluid
administ
iv
provid
addit
calori
transit
adequ
level
enter
feed
feed
rate
gradual
increas
next
day
eg
increas
mlkgh
day
mlkgh
day
repres
total
daili
intak
bodi
weight
simultan
iv
calor
support
dextros
gradual
withdrawn
feed
level
like
meet
rest
energi
requir
hospit
foal
depend
rate
clinic
improv
length
hospit
may
possibl
increas
volum
feed
bodi
weight
per
day
approxim
milk
intak
healthi
neonat
foal
clinic
monitor
includ
frequent
assess
gastrointestin
function
includ
gastric
reflux
intestin
sound
abdomin
distent
quantiti
qualiti
fece
gastric
reflux
bloat
colic
diarrhea
constip
indic
intoler
enter
feed
need
adjust
feed
program
may
involv
decreas
volum
frequenc
enter
feed
situat
may
concern
regard
abil
foal
gastrointestin
tract
digest
absorb
lactos
rotavir
infect
product
lactas
enterocyt
like
impair
situat
lactas
enzym
ad
milk
milk
replac
feed
rate
u
one
tablet
per
feed
addit
volum
enter
fluid
may
requir
foal
diarrhea
simpl
balanc
isoton
enter
solut
formul
ad
g
tabl
salt
nacl
g
lite
salt
nacl
kcl
g
bake
soda
nahco
per
liter
water
gener
prefer
support
foal
via
enter
rout
natur
physiolog
desir
rout
epitheli
cell
line
intestin
partial
depend
product
digest
energi
nutrient
unfortun
varieti
situat
foal
may
unabl
receiv
enter
nutrit
unabl
toler
volum
enter
nutrit
requir
support
basal
metabol
growth
rang
critic
ill
neonat
gastrointestin
complic
suckl
foal
sever
enterocol
rapid
institut
parenter
nutrit
aid
prevent
develop
proteincalori
malnutrit
substanti
energi
deficit
limit
parenter
nutrit
support
primarili
caus
expens
therapi
risk
secondari
complic
complic
may
includ
hyperglycemia
hypertriglyceridemia
thrombophleb
increas
risk
bloodstream
infect
primari
goal
parenter
nutrit
type
nutrit
support
ensur
patient
suppli
adequ
calori
support
basal
metabol
minimum
ideal
provid
addit
support
allow
ongo
growth
reason
initi
goal
parenter
nutrit
administr
foal
kcalkg
per
day
although
level
calor
support
fulli
meet
theoret
energi
requir
healthi
neonat
come
close
meet
rest
energi
requir
hospit
foal
situat
parenter
nutrit
use
pure
temporari
support
prevent
foal
enter
sever
catabol
state
protein
catabol
would
increas
use
amino
acid
energi
product
failur
provid
adequ
nutrit
support
may
also
substanti
neg
influenc
immun
respons
shortterm
parenter
supplement
less
hour
may
consist
iv
carbohydr
solut
requir
patient
receiv
balanc
nutrit
sourc
consist
carbohydr
amino
acid
lipid
parenter
nutrit
expect
administ
longer
period
complet
formula
use
carbohydratecontain
solut
repres
simplest
mean
provid
iv
calor
support
foal
solut
contain
dextros
use
sever
option
avail
includ
lr
dextros
salin
dextros
normosolm
dextros
hospira
lake
forest
il
plasmalyt
dextros
baxter
healthcar
corp
deerfield
il
fluid
contain
dextros
use
initi
fluid
resuscit
almost
certainli
result
deliveri
excess
amount
dextros
foal
degre
dehydr
result
profound
hyperglycemia
follow
initi
fluid
resuscit
solut
contain
electrolyt
well
dextros
salin
dextros
normosolm
dextros
plasmalyt
dextros
may
use
primari
fluid
mainten
therapi
foal
minim
ongo
fluid
loss
ideal
choic
mainten
solut
absenc
electrolyt
primarili
use
provid
free
water
patient
suffer
hyperosmolar
condit
calor
content
dextros
solut
kcalml
infus
rate
mlkg
per
hour
would
requir
deliv
approxim
kcalkg
per
day
kcalkgh
hday
kcalkgday
rate
infus
twice
consid
mainten
rate
neonat
foal
addit
care
must
alway
taken
adjust
infus
rate
dextrosecontain
solut
respons
chang
patient
fluid
statu
ensur
excess
amount
dextros
infus
especi
prematur
sick
foal
like
poorli
toler
dextros
infus
altern
dextros
solut
deliv
without
dilut
use
infus
pump
long
addit
isoton
fluid
administ
concurr
provid
dilut
avoid
endotheli
injuri
caus
hyperton
natur
solut
use
dextros
solut
avoid
infus
pump
avail
easi
inadvert
administ
excess
amount
dextros
lead
hyperglycemia
calor
content
dextros
solut
kcalml
infus
rate
mlkg
per
hour
solut
deliv
approxim
kcalkg
per
day
kcalkgh
hday
kcalkgday
low
rate
infus
mean
primari
fluid
need
patient
met
dextrosefre
isoton
electrolytecontain
fluid
infus
rate
alter
respons
chang
patient
fluid
statu
without
concern
relat
requir
nutrit
plan
end
first
hour
treatment
fluid
therapi
plan
nutrit
plan
revisit
determin
whether
patient
begin
reli
enter
fluid
nutrit
intak
continu
parenter
therapi
requir
dextrosecontain
fluid
incomplet
nutrit
sourc
use
primari
nutrit
sourc
hour
continu
parenter
nutrit
support
requir
formul
complet
solut
provid
amino
acid
possibl
lipid
one
import
aspect
provid
longer
term
hour
parenter
nutrit
foal
inclus
protein
sourc
metabol
respons
injuri
sepsi
increas
protein
degrad
muscl
tissu
catabol
respons
reduc
suppli
sourc
nitrogen
increas
energi
intak
recommend
ratio
nonprotein
calori
nitrogen
nonprotein
calori
per
gram
nitrogen
inclus
lipid
parenter
nutrit
formul
allow
provis
larger
number
calori
per
unit
volum
compar
solut
contain
dextros
anoth
advantag
lipid
emuls
isoton
moder
hyperton
parenter
nutrit
formul
potenti
decreas
risk
thrombophleb
unfortun
formul
parenter
nutrit
solut
lipid
increas
cost
solut
may
increas
risk
complic
hyperlipidemia
occur
associ
lipid
administr
foal
appear
result
advers
effect
lipid
emuls
prone
contamin
promot
bacteri
growth
risk
iv
line
lipidcontain
solut
administ
chang
daili
substanti
increas
client
cost
recent
report
use
lipidcontain
parenter
nutrit
solut
allow
provis
kcalkg
per
day
mean
kcalkgday
foal
oppos
kcalkg
per
day
mean
kcalkgday
dextrosebas
solut
two
basic
approach
formul
parenter
nutrit
foal
first
approach
involv
exact
determin
anticip
metabol
need
patient
follow
develop
formul
meet
need
fairli
precis
manner
use
mixtur
dextros
amino
acid
lipid
approach
fairli
complex
best
perform
use
computer
spreadsheet
aid
perform
variou
calcul
second
approach
practic
consist
use
two
basic
parenter
nutrit
formula
tabl
one
solut
intend
shortterm
use
consist
dextros
amino
acid
solut
solut
second
solut
incorpor
lipid
energi
sourc
prefer
longterm
administr
administr
foal
poorli
toler
infus
dextros
solut
ii
solut
formul
use
ml
dextros
dextros
baxter
healthcar
corp
clintec
nutrit
divis
deerfield
il
ml
amino
acid
travasol
baxter
healthcar
corp
clintec
nutrit
divis
deerfield
il
wherea
solut
ii
formul
ml
dextros
ml
lipid
intralipid
baxter
healthcar
corp
clintec
nutrit
divis
deerfield
il
ml
amino
acid
calor
densiti
solut
kcalml
solut
kcalml
solut
ii
ratio
nonprotein
calori
nitrogen
nonprotein
calori
per
gram
nitrogen
npcgn
solut
npcgn
solut
ii
easytous
shelfstabl
multichamb
bag
prepar
ident
solut
manufactur
human
use
costeffect
practic
use
foal
clinimix
sulfitefre
amino
acid
dextros
inject
baxter
healthcar
corp
clintec
nutrit
divis
deerfield
il
electron
infus
pump
alway
use
administ
parenter
nutrit
solut
rate
must
tightli
control
adjust
infus
rate
must
made
easili
accur
excess
rate
administr
easili
induc
profound
hyperglycemia
shown
speci
associ
sever
complic
increas
risk
death
solut
use
parenter
nutrit
hyperton
caus
injuri
vascular
endothelium
increas
risk
thrombophleb
reason
recommend
parenter
nutrit
solut
administ
polyurethan
longterm
cathet
place
jugular
vein
provid
central
line
foal
use
multiplelumen
cathet
allow
one
lumen
dedic
infus
parenter
nutrit
solut
minim
risk
contamin
cathet
manag
extrem
import
foal
receiv
parenter
nutrit
cathet
site
vein
monitor
least
twice
daili
heat
swell
exud
increas
resist
fluid
flow
cathet
may
indic
thrombosi
deeper
within
vasculatur
often
necessit
placement
cathet
altern
site
opposit
jugular
vein
cephal
vein
later
thorac
vein
compon
parenter
nutrit
solut
must
mix
steril
manner
administr
bag
contain
final
parenter
nutrit
composit
cover
brown
plastic
bag
administr
protect
light
degrad
amino
acid
within
solut
rate
infus
mlh
calcul
base
desir
kcalkg
per
day
administ
reason
initi
goal
kcalkg
per
day
initi
infus
rate
parenter
nutrit
solut
calcul
final
rate
rate
gradual
increas
everi
hour
follow
monitor
blood
glucos
concentr
ensur
hyperglycemia
blood
glucos
mgdl
present
patient
toler
parenter
nutrit
well
maintain
blood
glucos
concentr
near
normal
level
consider
given
increas
parenter
nutrit
administr
rate
maximum
kcalkg
per
day
parenter
nutrit
discontinu
recommend
infus
rate
gradual
reduc
decreas
infus
rate
increment
everi
hour
gradual
introduc
enter
feed
import
blood
glucos
monitor
continu
wean
process
detect
prevent
develop
hypoglycemia
foal
must
frequent
monitor
especi
initi
phase
parenter
nutrit
therapi
monitor
includ
gener
physic
examin
close
attent
neurolog
statu
respiratori
function
rectal
temperatur
also
close
monitor
fever
common
earli
manifest
system
infect
blood
glucos
concentr
frequent
monitor
initi
hourli
basi
patient
stabil
appropri
rate
parenter
nutrit
infus
follow
monitor
everi
hour
first
day
therapi
frequenc
blood
glucos
monitor
depend
stabil
patient
may
need
frequent
critic
ill
may
need
monitor
beyond
everi
hour
stabl
patient
monitor
urin
output
urin
glucos
concentr
may
aid
detect
hyperglycemia
although
actual
renal
threshold
glucos
well
describ
foal
glucosuria
diuresi
typic
seen
blood
glucos
level
exceed
mg
dl
addit
clinicopatholog
monitor
consist
daili
complet
blood
count
serum
chemistri
profil
critic
case
wherea
perform
everi
hour
stabl
patient
serum
electrolyt
monitor
least
twice
daili
particular
attent
paid
serum
potassium
concentr
decreas
rapidli
especi
foal
receiv
insulin
therapi
urin
output
monitor
continu
combin
intermitt
monitor
urin
glucos
concentr
risk
hyperglycemiainduc
diuresi
glucosuria
ideal
bodi
weight
assess
daili
basi
ensur
foal
least
maintain
bodi
weight
parenter
nutrit
foal
receiv
parenter
nutrit
solut
contain
lipid
monitor
develop
hypertriglyceridemia
insulin
therapi
critic
ill
foal
often
demonstr
carbohydr
intoler
make
difficult
achiev
even
conserv
rate
administr
iv
nutrit
situat
address
use
lipidcontain
parenter
nutrit
solut
ineffect
altern
administr
exogen
insulin
administr
insulin
neonat
foal
undertaken
lightli
therapi
place
addit
demand
clinician
nurs
staff
ensur
profound
hypoglycemia
occur
intermitt
dose
subcutan
insulin
may
offer
advantag
term
simplic
administr
expens
moder
effect
rout
administr
allow
chang
dosag
short
term
one
recommend
dosag
subcutan
insulin
foal
iu
regular
insulin
everi
hour
retrospect
report
foal
parenter
nutrit
describ
subcutan
insulin
dosag
rate
iukg
given
everi
hour
approach
recommend
risk
hypoglycemia
hyperglycemia
greater
cri
much
challeng
achiev
homeostasi
term
blood
glucos
concentr
use
intermitt
bolu
insulin
therapi
use
cri
administr
insulin
allow
fairli
rapid
onset
action
provid
simpl
time
mean
adjust
dosag
gradual
satur
cellular
insulin
receptor
maxim
effect
cri
insulin
typic
seen
roughli
minut
initi
infus
respons
alter
rate
infus
occur
similar
time
frame
one
take
care
avoid
alter
rate
infus
parenter
nutrit
solut
soon
chang
rate
insulin
infus
initi
insulin
infus
rate
iukg
per
hour
regular
insulin
report
well
toler
may
repres
reason
start
point
foal
intoler
parenter
nutrit
dosag
deriv
retrospect
studi
foal
treat
parenter
nutrit
report
initi
insulin
dose
rang
iukg
per
hour
mean
iukg
per
hour
interestingli
studi
final
insulin
dose
rang
remain
similar
iukg
per
hour
mean
iukg
per
hour
advoc
start
lower
dosag
foal
iukg
per
hour
conserv
approach
safe
less
risk
hypoglycemia
higher
dosag
rate
may
requir
longer
period
time
dose
titrat
high
enough
level
control
hyperglycemia
even
lower
dosag
rate
insulin
report
recent
retrospect
report
describ
insulin
infus
dosag
iukg
per
hour
therefor
initi
insulin
infus
rate
iukg
per
hour
repres
reason
start
point
finetun
insulin
therapi
best
avoid
simultan
alter
insulin
infus
rate
parenter
nutrit
infus
rate
lead
rollercoast
ride
blood
glucos
concentr
rise
fall
wildli
delay
bodi
respons
chang
box
blood
glucos
monitor
perform
least
hourli
first
hour
initi
insulin
cri
hyperglycemia
blood
glucos
mgdl
persist
beyond
first
hour
insulin
therapi
insulin
infus
rate
may
increas
follow
hourli
blood
glucos
monitor
hour
procedur
increas
insulin
infus
rate
may
repeat
hyperglycemia
persist
convers
hypoglycemia
blood
glucos
mgdl
note
bolu
mlkg
dextros
solut
administ
intraven
minut
blood
glucos
level
reassess
everi
minut
least
minut
ensur
hypoglycemia
recur
hypoglycemia
recur
second
bolu
dextros
administ
insulin
infus
rate
decreas
close
monitor
requir
minut
ensur
hypoglycemia
recur
hyperglycemia
develop
chang
insulin
infus
rate
usual
necessari
steadi
state
achiev
blood
glucos
level
stabl
desir
rate
parenter
nutrit
administr
achiev
patient
reassess
indic
one
find
foal
becom
even
insulin
resist
requir
addit
insulin
administr
avoid
hyperglycemia
may
overal
deterior
patient
condit
accompani
increas
system
inflamm
insulin
therapi
discontinu
insulin
administr
rate
gradual
titrat
downward
parallel
parenter
nutrit
rate
substanti
lag
chang
insulin
infus
rate
patient
respons
chang
time
allow
account
lag
critic
foal
wean
insulin
infus
receiv
form
enter
nutrit
time
period
may
wise
wean
parenter
nutrit
insulin
longer
period
time
hour
would
requir
foal
receiv
parenter
nutrit
alon
prevent
glucos
derang
